0001019687-13-001918.txt : 20130515 0001019687-13-001918.hdr.sgml : 20130515 20130515163737 ACCESSION NUMBER: 0001019687-13-001918 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130515 DATE AS OF CHANGE: 20130515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRECISION OPTICS Corp INC CENTRAL INDEX KEY: 0000867840 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 042795294 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-10647 FILM NUMBER: 13847762 BUSINESS ADDRESS: STREET 1: 22 EAST BROADWAY CITY: GARDNER STATE: MA ZIP: 01440 BUSINESS PHONE: 978-630-1800 MAIL ADDRESS: STREET 1: 22 EAST BROADWAY CITY: GARDNER STATE: MA ZIP: 01440 FORMER COMPANY: FORMER CONFORMED NAME: PRECISION OPTICS CORPORATION INC DATE OF NAME CHANGE: 19930328 FORMER COMPANY: FORMER CONFORMED NAME: PRECISION OPTICS CORP INC DATE OF NAME CHANGE: 19600201 10-Q 1 peye_10q-033113.htm FORM 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

S   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2013

 

or

 

 £   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                     

 

Commission File Number: 001-10647

 

PRECISION OPTICS CORPORATION, INC.

(Exact name of registrant as specified in its charter)

 

Massachusetts 04-2795294
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

 

22 East Broadway, Gardner, Massachusetts 01440-3338

(Address of principal executive offices) (Zip Code)

 

(978) 630-1800

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes T   No £

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes T   No £

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  £   Accelerated filer £
         
Non-accelerated filer  £   Smaller reporting company S
(Do not check if a smaller reporting company)        

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes £   No T

 

The number of shares outstanding of the issuer’s common stock, par value $0.01 per share, at April 24, 2013 was 4,455,134 shares.

 

 

 
 

 

PRECISION OPTICS CORPORATION, INC.

 

Table of Contents

 

  Page
PART I — FINANCIAL INFORMATION  
Item 1. Financial Statements 2
Consolidated Balance Sheets 2
Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2013 and 2012 3
Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2013 and 2012 4
Notes to Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 9
Item 3. Quantitative and Qualitative Disclosures About Market Risk 13
Item 4. Controls and Procedures 13
   
PART II — OTHER INFORMATION  
Item 1. Legal Proceedings 14
Item 1A. Risk Factors 15
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15
Item 3. Defaults Upon Senior Securities 15
Item 4. Mine Safety Disclosures (Not applicable.) 15
Item 5. Other Information 15
Item 6. Exhibits 15

 

 

1
 

PART I. FINANCIAL INFORMATION

  

Item 1. Financial Statements.

   

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

   March 31,
2013
   June 30,
2012
 
ASSETS          
CURRENT ASSETS          
Cash and Cash Equivalents  $1,278,384   $145,923 
Accounts Receivable, net   283,074    341,900 
Inventories, net   843,275    682,900 
Prepaid Expenses   72,255    33,719 
Total Current Assets   2,476,988    1,204,442 
PROPERTY AND EQUIPMENT          
Machinery and Equipment   2,359,518    2,355,968 
Leasehold Improvements   553,596    553,596 
Furniture and Fixtures   148,303    148,303 
Vehicles   19,674    19,674 
    3,081,091    3,077,541 
           
Less: Accumulated Depreciation   (3,051,369)   (3,035,584)
Net Property and Equipment   29,722    41,957 
           
TOTAL ASSETS  $2,506,710   $1,246,399 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
10% Senior Secured Convertible Notes  $   $51,250 
Accounts Payable   371,836    410,316 
Customer Advances   3,300    6,387 
Accrued Employee Compensation   188,441    171,205 
Accrued Professional Services   57,984    62,000 
Accrued Warranty Expense   25,000    25,000 
Other Accrued Liabilities   11,360    912 
Total Current Liabilities   657,921    727,070 
STOCKHOLDERS’ EQUITY          
Common Stock, $0.01 par value -
Authorized - 50,000,000 shares; Issued and Outstanding – 4,455,134 shares at March 31, 2013 and 1,251,339 shares at June 30, 2012
   44,551    12,513 
Additional Paid-in Capital   41,921,209    39,009,215 
Accumulated Deficit   (40,116,971)   (38,502,399)
Total Stockholders’ Equity   1,848,789    519,329 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $2,506,710   $1,246,399 

 

 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

2
 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED

MARCH 31, 2013 AND 2012

(UNAUDITED)

 

   Three Months
Ended March  31,
   Nine Months
Ended March  31,
 
   2013   2012   2013   2012 
Revenues  $655,341   $382,264   $1,717,406   $1,380,787 
                     
Cost of Goods Sold   496,580    371,941    1,348,834    1,119,850 
                     
Gross Profit   158,761    10,323    368,572    260,937 
                     
Research and Development Expenses, net   159,472    198,608    533,424    498,842 
                     
Selling, General and Administrative Expenses   350,180    309,913    900,060    837,987 
                     
Gain on Sale of Assets   (897)   (7,308)   (4,599)   (9,457)
                     
Total Operating Expenses   508,755    501,213    1,428,885    1,327,372 
                     
Operating Loss   (349,994)   (490,890)   (1,060,313)   (1,066,435)
                     
Gain on Sale of Patents               2,276,286 
                     
Non-cash Provision for Claims for Liquidated Damages           (629,000)       -
                     
Other Income       1    76,149    534 
                     
Interest Expense       (1,250)   (1,408)   (28,958)
                     
Net Income (Loss)  $(349,994)  $(492,139)  $(1,614,572)  $1,181,427 
                     
Income (Loss) Per Share:                    
     Basic  $(0.08)  $(0.40)  $(0.50)  $1.04 
     Diluted  $(0.08)  $(0.40)  $(0.50)  $0.97 
                     
Weighted Average Common Shares Outstanding:            
     Basic   4,279,467    1,245,339    3,211,274    1,135,432 
     Diluted   4,279,467    1,245,339    3,211,274    1,243,527 

 

 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

3
 

PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED

MARCH 31, 2013 AND 2012

(UNAUDITED)

 

   Nine Months
Ended March 31,
 
   2013   2012 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net Income (Loss)  $(1,614,572)  $1,181,427 
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -          
Depreciation and Amortization   15,785    18,225 
Gain on Sale of Patents       (2,276,286)
Gain on Sale of Assets   (4,599)   (9,457)
Gain on Settlement of Accounts Payable   (76,149)    
Stock-based Compensation Expense   73,913    52,160 
Non-cash Provision for Settlement of Claims for Liquidated Damages   629,000     
Non-cash Interest Expense   1,250    28,958 
Changes in Operating Assets and Liabilities -          
Accounts Receivable, net   58,826    29,345 
Inventories   (160,375)   (32,065)
Prepaid Expenses   (38,536)   (755)
Accounts Payable   37,669    (414,614)
Customer Advances   (3,087)   (13,673)
Accrued Expenses   23,668    123,466 
Net Cash Used In Operating Activities   (1,057,207)   (1,313,269)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Net Proceeds from Sale of Patents       2,463,171 
Purchases of Property and Equipment   (3,550)    
Additional Patent Costs       (1,724)
Proceeds from Sale of Assets   4,599    9,457 
Net Cash Provided By Investing Activities   1,049    2,470,904 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Gross Proceeds from September 2012 Private Placement of Common Stock and Warrants   2,500,015     
Private Placement Expenses Incurred and Paid as of March 31, 2013   (308,896)    
Proceeds From Exercise of Warrants to Purchase Common Stock (50,000 Shares)   50,000     
Payment of Principal and Interest on 10% Senior Convertible Notes   (52,500)   (740,972)
Net Cash Provided by (Used In) Financing Activities   2,188,619    (740,972)
           
NET INCREASE IN CASH AND CASH EQUIVALENTS   1,132,461    416,663 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   145,923    19,556 
           
CASH AND CASH EQUIVALENTS, END OF PERIOD  $1,278,384   $436,219 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash Paid for Income Taxes  $912   $912 

 

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:        
Issuance of Common Stock and Warrants for Settlement of Claims for Liquidated Damages (370,000 shares and 370,000 warrants)  $629,000   $ 
Issuance of Common Stock to Satisfy Deferred Compensation Obligations (245,326 shares)  $   $674,645 

 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

4
 

PRECISION OPTICS CORPORATION, INC.

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

 

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation and Operations

 

The accompanying consolidated financial statements include the accounts of Precision Optics Corporation, Inc. and its wholly-owned subsidiaries (the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation.

 

These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the third quarter of the Company’s fiscal year 2013. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s consolidated financial statements for the year ended June 30, 2012, together with the Report of Independent Registered Public Accounting Firm filed under cover of the Company’s 2012 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

 

Use of Estimates

 

The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Income (Loss) Per Share

 

Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss (adjusted by adding back interest expense on the Company’s 10% Senior Secured Convertible Notes issued on June 25, 2008, if applicable) by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options, warrants and shares issuable upon conversion of the 10% Senior Secured Convertible Notes. For the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013, the effect of such securities was anti-dilutive and not included in the diluted calculation because of the net loss generated in those periods.

 

The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:

 

   Three Months
Ended March 31
   Nine Months
Ended March 31
 
   2013   2012   2013   2012 
                 
Net Income (Loss) – Basic  $(349,994)  $(492,139)  $(1,614,572)  $1,181,427 
Interest Expense on Senior Convertible Notes               28,958 
Net Income (Loss) – Diluted  $(349,994)  $(492,139)  $(1,614,572)  $1,210,385 
                     
Basic Weighted Average Shares Outstanding   4,279,467    1,245,339    3,211,274    1,135,432 
Potentially Dilutive Securities               108,095 
Diluted Weighted Average Shares Outstanding   4,279,467    1,245,339    3,211,274    1,243,527 
                     
Income (Loss) Per Share                    
Basic  $(0.08)  $(0.40)  $(0.50)  $1.04 
Diluted  $(0.08)  $(0.40)  $(0.50)  $0.97 

 

The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 3,435,000 and 811,000 for the three months ended March 31, 2013 and 2012, respectively, and approximately 3,435,000 and 620,000 for the nine months ended March 31, 2013 and 2012, respectively.

 

5
 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets.

 

2.  INVENTORIES

 

Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:

 

    March 31,
2013
    June 30,
2012
 
Raw Materials   $ 298,244     $ 277,392  
Work-In-Progress     348,588       289,748  
Finished Goods     196,443       115,760  
Total Inventories   $ 843,275     $ 682,900  

 

3. 10% SENIOR SECURED CONVERTIBLE NOTES

 

On June 25, 2008, the Company entered into a purchase agreement, as amended on December 11, 2008, with institutional and other accredited investors (the “Investors”) pursuant to which it sold a total of $600,000 of 10% Senior Secured Convertible Notes (the “Notes”). The Company repaid the outstanding principal and accrued interest respectively owed to Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. on December 15, 2011, and repaid the outstanding obligations owed to Mr. Arnold Schumsky on September 28, 2012. As of September 28, 2012, the Notes held by the Investors have been satisfied in full and the obligations thereunder have been terminated.

 

The Notes consisted of the following:

  

   March 31,
2013
   June 30,
2012
 
10% Senior Secured Convertible Notes issued on June 25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest were due at maturity, September 30, 2012  $   $50,000 
Accrued interest—10% coupon due on September 30, 2012       1,250 
   $   $51,250 

   

4. STOCK-BASED COMPENSATION

 

Stock-based compensation costs recognized during the quarters ended March 31, 2013 and 2012 amounted to $52,898 and $34,260, respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $50,440; 2012 - $33,360), research and development expenses (2013 - $550; 2012 - $0) and cost of goods sold (2013 - $1,908; 2012 - $900). Stock-based compensation costs recognized during the nine month periods ended March 31, 2013 and 2012 amounted to $73,913 and $52,160, respectively, and were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $66,539; 2012 - $45,860), research and development expenses (2013 - $1,650; 2012 - $0) and cost of goods sold (2013 - $5,724; 2012 - $6,300). No compensation has been capitalized because such amounts would have been immaterial.  No income tax provision was recorded in the third quarter or first nine months of fiscal years 2013 or 2012 because of the losses generated or the availability of loss carryforwards to offset any anticipated taxable income.

 

There were no stock option grants or cancellations during the quarter ended March 31, 2013.

 

As of March 31, 2013, the unrecognized compensation costs related to options vesting of $167,442 will be recognized over a period of approximately 1.25 years.

 

6
 

Information related to the stock options outstanding as of March 31, 2013 is as follows:

 

Range of Exercise
Prices
    Number of
Shares
    Weighted-Average
Remaining
Contractual
Life (years)
    Weighted-Average
Exercise Price
    Exercisable
Number
of Shares
    Exercisable
Weighted-Average
Exercise Price
 
$ 1.20       207,800       8.93     $ 1.20       57,800     $ 1.20  
$ 0.85       9,000       9.76       0.85       9,000       0.85  
$ 0.55       51,000       8.87       0.55       20,334       0.55  
$ 0.27       40,000       8.29       0.27       20,000       0.27  
$ 1.35       1,200       6.65       1.35       1,200       1.35  
$ 1.25       1,200       5.66       1.25       1,200       1.25  
$ 6.25       1,600       3.67       6.25       1,600       6.25  
$ 7.75       1,200       4.66       7.75       1,200       7.75  
$ 11.50       800       2.67       11.50       800       11.50  
$ 13.75       50,427       3.11       13.75       50,427       13.75  
$ 20.75       37,360       2.21       20.75       37,360       20.75  
$ 0.27–$20.75       401,587       7.46     $ 4.48       200,921     $ 7.93  

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of March 31, 2013 was $11,200 and $5,600, respectively.

 

5. SALE OF STOCK

 

On September 28, 2012, the Company closed on agreements with accredited investors (the “Investors”) for the sale and purchase of units consisting of an aggregate of (i) 2,777,795 shares of the Company’s common stock, and (ii) warrants to purchase an aggregate of 1,944,475 shares of common stock, at a per unit price of $0.90. Each unit consisted of one share of common stock and 70% warrant coverage. The warrants have an exercise price of $1.25 per share, subject to adjustment and a call provision if certain market price targets are reached, an expiration date of September 28, 2017, and are exercisable in whole or in part, at any time prior to expiration. Certain directors and officers participated in the offering and purchased a total aggregate amount of approximately $80,000 of units in the offering.

 

The Company received $2.5 million in gross proceeds from the offering. The Company retained Loewen, Ondaatje, McCutcheon USA LTD as the exclusive placement agent for the offering. In addition to the payment of certain cash fees upon closing of the offering, the Company issued a warrant to the placement agent to purchase up to 194,446 shares of common stock on substantially similar terms to the warrants issued in the offering, except that the placement agent warrant has an exercise price of $0.95 per share. The Company anticipates using the net proceeds from the offering to fund start-up costs associated with the previously-announced order for micro endoscopes as well as other recently received orders for new products in addition to working capital needs and for general corporate purposes.

 

In conjunction with the offering, the Company also entered into a registration rights agreement dated September 28, 2012 with the Investors, whereby it was obligated to file a registration statement with the Securities and Exchange Commission (the “SEC”) on or before thirty calendar days after September 28, 2012 to register the resale by the Investors of the 2,777,795 shares of common stock purchased in the offering, and the 1,944,475 shares of common stock underlying the warrants purchased in the offering. The Company filed a registration statement with the SEC on October 26, 2012, prior to the filing deadline. The registration statement became effective on December 14, 2012. The Company is obligated to continue to keep the securities registered and, in the event the Company does not comply with such provision of the registration rights agreement, it may have to pay damages to the Investors.

 

In conjunction with the offering, certain anti-dilution provisions of the warrants issued in conjunction with the Company’s June 25, 2008 financing transaction were triggered. As a result, the number of existing June 25, 2008 warrants increased from 318,621 to 469,831 and the related exercise price of the warrants decreased from $1.74 per share to $1.18 per share. The June 25, 2008 warrants expire on June 25, 2015.

 

Pursuant to the Tax Reform Act of 1986, the utilization of net operating loss carryforwards and other tax benefits are subject to an annual limitation if a cumulative change of ownership of more than 50% occurs over a three-year period. As a result of the September 2012 private placement of the Company’s common stock, the Company believes it may have triggered significant limitations on the utilization of those tax attributes. The limitations, if triggered, would allow the use of the value of approximately $34,000 of Federal carryforward losses annually for the next twenty years, and the same amount for state purposes for 20 years.

 

7
 

In December 2012, stock purchase warrants with an exercise price of $1.00 per share for 50,000 shares of the Company’s common stock were exercised, and accordingly, 50,000 shares of restricted common stock were issued.

 

6. SALE OF ASSETS

 

During the nine months ended March 31, 2013 and 2012, respectively, the Company sold equipment that was previously written off for proceeds totaling $4,599 and $9,457, respectively, and recorded a gain of $4,599 and $9,457, respectively, which is included within operating expenses in the accompanying consolidated statements of operations.

 

7. SALE OF PATENTS

 

On July 28, 2011, the Company entered into an asset purchase agreement with Intuitive Surgical Operations, Inc. (“Intuitive Surgical”), in which it received gross proceeds of $2,500,000 (less transaction expenses of  $36,829) in connection with the sale of certain intellectual property. Pursuant to the agreement, the Company agreed to assign to Intuitive Surgical all of its currently issued and non-expired patents and pending patent applications, and Intuitive Surgical agreed to grant back to the Company a royalty-free, worldwide license to the patents in all fields outside of medical robotics, except in certain exceptional circumstances.

 

In connection with this agreement, the Company recorded a gain on the sale of such intellectual property of $2,276,286 in the quarter ended September 30, 2011.

  

8. SETTLEMENT OF ACCOUNTS  PAYABLE

 

In December 2012, the Company settled $106,149 of accounts payable with a vendor for a negotiated payment of $30,000, and recorded a gain of $76,149. The gain is included within other income for the nine months ended March 31, 2013 in the accompanying consolidated statements of operations.  

 

9. CLAIMS FOR LIQUIDATED DAMAGES

 

Settlement Agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P.

 

On January 17, 2013, the Company received a demand letter from two of its stockholders, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. (along with Special Situations Fund III QP, L.P., “Special Situations”). The letter alleged that the Company failed to maintain a current registration statement for the sale of stock purchased by Special Situations pursuant to registration rights agreements entered into with the Company on February 1, 2007 and June 25, 2008, and sought prompt payment of $719,100 as liquidated damages and an amendment to the terms of certain warrants purchased in 2008. A registration statement covering the shares in question is currently effective.

 

On February 12, 2013, the Company entered into a settlement agreement with Special Situations (the “Settlement Agreement”). Without agreeing to the alleged damages, the Company entered into the Settlement Agreement in order to resolve the claim without requiring a cash payment or extended distraction of its resources away from operational activities. Under the terms of the Settlement Agreement, Special Situations agreed to forego their claims for cash damages. In return, the Company agreed to: (a) issue an aggregate of (i) 350,000 shares of common stock, and (ii) warrants to purchase an aggregate of 350,000 shares of common stock (the “Securities”), and (b) amend the expiration date of the warrants issued to Special Situations in conjunction with the Company’s June 25, 2008 private placement (the “2008 Warrants”), as payment in full of the alleged damages sought by Special Situations. The Securities were issued on February 12, 2013. The expiration date of the 2008 Warrants was amended from June 25, 2015 to May 11, 2017. The new warrants issued in connection with the Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration.

 

In conjunction with the Settlement Agreement, the Company also entered into a registration rights agreement dated February 12, 2013 with Special Situations, whereby it is obligated to register the resale by Special Situations of the Securities, consisting of 350,000 shares of common stock and the 350,000 shares of common stock underlying the warrants issued on February 12, 2013. A registration statement covering the Securities was declared effective on April 26, 2013.

 

Letter From one of the Company’s Stockholders

 

On March 21, 2013, the Company received a letter from one of its stockholders demanding either (i) return of its capital investment in the Company and rescission of the purchase agreement entered into by the Company and the stockholder in September 2012, or (ii) compensation for its alleged damages in the amount of $179,316. The stockholder claims that the Company’s settlement agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., disclosed in the Company’s Current Report on Form 8-K filed February 13, 2013, prompted the stockholder’s letter.

 

8
 

To the Company’s knowledge, the stockholder has not filed a lawsuit. The Company does not believe that the stockholder’s claims have any merit. In the event the stockholder files a lawsuit, it intends to vigorously defend against any claims.

 

Settlement Agreement with Joel Pitlor

 

On February 12, 2013, the Company entered into a settlement agreement with one of its directors and stockholders, Joel Pitlor (the “Pitlor Settlement Agreement”). Under the terms of the Pitlor Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Pitlor under the registration rights agreement the Company entered into with Mr. Pitlor, and other parties, on February 1, 2007. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Pitlor Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Pitlor Settlement Agreement.

 

By virtue of Mr. Pitlor’s directorship with the Company, he is considered a related party of the Company under federal securities law. The Company’s Board of Directors has acknowledged that Mr. Pitlor’s entry into the Pitlor Settlement Agreement is a related party transaction and has approved such transaction.

 

Settlement Agreement with Arnold Schumsky

 

On February 12, 2013, the Company also entered into a settlement agreement with one of its stockholders, Arnold Schumsky (the “Schumsky Settlement Agreement”). The terms of the Schumsky Settlement Agreement and the accompanying Form of Warrant of the Schumsky Settlement Agreement are substantially similar to the terms of the Pitlor Settlement Agreement and the accompanying Form of Warrant of the Pitlor Settlement Agreement. Under the terms of the Schumsky Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Schumsky under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on February 1, 2007 and under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on June 25, 2008. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Schumsky Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Schumsky Settlement Agreement.

 

The Company has estimated the fair value of the non-cash consideration exchanged for settlement of claims with Special Situations, Mr. Pitlor, and Mr. Schumsky on February 12, 2013 to be a total of $629,000 as of December 31, 2012, and has recorded this amount as a non-cash expense and current liability in its consolidated financial statements as of December 31, 2012, and for the quarter and six months then ended.

 

The Company used the Black-Scholes option-pricing model for determining the estimated fair value of the new warrants to be issued to Special Situations, Mr. Pitlor, and Mr. Schumsky, and for determining the value of the extension of the maturity date of the 2008 Warrants held by Special Situations. The Company valued its issued common stock as of the closing price of the stock at December 31, 2012, which was $0.85 per share.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and notes to those statements included elsewhere in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 and our audited consolidated financial statements for the year ended June 30, 2012 included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

 

This Quarterly Report on Form 10-Q contains forward-looking statements. When used in this report, the words “expects,” “anticipates,” “suggests,” “believes,” “intends,” “estimates,” “plans,” “projects,” “continue,” “ongoing,” “potential,” “expect,” “predict,” “believe,” “intend,” “may,” “will,” “should,” “could,” “would” and similar expressions are intended to identify forward-looking statements. You should not place undue reliance on these forward-looking statements.  Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in this report, the risks described in our Annual Report on Form 10-K for the year ended June 30, 2012 and other reports we file with the Securities and Exchange Commission.  Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made.  We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.

 

9
 

Overview

 

We have been developing and manufacturing advanced optical instruments since 1982. Today, the vast majority of our business is the design and manufacture of high-quality medical devices and approximately 10% of our business is the design and manufacture of military and industrial products. Our medical instrumentation line includes traditional endoscopes and endocouplers as well as other custom imaging and illumination products for use in minimally invasive surgical procedures. Much of our recent development efforts have been targeted at the development of next generation endoscopes. For the last ten years, we have funded internal research and development programs to develop next generation capabilities for designing and manufacturing 3D endoscopes and very small Microprecision™ lenses, anticipating future requirements as the surgical community continues to demand smaller and more enhanced imaging systems for minimally invasive surgery. Our unique proprietary technology in these areas, combined with recent developments in the areas of 3D displays and millimeter sized image sensors, has allowed us to begin commercialization of these technologies. We believe that new products based on these technologies provide enhanced imaging for existing surgical procedures and can enable development of many new procedures. While we have continued to provide custom optics solutions to our medical device company customers, we have simultaneously focused significant development efforts on further advancement of proprietary technology for 3D endoscopy and Microprecision™ optical components and micro medical camera assemblies.

 

We incorporated in Massachusetts in December 1982 and have been publicly-owned since November 1990. References to our Company contained herein include our two wholly-owned subsidiaries, Precise Medical, Inc. and Wood’s Precision Optics Corporation, Limited, except where the context otherwise requires. Our website is www.poci.com. Information contained on our website does not constitute part of this report.

 

Critical Accounting Policies and Estimates

 

This management’s discussion and analysis of financial condition and results of operations are based upon our unaudited consolidated financial statements, which have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

There have been no significant changes in our critical accounting policies as disclosed in the Notes to our Financial Statements contained in our Annual Report on Form 10-K for the year ended June 30, 2012 filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

 

Results of Operations

 

Our total revenues for the quarter ended March 31, 2013, the third quarter of our fiscal year 2013, were $655,341, as compared to $382,264 for the same period in the prior year, an increase of $273,077, or 71.4%, and as compared to $498,667 for the quarter ended December 31, 2012, a sequential increase of $156,674, or 31.4%. Our total revenues for the nine months ended March 31, 2013 were $1,717,406, as compared to $1,380,787 for the same period in the prior year, which reflects an increase of $336,619, or 24.4%. The increase in revenues for the quarter and nine months ended March 31, 2013 as compared to the same periods in the prior year was primarily due to higher unit volume sales of the advanced surgical visualization system used in spinal surgery, partially offset by lower unit volume sales of endoscopes, endocouplers and micro optics.

 

Revenues from our largest customers, as a percentage of our total revenues, for the nine months ended March 31, 2013 and 2012, were as follows:

 

   2013   2012 
Customer A   55%    15% 
Customer B   15    36 
Customer C       11 
All Others   30    38 
    100%    100% 

  

No other customer accounted for more than 10% of our revenues during those periods.

 

Gross profit for the quarter ended March 31, 2013 was $158,761, as compared to $10,323 for the same period in the prior year, which reflects an increase of $148,438. Gross profit for the quarter ended March 31, 2013 as a percentage of our revenues was 24.2%, an increase from the gross profit percentage of 2.7% for the same period in the prior year. Gross profit for the nine months ended March 31, 2013 was $368,572, as compared to $260,937 for the same period in the prior year, which reflects an increase of $107,635.

 

10
 

Gross profit for the nine months ended March 31, 2013 as a percentage of our revenues was 21.5%, an increase from the gross profit percentage of 18.9% for the same period in the prior year. The increases in our gross profit percentages for the quarter and nine months ended March 31, 2013 were primarily due to higher overall unit sales volume, partially offset by higher consulting expenses, less favorable product mix and certain nonrecurring manufacturing startup expenses related to the introduction of new products as compared to the same periods in the prior year. Our quarterly gross profit and gross profit percentage depend on a number of factors, including overall sales volume and mix of products sold among others, and therefore vary from quarter to quarter.

 

Research and development expenses were $159,472 for the quarter ended March 31, 2013, as compared to $198,608 for the same period in the prior year, which reflects a decrease of $39,136, or 19.7%. The decrease in research and development expenses for the quarter ended March 31, 2013 as compared to same period in the prior year was primarily due to lower labor and materials costs incurred on product development activities, and by increased reimbursements received from customers for research and development activities. Quarterly research and development expenses depend on our assessment of new product opportunities and available resources. Research and development expenses were net of reimbursement of related costs of $15,250 and $11,822 during the quarters ended March 31, 2013 and 2012, respectively. Research and development expenses were $533,424 for the nine months ended March 31, 2013, as compared to $498,842 for the same period in the prior year, which reflects an increase of $34,582, or 6.9%.  The increase in the nine month period ended March 31, 2013 as compared to the same period in the prior year was primarily due to higher labor and materials costs incurred on product development activities, partially offset by increased reimbursements received from customers for such activities. Research and development expenses were net of reimbursement of related costs of $76,230 and $49,252 during the nine months ended March 31, 2013 and 2012, respectively.

 

Selling, general and administrative expenses were $350,180 for the quarter ended March 31, 2013, as compared to $309,913 for the same period in the prior year, which reflects an increase of $40,267, or 13.0%. The increase in selling, general and administrative expenses for the quarter ended March 31, 2013 as compared to the same period in the prior year was primarily due to higher stock-based compensation expenses. Selling, general and administrative expenses were $900,060 for the nine months ended March 31, 2013, as compared to $837,987 for the same period in the prior year, which reflects an increase of $62,073, or 7.4%. The increase in the nine month period ended March 31, 2013 as compared to the same period in the prior year was primarily due to higher stock-based compensation, consulting and insurance expenses.

 

In December 2012, we settled $106,149 of accounts payable with a vendor for a negotiated payment of $30,000, and recorded a gain of $76,149. The gain is included within other income for the nine months ended March 31, 2013 in the accompanying consolidated statements of operations.  

 

No income tax provision was recorded in the third quarter or nine months of fiscal years 2013 or 2012 because of the availability of loss carryforwards to offset any anticipated taxable income in those fiscal years.

 

Liquidity and Capital Resources

 

In July 2011, we received $2.5 million in connection with our entry into an asset purchase agreement with Intuitive Surgical Operations, Inc. This influx of capital allowed us to retire a substantial portion of outstanding long term debt and to satisfy operating cash requirements through September 2012.

 

On September 28, 2012, we closed on agreements with accredited investors (the “Investors”) for the sale and purchase of units consisting of an aggregate of (i) 2,777,795 shares of our common stock, and (ii) warrants to purchase an aggregate of 1,944,475 shares of common stock, at a per unit price of $0.90. Each unit consisted of one share of common stock and 70% warrant coverage. The warrants have an exercise price of $1.25 per share, subject to adjustment and a call provision if certain market price targets are reached, an expiration date of September 28, 2017, and are exercisable in whole or in part, at any time prior to expiration. We received $2.5 million in gross proceeds from the offering. Certain directors and officers participated in the offering and purchased a total aggregate amount of approximately $80,000 of units in the offering.

  

We intend to build upon recent successes in operational results, technology development and new product introductions. We believe the following technology areas continue to represent significant opportunities for future sales growth of our Company:

 

  Microprecision™ optical elements and micro medical camera assemblies with sizes on the order of 1 mm and smaller, that enable the introduction of imaging capabilities in locations in the body previously inaccessible; and
     
  next generation handheld 3D endoscopes that provide high definition 3D images for use in minimally invasive surgery.

 

We compete in a highly technical, very competitive and in most cases, price driven segment of the medical instrument marketplace where products can take years to develop and introduce to distributors and end users. Furthermore, research and development, manufacturing, marketing and distribution activities are strictly regulated by the FDA, ISO and other regulatory bodies that, while intended to enhance the ultimate quality and functionality of products produced, can contribute to the significant cost and time needed to maintain existing products and develop and introduce product enhancements and new product innovations.

 

We have traditionally funded working capital needs through product sales, management of working capital components of our business, and by cash received from public and private offerings of our common stock, warrants to purchase shares of our common stock and convertible notes. We have incurred quarter to quarter operating losses during our efforts to develop current products including Microprecision™ optical elements, micro medical camera assemblies and 3D endoscopes. Our management expects that such operating losses will continue until sales increase to breakeven and profitable levels. Our management also believes that the opportunities represented by these products have the potential to generate sales increases to achieve breakeven and profitable results.

 

11
 

During the quarter ended March 31, 2013, we incurred a net loss from operations of $349,994 and used cash in operating activities of $343,539, a $142,003 improvement from the cash used in operating activities of $485,542 recorded for the previous quarter ended December 31, 2012. As of March 31, 2013, cash and cash equivalents were $1,278,384, accounts receivable were $283,074, and current liabilities were $657,921.

 

Capital equipment expenditures during the nine months ended March 31, 2013 were $3,550. Future capital equipment expenditures will be dependent upon future sales and success of ongoing research and development efforts.

 

Contractual cash commitments for the fiscal years subsequent to March 31, 2013 are summarized as follows:

 

   2013   2014   Thereafter   Total 
Operating Leases  $11,833   $17,180   $6,136   $35,149 
                     

We have contractual cash commitments related to open purchase orders as of March 31, 2013 of approximately $186,000.

 

Trends and Uncertainties That May Affect Future Results

 

During fiscal year 2010 after implementing a number of changes to reduce cash usage and increase sales and profitability, our cash flow was positive for the first time in many years. In fiscal year 2011, the major focus of our senior management shifted to finding a long-term solution to our obligations under the 10% Senior Secured Convertible Notes (the “Notes”) issued on June 25, 2008, which initially became due just before the beginning of fiscal year 2011. While we continued to work during fiscal year 2011 to advance product development and sales and marketing efforts, the requirement to find a solution for the Notes while simultaneously continuing operations of our Company with limited capital resources resulted in an overall reduction in sales volume and delay of business plans. With the consummation of an asset purchase agreement with Intuitive Surgical in July 2011, we received sufficient cash to retire the Notes, and to provide working capital for our Company. On September 28, 2012, we received $2.5 million in connection with our completion of an offering of stock and warrants and we anticipate the proceeds will be used for working capital purposes and for the development of new products.

 

We are excited about the continued development, commercialization, and market acceptance of our new products and technical innovations based upon our unique proprietary technology. As previously announced, we received a follow-on purchase order for $660,000 for custom-designed endoscopes to be manufactured and delivered over a sixteen-month period beginning in July 2013. The endoscopes represent two distinct designs which include various aspects of our unique proprietary MicroprecisionTM lens technology and optical visualization system expertise. As previously disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission on April 18, 2012, we accepted an order from a customer to purchase endoscopes for a total purchase amount of $1,032,000 (the “April 2012 Order”). We are continuing to complete pre-production activities to enable shipments against our previously announced orders, including the April 2012 Order, for products incorporating Microprecision™ technology for very small endoscopes and micro medical cameras with diameters on the order of 1 millimeter and smaller. Nearly all validation testing has been successfully completed in connection with the pre-production requirements for the April 2012 Order for small endoscopes. We expect production shipments of this product to begin within the next few months.

 

We have also focused recent operational efforts on sales and marketing activities intended to broaden awareness of the benefits of our new technology platforms, which we believe are ready for general application to medical device projects requiring surgery-grade visualization from sub-millimeter sized devices and handheld 3D endoscopy. During January and February of 2013, we visited three large medical device companies who are existing customers of ours and conducted successful demonstrations of our latest technology and products. All three of these meetings have led to additional, ongoing discussions related to near- and long-term business opportunities, including, in all three cases, customer-initiated requests for quotations for new products based on our proprietary technology.

 

From February 5 through February 7, 2013, we attended the SPIE Photonics West Conference in San Francisco, California, where we exhibited our latest technology, and from February 12 through February 14, 2013, we exhibited our technology at the Medical Design & Manufacturing (MD&M) West show located in Anaheim, California. Our new technology has been well received during these recent trade shows, which have already resulted in follow on discussions with a number of existing and new potential customers.

 

Due to the introductory stage of many of our new products and the unpredictable timing of orders from customers, it is difficult to predict with certainty the detailed rate of future revenue growth. However, during the last 12 months, we have received significant new orders for a number of new products including the April 2012 Order for small endoscopes and an approximate $250,000 order for micro medical camera assemblies, both of which rely on our Microprecision™ lens technology. We believe these orders will help to increase our revenues in future quarters. Also, we expect that current discussions with existing and new potential customers could lead to increases in our revenues. To continue to support orders for new products as well as ongoing and future discussions, we intend to continue to develop and commercialize new products and technical innovations, including:

 

12
 

 

  new components and instruments utilizing our patented Microprecision™ lens technology for optical components and micro medical camera assemblies with sizes on the order of 1 mm and smaller; and
     
  new handheld 3D endoscopes for use in minimally invasive surgery.

 

Over the past few years, we have implemented significant changes in new product and technology development by shifting the emphasis of research and development efforts from developing underlying technologies to commercializing the applications of these new technologies. These efforts have already been realized to some degree in the area of Microprecision™ lenses with ongoing shipments now in place and with shipments against new orders already received for micro medical camera assemblies expected to begin in the next few months. While most of our current orders for Microprecision™ lenses support medical applications, we are now beginning to explore additional applications including those in the defense and surveillance markets.

 

We have developed and manufactured prototypes of a new 3D endoscope with high definition quality imaging and 10 mm diameter for use in general laparoscopic surgery. This next generation 3D endoscope has been evaluated by a number of medical professionals and has been received enthusiastically. We believe that with the advent of commercially available high quality flat panel 3D displays, hand-held 3D endoscopy represents an opportunity for sales growth for our Company.

 

For the nine months ended March 31, 2013, revenues from our largest customer were 55% of total sales, as compared to 15% of total sales for the same period in the prior year. The concentration of sales to certain significant customers may fluctuate depending on factors such as the magnitude and the timing of receipt and fulfillment of customer orders, and may vary significantly from period to period. However, we believe that the introduction of new products with new customers, including those discussed above, will reduce the influence of any one customer on sales in any specific period.

 

Off-Balance Sheet Arrangements

 

We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

  

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

As a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

 

Item 4. Controls and Procedures.

 

Management’s Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and our Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures, including internal control over financial reporting, were not effective, as of March 31, 2013, to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended (i) is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are intended to be designed to provide reasonable assurance that such information is accumulated and communicated to our management. Based on this evaluation, our management concluded that our internal control over financial reporting was not effective as of March 31, 2013.

 

The following is a description of two material weaknesses in our internal control over financial reporting:

 

Segregation of Duties: As previously disclosed in our annual reports on Form 10-K for the fiscal years ended June 30, 2008, 2009, 2010, 2011, and 2012, our management identified a control deficiency during the 2008 fiscal year because we lacked sufficient staff to segregate accounting duties. We believe the control deficiency resulted primarily because we have the equivalent of one and one-half persons performing all accounting-related on-site duties. As a result, we did not maintain adequate segregation of duties within our critical financial reporting applications, the related modules and financial reporting processes. This control deficiency could result in a misstatement of balance sheet and income statement accounts in our interim or annual consolidated financial statements that would not be detected. Accordingly, management has determined that this control deficiency constitutes a material weakness.

 

13
 

To address and remediate the material weakness in internal control over financial reporting described above, beginning with the quarter ended September 30, 2008, we instituted a procedure whereby our Chief Executive Officer, our Chief Financial Officer and other members of our Board of Directors perform a higher level review of the quarterly reports on Form 10-Q and annual reports on Form 10-K prior to filing.

 

We believe that the step outlined above strengthens our internal control over financial reporting and mitigates the material weakness described above. As part of our assessment of internal control over financial reporting for the quarter ended March 31, 2013, our management has evaluated this additional control and has determined that it is operating effectively.

 

Inventory Valuation: As previously disclosed in our annual reports on Form 10-K for the fiscal years ended June 30, 2009, 2010, 2011 and 2012, we reported a material weakness with respect to the valuation of our inventories. Specifically, the amounts used to value our inventory at June 30, 2009 with respect to overhead rates and purchased items were often inconsistent with the supporting documentation, due to year-to-year changes in overhead rates and costs of purchased items that were not properly reflected in inventory valuation. Accordingly, management had determined that this control deficiency constituted a material weakness as of June 30, 2009. One audit adjustment of approximately $58,000 to our audited financial statements as of June 30, 2011 was necessary as a result of this condition.

 

To address and remediate the material weakness in internal control over financial reporting described above, beginning in the quarter ended September 30, 2009 and continuing through the quarter ended March 31, 2013, we implemented procedures to improve our inventory controls and documentation surrounding inventory valuation for overhead rates, and performed procedures to ensure that the pricing of inventory items was consistent with the supporting documentation. We believe that the step outlined above strengthens our internal control over financial reporting and mitigates the material weakness described above.

 

We intend to continue to remediate material weaknesses and enhance our internal controls but cannot guarantee that our efforts will result in remediation of our material weaknesses or that new issues will not be exposed in this process.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2013, which is covered by this quarterly report on Form 10-Q, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

     

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

Settlement Agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P.

 

As previously disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission on January 24, 2013, we received a demand letter from two of our stockholders, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. (along with Special Situations Fund III QP, L.P., “Special Situations”) on January 17, 2013. The letter alleged that we failed to maintain a current registration statement for the sale of stock purchased by Special Situations pursuant to registration rights agreements entered into with us on February 1, 2007 and June 25, 2008, and sought prompt payment of $719,100 as liquidated damages and an amendment to the terms of certain warrants purchased in 2008. A registration statement covering the shares in question is currently effective.

 

On February 12, 2013, we entered into a settlement agreement with Special Situations (the “Settlement Agreement”). Without agreeing to the alleged damages, we entered into the Settlement Agreement in order to resolve the claim without requiring a cash payment or extended distraction of our resources away from operational activities. Under the terms of the Settlement Agreement, Special Situations agreed to forego their claims for cash damages. In return, we agreed to: (a) issue an aggregate of (i) 350,000 shares of our common stock, and (ii) warrants to purchase an aggregate of 350,000 shares of our common stock (the “Securities”), and (b) amend the expiration date of the warrants issued to Special Situations in conjunction with our June 25, 2008 private placement (the “2008 Warrants”), as payment in full of the alleged damages sought by Special Situations. The Securities were issued on February 12, 2013. The expiration date of the 2008 Warrants was amended from June 25, 2015 to May 11, 2017. The new warrants issued in connection with the Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration.

 

In conjunction with the Settlement Agreement, we also entered into a registration rights agreement dated February 12, 2013 with Special Situations, whereby we were obligated to register the resale by Special Situations of the Securities, consisting of 350,000 shares of our common stock and the 350,000 shares of our common stock underlying the warrants issued on February 12, 2013. A registration statement covering the Securities was declared effective on April 26, 2013.

 

14
 

Letter From one of our Stockholders

 

On March 21, 2013, we received a letter from one of our stockholders demanding either (i) return of its capital investment in our Company and rescission of the purchase agreement entered into by us and the stockholder in September 2012, or (ii) compensation for its alleged damages in the amount of $179,316. The stockholder claims that our settlement agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., disclosed in our Current Report on Form 8-K filed February 13, 2013, prompted the stockholder’s letter.

 

To our knowledge, the stockholder has not filed a lawsuit. We do not believe that the stockholder’s claims have any merit. In the event the stockholder files a lawsuit, we intend to vigorously defend against any claims.

 

Our Company, on occasion, may also be involved in other legal matters arising in the ordinary course of our business. While management believes that such matters are currently insignificant, matters arising in the ordinary course of business for which we are or could become involved in litigation may have a material adverse effect on our business, financial condition or results of operations. We are not aware of any pending or threatened litigation against us or our officers and directors in their capacity as such that could have a material impact on our operations or finances, other than as set forth above.

 

Item 1A. Risk Factors.

 

There have been no material changes from the risk factors previously disclosed in our annual report on Form 10-K for the fiscal year ended June 30, 2012, as filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On February 15, 2013, we issued 6,000 unregistered shares of our common stock to a consultant as consideration for consulting services, and such shares were valued at $4,740.

 

With respect to the issuance of securities described above, we relied on the Section 4(2) exemption from securities registration under the federal securities laws for transactions not involving any public offering. No advertising or general solicitation was employed in offering the securities. The securities were issued to an accredited investor. The securities were offered for investment purposes only and not for the purpose of resale or distribution, and the transfer thereof was appropriately restricted by us.

 

Item 3. Defaults Upon Senior Securities.

 

As of March 31, 2013, we are not in default with respect to any indebtedness.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

Exhibit   Description
     
2.1   Asset Purchase Agreement between the Company and Optometrics Corporation, dated January 18, 2008 (included as Exhibit 2.1 to the Form 8-K filed January 25, 2008 and incorporated herein by reference).
     
3.1   Articles of Organization of Precision Optics Corporation, Inc., as amended (included as Exhibit 3.1 to the Form SB-2 filed March 16, 2007 and incorporated herein by reference).
     
3.2   Bylaws of Precision Optics Corporation, Inc. (included as Exhibit 3.2 to the Form S-1 filed December 18, 2008 and incorporated herein by reference).
     
3.3   Articles of Amendment to the Articles of Organization of Precision Optics Corporation, Inc., dated November 25, 2008 and effective December 11, 2008 (included as Exhibit 3.1 to the Form 8-K filed December 11, 2008 and incorporated herein by reference).
     

 

15
 

 

4.1   Registration Rights Agreement by and among the Company and each investor named therein, dated February 1, 2007 (included as Exhibit 4.1 to the Form 8-K filed February 2, 2007 and incorporated herein by reference).
     
4.2   Form of Warrant to Purchase Shares of Common Stock (included as Exhibit 4.2 to the Form 8-K filed February 2, 2007 and incorporated herein by reference).
     
4.3   Registration Rights Agreement by and among the Company and each investor named therein, dated June 25, 2008 (included as Exhibit 4.1 to the Form 8-K filed June 27, 2008 and incorporated herein by reference).
     
4.4   Form of Warrant to Purchase Shares of Common Stock, dated June 25, 2008 (included as Exhibit 4.2 to the Form 8-K filed June 27, 2008 and incorporated herein by reference).
     
4.5   Form of 10% Senior Secured Convertible Note, dated June 25, 2008 (included as Exhibit 4.3 to the Form 8-K filed June 27, 2008 and incorporated herein by reference).
     
4.6   Form of Warrant to Purchase Shares of Common Stock, dated September 28, 2012 (included as Exhibit 4.1 to the Form 8-K filed October 2, 2012 and incorporated herein by reference).
     
4.7   Registration Rights Agreement by and among the Company and each investor named therein, dated September 28, 2012 (included as Exhibit 4.2 to the Form 8-K filed October 2, 2012 and incorporated herein by reference).
     
4.8   Warrant to Purchase Shares of Common Stock issued to Loewen, Ondaatje, McCutcheon USA LTD, dated September 28, 2012 (included as Exhibit 4.3 to the Form 8-K filed October 2, 2012 and incorporated herein by reference).
     
4.9   Form of Warrant to Purchase Shares of Common Stock (Special Situations Settlement), dated February 12, 2013 (included as Exhibit 4.1 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
4.10   Registration Rights Agreement by and among the Company, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., dated February 12, 2013 (included as Exhibit 4.2 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
4.11   Form of Warrant to Purchase Shares of Common Stock (Pitlor and Schumsky Settlement), dated February 12, 2013 (included as Exhibit 4.3 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
10.1   Precision Optics Corporation, Inc. 1997 Incentive Plan, as amended and restated (included as Exhibit 10.1 to the Form 10-QSB filed November 13, 2003 and incorporated herein by reference).
     
10.2   Precision Optics Corporation, Inc. 2006 Equity Incentive Plan (included as Exhibit 99.1 to the Form 8-K filed December 4, 2006 and incorporated herein by reference).
     
10.3   Purchase Agreement by and among the Company and each investor named therein, dated February 1, 2007 (included as Exhibit 10.1 to the Form 8-K filed February 2, 2007 and incorporated herein by reference).
     
10.4   Form of Incentive Stock Option Certificate (included as Exhibit 10.1 to the Form 10-QSB filed February 14, 2007 and incorporated herein by reference).
     
10.5   Form of Nonstatutory Stock Option Certificate (included as Exhibit 10.2 to the Form 10-QSB filed February 14, 2007 and incorporated herein by reference).
     
10.6   Purchase Agreement by and among the Company and each investor named therein, dated June 25, 2008 (included as Exhibit 10.1 to the Form 8-K filed June 27, 2008 and incorporated herein by reference).
     
10.7   Pledge and Security Agreement by and among the Company and each investor named therein, dated June 25, 2008 (included as Exhibit 10.2 to the Form 8-K filed June 27, 2008 and incorporated herein by reference).
     
10.8   Consulting Agreement between the Company and Jack P. Dreimiller, dated August 15, 2008 (included as Exhibit 10.1 to the Form 8-K filed August 18, 2008 and incorporated herein by reference).
     
10.9   Side Letter Agreement between the Company and the investors signatory to the Purchase Agreement, dated November 25, 2008 (included as Exhibit 10.1 to the Form 8-K filed December 11, 2008 and incorporated herein by reference).
     
10.10   Side Letter Agreement between the Company and the holders signatory to the 10% Senior Secured Convertible Note, dated December 11, 2008 (included as Exhibit 10.15 to the Form S-1 filed December 18, 2008 and incorporated herein by reference).

 

16
 

 

10.11   Side Letter Agreement between the Company and the holders signatory to the 10% Senior Secured Convertible Note, dated April 2, 2009 (included as Exhibit 10.16 to the Form S-1/A filed April 6, 2009 and incorporated herein by reference).
     
10.12   Compensation Agreement with Richard E. Forkey, dated December 3, 2010 (included as Exhibit 10.11 to the Form 8-K filed December 6, 2010 and incorporated herein by reference).
     
10.13   Compensation Agreement with Joseph N. Forkey, dated December 3, 2010 (included as Exhibit 10.12 to the Form 8-K filed December 6, 2010 and incorporated herein by reference).
     
10.14   Compensation Agreement with Joel R. Pitlor, dated December 3, 2010 (included as Exhibit 10.13 to the Form 8-K filed December 6, 2010 and incorporated herein by reference).
     
10.15   Asset Purchase Agreement between the Company and Intuitive Surgical Operations, Inc., dated July 27, 2011 (included as Exhibit 10.1 to the Form 8-K filed August 3, 2011 and incorporated herein by reference).
     
10.16   Amendment to Pledge and Security Agreement by and among the Company and each investor named therein, dated July 27, 2011 (included as Exhibit 10.2 to the Form 8-K filed August 3, 2011 and incorporated herein by reference).
     
10.17   Demand Note in the amount of $10,000, dated July 13, 2011, issued by the Company to Dr. Joseph N. Forkey (included as Exhibit 10.22 to the Form 10-K filed September 28, 2011, and incorporated herein by reference.)
     
10.18   Precision Optics Corporation, Inc. 2011 Equity Incentive Plan, dated October 13, 2011 (included as Exhibit 10.2 to Form S-8 filed October 14, 2011, and incorporated herein by reference.)
     
10.19   Precision Optics Corporation, Inc. 2011 Deferred Compensation Plan, dated October 13, 2011 (included as Exhibit 10.3 to Form S-8 filed October 14, 2011, and incorporated herein by reference.)
     
10.20   Side Letter Agreement to the Compensation Agreement with Richard E. Forkey, dated October 14, 2011 (included as Exhibit 10.4 to the Form 8-K filed October 19, 2011 and incorporated herein by reference).
     
10.21   Side Letter Agreement to the Compensation Agreement with Joseph N. Forkey, dated October 14, 2011 (included as Exhibit 10.5 to the Form 8-K filed October 19, 2011 and incorporated herein by reference).
     
10.22   Side Letter Agreement to the Compensation Agreement with Joel N. Pitlor, dated October 14, 2011 (included as Exhibit 10.6 to the Form 8-K filed October 19, 2011 and incorporated herein by reference).
     
10.23   Endorsement to 10% Senior Secured Convertible Note by the Company, dated October 31, 2011, and accepted by Special Situations Private Equity Fund, L.P. (included as Exhibit 10.2 to the Form 8-K filed November 3, 2011 and incorporated herein by reference).
     
10.24   Endorsement to 10% Senior Secured Convertible Note by the Company, dated October 31, 2011, and accepted by Special Situations Fund III QP, L.P. (included as Exhibit 10.3 to the Form 8-K filed November 3, 2011 and incorporated herein by reference).
     
10.25   Endorsement to 10% Senior Secured Convertible Note by the Company, dated July 31, 2012, and accepted by Arnold Schumsky (included as Exhibit 10.27 to the Form 10-K filed October 15, 2012, and incorporated herein by reference.)
     
10.26   Endorsement to 10% Senior Secured Convertible Note by the Company, dated August 31, 2012, and accepted by Arnold Schumsky (included as Exhibit 10.28 to the Form 10-K filed October 15, 2012, and incorporated herein by reference.)
     
10.27   Notice of Repayment of 10% Senior Secured Convertible Note in Full by the Company, dated September 28, 2012, and accepted by Arnold Schumsky (included as Exhibit 10.29 to the Form 10-K filed October 15, 2012, and incorporated herein by reference.)

 

10.28   Purchase Agreement by and among the Company and each investor named therein, dated September 28, 2012 (included as Exhibit 10.1 to the Form 8-K filed October 2, 2012 and incorporated herein by reference).
     

 

17
 

 

10.29   Settlement Agreement by and among the Company, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., dated February 12, 2013 (included as Exhibit 10.1 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
10.30   Settlement Agreement by and between the Company and Joel Pitlor, dated February 12, 2013 (included as Exhibit 10.2 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
10.31   Settlement Agreement by and between the Company and Arnold Schumsky, dated February 12, 2013 (included as Exhibit 10.3 to the Form 8-K filed February 13, 2013 and incorporated herein by reference).
     
31.1   Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
     
31.2   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
     
32.1   Certification of Officers pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
     
101.INS*   XBRL Instance Document (filed herewith).
101.SCH*   XBRL Taxonomy Extension Schema (filed herewith).
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase (filed herewith).
101.DEF*   XBRL Taxonomy Extension Definition Linkbase (filed herewith).
101.LAB*   XBRL Taxonomy Extension Label Linkbase (filed herewith).
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase (filed herewith).

 

*Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

18
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  PRECISION OPTICS CORPORATION, INC.
     
Date: May 15, 2013 By: /s/ Joseph N. Forkey
    Joseph N. Forkey
   

Chief Executive Officer

(Principal Executive Officer)

     
     
Date: May 15, 2013 By: /s/ Jack P. Dreimiller
    Jack P. Dreimiller
   

Chief Financial Officer 

(Principal Financial Officer and Principal Accounting Officer)

 

 

19

 

EX-31.1 2 peye_10q-ex3101.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

I, Joseph N. Forkey, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Precision Optics Corporation, Inc. for the quarter ended March 31, 2013;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

  By:  /s/ Joseph N. Forkey
Date: May 15, 2013   Joseph N. Forkey
    Chief Executive Officer
    (Principal Executive Officer)

 

EX-31.2 3 peye_10q-ex3102.htm CERTIFICATION

Exhibit 31.2

 

   

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

I, Jack P. Dreimiller, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Precision Optics Corporation, Inc. for the quarter ended March 31, 2013;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  By:  /s/ Jack P. Dreimiller
Date: May 15, 2013   Jack P. Dreimiller
    Chief Financial Officer
    (Principal Financial Officer and Principal Accounting Officer)

 

 

EX-32.1 4 peye_10q-ex3201.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of Precision Optics Corporation, Inc., a Massachusetts corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:

 

The Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: May 15, 2013 By: /s/ Joseph N. Forkey  
    Joseph N. Forkey  
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 

Date: May 15, 2013 By: /s/ Jack P. Dreimiller  
    Jack P. Dreimiller  
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

 

A signed original of this written statement required by Section 906 has been provided to Precision Optics Corporation, Inc. and will be retained by Precision Optics Corporation, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. 

EX-101.INS 5 peye-20130331.xml XBRL INSTANCE FILE 0000867840 2012-07-01 2013-03-31 0000867840 2012-06-30 0000867840 2013-03-31 0000867840 2011-07-01 2012-03-31 0000867840 PEYE:Option1Member 2012-07-01 2013-03-31 0000867840 PEYE:Option2Member 2012-07-01 2013-03-31 0000867840 PEYE:Option3Member 2012-07-01 2013-03-31 0000867840 PEYE:Option4Member 2012-07-01 2013-03-31 0000867840 PEYE:Option5Member 2012-07-01 2013-03-31 0000867840 PEYE:Option6Member 2012-07-01 2013-03-31 0000867840 PEYE:Option7Member 2012-07-01 2013-03-31 0000867840 PEYE:Option8Member 2012-07-01 2013-03-31 0000867840 PEYE:Option9Member 2012-07-01 2013-03-31 0000867840 PEYE:Option10Member 2012-07-01 2013-03-31 0000867840 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-07-01 2013-03-31 0000867840 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2011-07-01 2012-03-31 0000867840 us-gaap:CostOfSalesMember 2012-07-01 2013-03-31 0000867840 us-gaap:CostOfSalesMember 2011-07-01 2012-03-31 0000867840 us-gaap:ResearchAndDevelopmentExpenseMember 2012-07-01 2013-03-31 0000867840 us-gaap:ResearchAndDevelopmentExpenseMember 2011-07-01 2012-03-31 0000867840 2011-06-30 0000867840 2012-03-31 0000867840 2013-01-01 2013-03-31 0000867840 2012-01-01 2012-03-31 0000867840 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-01-01 2012-03-31 0000867840 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-01-01 2013-03-31 0000867840 us-gaap:ResearchAndDevelopmentExpenseMember 2012-01-01 2012-03-31 0000867840 us-gaap:ResearchAndDevelopmentExpenseMember 2013-01-01 2013-03-31 0000867840 us-gaap:CostOfSalesMember 2012-01-01 2012-03-31 0000867840 us-gaap:CostOfSalesMember 2013-01-01 2013-03-31 0000867840 2013-04-24 0000867840 PEYE:Option11Member 2012-07-01 2013-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure PRECISION OPTICS Corp INC 0000867840 10-Q 2013-03-31 false --06-30 No No Yes Smaller Reporting Company Q3 2013 4455134 1204442 2476988 33719 72255 682900 843275 341900 283074 145923 1278384 19556 436219 3077541 3081091 19674 19674 148303 148303 553596 553596 2355968 2359518 41957 29722 3035584 3051369 1246399 2506710 727070 657921 912 11360 25000 25000 62000 57984 171205 188441 6387 3300 410316 371836 51250 12513 44551 39009215 41921209 -38502399 -40116971 519329 1848789 1246399 2506710 0.01 0.01 50000000 50000000 1251339 4455134 1251339 4455134 368572 260937 158761 10323 1348834 1119850 496580 371941 1717406 1380787 655341 382264 1428885 1327372 508755 501213 900060 837987 350180 309913 533424 498842 159472 198608 629000 2276286 -1060313 -1066435 -349994 -490890 -1614572 1181427 -349994 -492139 1408 28958 1250 76149 534 1 -0.50 0.97 -0.08 -0.40 -0.50 1.04 -0.08 -0.40 3211274 1243527 4279467 1245339 3211274 1135432 4279467 1245339 15785 18225 -1057207 -1313269 -3087 -13673 37669 -414614 -160375 -32065 58826 29345 1250 28958 629000 73913 52160 66539 45860 5724 6300 1650 0 52898 34260 33360 50440 0 550 900 1908 -76149 4599 9457 897 7308 1049 2470904 1724 2463171 2188619 -740972 52500 740972 50000 308896 2500015 1132461 416663 912 912 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Principles of Consolidation and Operations</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The accompanying consolidated financial statements include the accounts of Precision Optics Corporation,&#160;Inc. and its wholly-owned subsidiaries (the &#147;Company&#148;). All significant intercompany accounts and transactions have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the third quarter of the Company&#146;s fiscal year 2013. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company&#146;s consolidated financial statements for the year ended June&#160;30, 2012, together with the Report of Independent Registered Public Accounting Firm filed under cover of the Company&#146;s 2012 Annual Report on Form&#160;10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Use of Estimates</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt"><u>Income (Loss) Per Share</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss (adjusted by adding back interest expense on the Company&#146;s 10% Senior Secured Convertible Notes issued on June 25, 2008, if applicable) by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options, warrants and shares issuable upon conversion of the 10% Senior Secured Convertible Notes. For the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013, the effect of such securities was anti-dilutive and not included in the diluted calculation because of the net loss generated in those periods.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Three Months </b><br /> <b>Ended March 31</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Nine Months </b><br /> <b>Ended March 31</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2013</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2013</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 32%"><font style="font-size: 8pt">Net Income (Loss) &#150; Basic</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">(349,994</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">(492,139</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">(1,614,572</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">1,181,427</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Interest Expense on Senior Convertible Notes</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">28,958</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Net Income (Loss) &#150; Diluted</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(349,994</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(492,139</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(1,614,572</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">1,210,385</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Basic Weighted Average Shares Outstanding</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">4,279,467</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">1,245,339</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">3,211,274</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">1,135,432</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Potentially Dilutive Securities</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">108,095</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Diluted Weighted Average Shares Outstanding</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">4,279,467</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">1,245,339</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">3,211,274</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">1,243,527</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Income (Loss) Per Share</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 9pt"><font style="font-size: 8pt">Basic</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.08</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.40</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.50</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">1.04</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt; padding-left: 9pt"><font style="font-size: 8pt">Diluted</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.08</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.40</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">(0.50</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">0.97</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 3,435,000 and 811,000 for the three months ended March 31, 2013 and 2012, respectively, and approximately 3,435,000 and 620,000 for the nine months ended March 31, 2013 and 2012, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 8pt"><u>Income Taxes</u></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31,</b><br /> <b>2013</b></font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b><br /> <b>2012</b></font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="width: 70%; padding-left: 0.25in; text-indent: -0.25in"><font style="font-size: 8pt">Raw Materials</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">298,244</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 3%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 8pt">277,392</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.25in; text-indent: -0.25in"><font style="font-size: 8pt">Work-In-Progress</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">348,588</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">289,748</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Finished Goods</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">196,443</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-left: 0.25in"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">115,760</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Total Inventories</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">843,275</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-left: 0.25in"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">682,900</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">On June 25, 2008, the Company entered into a purchase agreement, as amended on December 11, 2008, with institutional and other accredited investors (the &#147;Investors&#148;) pursuant to which it sold a total of $600,000 of 10% Senior Secured Convertible Notes (the &#147;Notes&#148;). The Company repaid the outstanding principal and accrued interest respectively owed to Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. on December 15, 2011, and repaid the outstanding obligations owed to Mr. Arnold Schumsky on September 28, 2012. As of September 28, 2012, the Notes held by the Investors have been satisfied in full and the obligations thereunder have been terminated.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">The Notes consisted of the following:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font-size: 8pt">&#160;&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31,</b><br /> <b>2013</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>June&#160;30,</b><br /> <b>2012</b></font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 66%; padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">10% Senior Secured Convertible Notes issued on June&#160;25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest were due at maturity, September 30, 2012</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 2%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">50,000</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.25in"><font style="font-size: 8pt">Accrued interest&#151;10% coupon due on September&#160;30, 2012</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,250</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">51,250</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation costs recognized during the quarters ended March&#160;31, 2013 and 2012 amounted to $52,898 and $34,260, respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $50,440; 2012 - $33,360), research and development expenses (2013 - $550; 2012 - $0) and cost of goods sold (2013 - $1,908; 2012 - $900). Stock-based compensation costs recognized during&#160;the nine month periods ended March 31, 2013 and 2012 amounted to $73,913 and $52,160, respectively, and were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $66,539; 2012 - $45,860), research and development expenses (2013 - $1,650; 2012 - $0) and cost of goods sold (2013 - $5,724; 2012 - $6,300). No compensation has been capitalized because such amounts would have been immaterial.&#160;&#160;No income tax provision was recorded in the third quarter or first nine months of fiscal years 2013 or 2012 because of the losses generated or the availability of loss carryforwards to offset any anticipated taxable income.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no stock option grants or cancellations during the quarter ended March 31, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2013, the unrecognized compensation costs related to options&#160;vesting of $167,442 will be&#160;recognized over a period of approximately 1.25 years.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Information related to the stock options outstanding as of March 31, 2013 is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Range of Exercise </b></font><br /> <font style="font-size: 8pt"><b>Prices</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of </b></font><br /> <font style="font-size: 8pt"><b>Shares</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Weighted-Average </b></font><br /> <font style="font-size: 8pt"><b>Remaining </b></font><br /> <font style="font-size: 8pt"><b>Contractual </b></font><br /> <font style="font-size: 8pt"><b>Life (years)</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Weighted-Average </b></font><br /> <font style="font-size: 8pt"><b>Exercise Price</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable </b></font><br /> <font style="font-size: 8pt"><b>Number </b></font><br /> <font style="font-size: 8pt"><b>of Shares</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable </b></font><br /> <font style="font-size: 8pt"><b>Weighted-Average </b></font><br /> <font style="font-size: 8pt"><b>Exercise Price</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 8pt">1.20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">207,800</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">8.93</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">1.20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">57,800</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">1.20</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">0.85</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9.76</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.85</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.85</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">0.55</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">51,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">8.87</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.55</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">20,334</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.55</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">0.27</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">40,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">8.29</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.27</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">20,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.27</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">1.35</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">6.65</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.35</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.35</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">1.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">5.66</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">6.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,600</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">3.67</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">6.25</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,600</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">6.25</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">7.75</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4.66</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">7.75</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,200</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">7.75</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">11.50</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2.67</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">11.50</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">800</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">11.50</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">13.75</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">50,427</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">3.11</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">13.75</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">50,427</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">13.75</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">20.75</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">37,360</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2.21</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">20.75</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">37,360</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">20.75</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">0.27&#150;$20.75</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">401,587</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">7.46</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">4.48</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">200,921</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">7.93</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate intrinsic value of the Company&#146;s &#147;in-the-money&#148; outstanding and exercisable options as of March 31, 2013 was $11,200 and $5,600, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended March&#160;31, 2013 and 2012, respectively, the Company sold equipment that was previously written off for proceeds totaling $4,599 and $9,457, respectively, and recorded a gain of $4,599 and $9,457, respectively, which is included within operating expenses in the accompanying consolidated statements of operations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 28, 2011, the Company entered into an asset purchase agreement with Intuitive Surgical Operations, Inc. (&#147;Intuitive Surgical&#148;), in which it received gross proceeds of $2,500,000 (less transaction expenses of&#160;&#160;$36,829) in connection with the sale of certain intellectual property. Pursuant to the agreement, the Company agreed to assign to Intuitive Surgical all of its currently issued and non-expired patents and pending patent applications, and Intuitive Surgical agreed to grant back to the Company a royalty-free, worldwide license to the patents in all fields outside of medical robotics, except in certain exceptional circumstances.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with this agreement, the Company recorded a gain on the sale of such intellectual property of $2,276,286 in the quarter ended September 30, 2011.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2012, the Company settled $106,149 of accounts payable with a vendor for a negotiated payment of $30,000, and recorded a gain of $76,149. The gain is included within other income for the nine months ended March 31, 2013 in the<font style="color: black"> accompanying</font> consolidated statements of operations. &#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of Precision Optics Corporation,&#160;Inc. and its wholly-owned subsidiaries (the &#147;Company&#148;). All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the third quarter of the Company&#146;s fiscal year 2013. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company&#146;s consolidated financial statements for the year ended June&#160;30, 2012, together with the Report of Independent Registered Public Accounting Firm filed under cover of the Company&#146;s 2012 Annual Report on Form&#160;10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss (adjusted by adding back interest expense on the Company&#146;s 10% Senior Secured Convertible Notes issued on June 25, 2008, if applicable) by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options, warrants and shares issuable upon conversion of the 10% Senior Secured Convertible Notes. For the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013, the effect of such securities was anti-dilutive and not included in the diluted calculation because of the net loss generated in those periods.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Three Months </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Ended March 31</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Nine Months </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Ended March 31</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Net Income (Loss) &#150; Basic</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(349,994</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(492,139</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(1,614,572</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,181,427</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Interest Expense on Senior Convertible Notes</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">28,958</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Net Income (Loss) &#150; Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(349,994</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(492,139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(1,614,572</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,210,385</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Basic Weighted Average Shares Outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4,279,467</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,245,339</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3,211,274</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,135,432</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Potentially Dilutive Securities</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">108,095</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Diluted Weighted Average Shares Outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4,279,467</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,245,339</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3,211,274</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,243,527</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Income (Loss) Per Share</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Basic</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.08</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.40</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.50</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.04</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.08</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.40</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.50</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.97</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 3,435,000 and 811,000 for the three months ended March 31, 2013 and 2012, respectively, and approximately 3,435,000 and 620,000 for the nine months ended March 31, 2013 and 2012, respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Three Months </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Ended March 31</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Nine Months </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Ended March 31</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Net Income (Loss) &#150; Basic</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(349,994</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(492,139</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(1,614,572</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,181,427</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Interest Expense on Senior Convertible Notes</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">28,958</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Net Income (Loss) &#150; Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(349,994</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(492,139</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(1,614,572</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,210,385</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Basic Weighted Average Shares Outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4,279,467</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,245,339</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3,211,274</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,135,432</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Potentially Dilutive Securities</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">108,095</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Diluted Weighted Average Shares Outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4,279,467</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,245,339</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3,211,274</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,243,527</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Income (Loss) Per Share</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Basic</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.08</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.40</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.50</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.04</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.08</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.40</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 9pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">(0.50</font></td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="padding-left: 9pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.97</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>March 31,</b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>June&#160;30,</b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 73%; padding-left: 18pt; text-indent: -18pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Raw Materials</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">298,244</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">277,392</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 18pt; text-indent: -18pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Work-In-Progress</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">348,588</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">289,748</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Finished Goods</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">196,443</font></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 18pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">115,760</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Total Inventories</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">843,275</font></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 18pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">682,900</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Notes consisted of the following:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>March 31,</b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>June&#160;30,</b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; padding-left: 9pt; text-indent: -9pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">10% Senior Secured Convertible Notes issued on June&#160;25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest were due at maturity, September 30, 2012</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">50,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 18pt; text-indent: -18pt; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">Accrued interest&#151;10% coupon due on September&#160;30, 2012</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 18pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 18pt; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 18pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,250</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">&#150;</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">51,250</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">Information related to the stock options outstanding as of March 31, 2013 is as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Range of Exercise </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Prices</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Number of </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Shares</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Weighted-Average </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Remaining </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Contractual </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Life (years)</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Weighted-Average </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Exercisable </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Number </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>of Shares</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif"><b>Exercisable </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Weighted-Average </b></font><br /> <font style="font: 8pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.20</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">207,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">8.93</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.20</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">57,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.20</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.85</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">9,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">9.76</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.85</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">9,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.85</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.55</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">51,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">8.87</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.55</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">20,334</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.55</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.27</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">40,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">8.29</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.27</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">20,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.27</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.35</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">6.65</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.35</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.35</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.25</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">5.66</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.25</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1.25</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">6.25</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,600</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3.67</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">6.25</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,600</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">6.25</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">7.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4.66</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">7.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">1,200</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">7.75</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">11.50</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2.67</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">11.50</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">11.50</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">13.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">50,427</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">3.11</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">13.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">50,427</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">13.75</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">20.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">37,360</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">2.21</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">20.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">37,360</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">20.75</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">0.27&#150;$20.75</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">401,587</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">7.46</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">4.48</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">200,921</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 8pt Times New Roman, Times, Serif">7.93</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate intrinsic value of the Company&#146;s &#147;in-the-money&#148; outstanding and exercisable options as of March 31, 2013 was $11,200 and $5,600, respectively.</p> -1614572 1210385 -349994 -492139 28958 -1614572 1181427 -349994 -492139 3211274 1243527 4279467 1245339 108095 3435000 620000 3435000 811000 115760 196443 289748 348588 277392 298244 50000 1250 0.27 to 20.75 1.2 0.85 0.55 0.27 1.35 1.25 6.25 7.75 11.5 13.75 20.75 401587 207800 9000 51000 40000 1200 1200 1600 1200 800 50427 37360 4.48 1.20 0.85 0.55 0.27 1.35 1.25 6.25 7.75 11.50 13.75 20.75 200921 57800 9000 20334 20000 1200 1200 1600 1200 800 50427 37360 P7Y5M15D P8Y11M2D P9Y9M4D P8Y10M10D P8Y3M14D P6Y7M24D P5Y7M28D P3Y8M1D P4Y7M28D P2Y8M1D P3Y1M10D P2Y2M15D 167442 P1Y3M -38536 -755 23668 123466 3550 4599 9457 50000 245326 7.93 1.20 0.85 0.55 0.27 1.35 1.25 6.25 7.75 11.50 13.75 20.75 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On September 28, 2012, the Company closed on agreements with accredited investors (the &#147;Investors&#148;) for the sale and purchase of units consisting of an aggregate of (i) 2,777,795 shares of the Company&#146;s common stock, and (ii) warrants to purchase an aggregate of 1,944,475 shares of common stock, at a per unit price of $0.90. Each unit consisted of one share of common stock and 70% warrant coverage. The warrants have an exercise price of $1.25 per share, subject to adjustment and a call provision if certain market price targets are reached, an expiration date of September 28, 2017, and are exercisable in whole or in part, at any time prior to expiration. Certain directors and officers participated in the offering and purchased a total aggregate amount of approximately $80,000 of units in the offering.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">The Company received $2.5 million in gross proceeds from the offering. The Company retained Loewen, Ondaatje, McCutcheon USA LTD as the exclusive placement agent for the offering. In addition to the payment of certain cash fees upon closing of the offering, the Company issued a warrant to the placement agent to purchase up to 194,446 shares of common stock on substantially similar terms to the warrants issued in the offering, except that the placement agent warrant has an exercise price of $0.95 per share. The Company anticipates using the net proceeds from the offering to fund start-up costs associated with the previously-announced order for micro endoscopes as well as other recently received orders for new products in addition to working capital needs and for general corporate purposes.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">In conjunction with the offering, the Company also entered into a registration rights agreement dated September 28, 2012 with the Investors, whereby it was obligated to file a registration statement with the Securities and Exchange Commission (the &#147;SEC&#148;) on or before thirty calendar days after September 28, 2012 to register the resale by the Investors of the 2,777,795 shares of common stock purchased in the offering, and the 1,944,475 shares of common stock underlying the warrants purchased in the offering. The Company filed a registration statement with the SEC on October 26, 2012, prior to the filing deadline. The registration statement became effective on December 14, 2012. The Company is obligated to continue to keep the securities registered and, in the event the Company does not comply with such provision of the registration rights agreement, it may have to pay damages to the Investors.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">In conjunction with the offering, certain anti-dilution provisions of the warrants issued in conjunction with the Company&#146;s June 25, 2008 financing transaction were triggered. As a result, the number of existing June 25, 2008 warrants increased from 318,621 to 469,831 and the related exercise price of the warrants decreased from $1.74 per share to $1.18 per share. The June 25, 2008 warrants expire on June 25, 2015.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">Pursuant to the Tax Reform Act of 1986, the utilization of net operating loss carryforwards and other tax benefits are subject to an annual limitation if a cumulative change of ownership of more than 50% occurs over a three-year period. As a result of the September 2012 private placement of the Company&#146;s common stock, the Company believes it may have triggered significant limitations on the utilization of those tax attributes. The limitations, if triggered, would allow the use of the value of approximately $34,000 of Federal carryforward losses annually for the next twenty years, and the same amount for state purposes for 20 years.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">In December 2012, stock purchase warrants with an exercise price of $1.00 per share for 50,000 shares of the Company&#146;s common stock were exercised, and accordingly, 50,000 shares of restricted common stock were issued.</font></p> 629000 674645 370000 370000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt"><i>Settlement Agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P.</i></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On January 17, 2013, the Company received a demand letter from two of its stockholders, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. (along with Special Situations Fund III QP, L.P., &#147;Special Situations&#148;). The letter alleged that the Company failed to maintain a current registration statement for the sale of stock purchased by Special Situations pursuant to registration rights agreements entered into with the Company on February 1, 2007 and June 25, 2008, and sought prompt payment of $719,100 as liquidated damages and an amendment to the terms of certain warrants purchased in 2008. A registration statement covering the shares in question is currently effective.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On February 12, 2013, the Company entered into a settlement agreement with Special Situations (the &#147;Settlement Agreement&#148;). Without agreeing to the alleged damages, the Company entered into the Settlement Agreement in order to resolve the claim without requiring a cash payment or extended distraction of its resources away from operational activities. Under the terms of the Settlement Agreement, Special Situations agreed to forego their claims for cash damages. In return, the Company agreed to: (a) issue an aggregate of (i) 350,000 shares of common stock, and (ii) warrants to purchase an aggregate of 350,000 shares of common stock (the &#147;Securities&#148;), and (b) amend the expiration date of the warrants issued to Special Situations in conjunction with the Company&#146;s June 25, 2008 private placement (the &#147;2008 Warrants&#148;), as payment in full of the alleged damages sought by Special Situations. The Securities were issued on February 12, 2013. The expiration date of the 2008 Warrants was amended from June 25, 2015 to May 11, 2017. The new warrants issued in connection with the Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">In conjunction with the Settlement Agreement, the Company also entered into a registration rights agreement dated February 12, 2013 with Special Situations, whereby it is obligated to register the resale by Special Situations of the Securities, consisting of 350,000 shares of common stock and the 350,000 shares of common stock underlying the warrants</font><font style="font-size: 8pt"> <font style="font-family: Times New Roman, Times, Serif">issued on February 12, 2013. A registration statement covering the Securities was declared effective on April 26, 2013.</font></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt"><i>Letter From one of the Company&#146;s Stockholders</i></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On March 21, 2013, the Company received a letter from one of its stockholders demanding either (i) return of its capital investment in the Company and rescission of the purchase agreement entered into by the Company and the stockholder in September 2012, or (ii) compensation for its alleged damages in the amount of $179,316. The stockholder claims that the Company&#146;s settlement agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., disclosed in the Company&#146;s Current Report on Form 8-K filed February 13, 2013, prompted the stockholder&#146;s letter.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">To the Company&#146;s knowledge, the stockholder has not filed a lawsuit. The Company does not believe that the stockholder&#146;s claims have any merit. In the event the stockholder files a lawsuit, it intends to vigorously defend against any claims.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt"><i>Settlement Agreement with Joel Pitlor</i></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On February 12, 2013, the Company entered into a settlement agreement with one of its directors and stockholders, Joel Pitlor (the &#147;Pitlor Settlement Agreement&#148;). Under the terms of the Pitlor Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Pitlor under the registration rights agreement the Company entered into with Mr. Pitlor, and other parties, on February 1, 2007. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Pitlor Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Pitlor Settlement Agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">By virtue of Mr. Pitlor&#146;s directorship with the Company, he is considered a related party of the Company under federal securities law. The Company&#146;s Board of Directors has acknowledged that Mr. Pitlor&#146;s entry into the Pitlor Settlement Agreement is a related party transaction and has approved such transaction.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt"><i>Settlement Agreement with Arnold Schumsky</i></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">On February 12, 2013, the Company also entered into a settlement agreement with one of its stockholders, Arnold Schumsky (the &#147;Schumsky Settlement Agreement&#148;). The terms of the Schumsky Settlement Agreement and the accompanying Form of Warrant of the Schumsky Settlement Agreement are substantially similar to the terms of the Pitlor Settlement Agreement and the accompanying Form of Warrant of the Pitlor Settlement Agreement. Under the terms of the Schumsky Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Schumsky under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on February 1, 2007 and under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on June 25, 2008. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Schumsky Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Schumsky Settlement Agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">The Company has estimated the fair value of the non-cash consideration exchanged for settlement of claims with Special Situations, Mr. Pitlor, and Mr. Schumsky on February 12, 2013 to be a total of $629,000 as of December 31, 2012, and has recorded this amount as a non-cash expense and current liability in its consolidated financial statements as of December 31, 2012, and for the quarter and six months then ended.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 8pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 8pt">The Company used the Black-Scholes option-pricing model for determining the estimated fair value of the new warrants to be issued to Special Situations, Mr. Pitlor, and Mr. Schumsky, and for determining the value of the extension of the maturity date of the 2008 Warrants held by Special Situations. The Company valued its issued common stock as of the closing price of the stock at December 31, 2012, which was $0.85 per share.</font></p> EX-101.SCH 6 peye-20130331.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - 2. INVENTORIES link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - 4. STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - 5. SALE OF STOCK link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - 6. SALE OF ASSETS link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - 7. SALE OF PATENTS link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - 8. SETTLEMENT OF ACCOUNTS PAYABLE link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - 9. CLAIMS FOR LIQUIDATED DAMAGES link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - 2. INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Tables) link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - 4. STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - 2. INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - 4. STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - 4. STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - 6. SALE OF ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 peye-20130331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 peye-20130331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 peye-20130331_lab.xml XBRL LABEL FILE Machinery and equipment Property, Plant and Equipment, Type [Axis] Leasehold improvements Furniture and fixtures Vehicles Customer A Major Customers [Axis] Customer B Customer C All others Option Option Indexed to Issuer's Equity [Axis] Option 1 Exercise Price Range [Axis] Option 2 Option 3 Option 4 Option 5 Option 6 Option 7 Option 8 Option 9 Option 10 Customer 1 Customer 2 Customer 3 Customer 4 Customer 5 Selling, General and Administrative Expenses Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Cost of Goods Sold Research and Development Expenses 2011 Plan 2006 Plan 1997 Plan Option 11 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and Cash Equivalents Accounts Receivable, net Inventories, net Prepaid Expenses Total Current Assets PROPERTY AND EQUIPMENT Machinery and Equipment Leasehold Improvements Furniture and Fixtures Vehicles Total Less: Accumulated Depreciation Net Property and Equipment TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES 10% Senior Secured Convertible Notes Accounts Payable Customer Advances Accrued Employee Compensation Accrued Professional Services Accrued Warranty Expense Other Accrued Liabilities Total Current Liabilities STOCKHOLDERS' EQUITY Common Stock, $0.01 par value - Authorized - 50,000,000 shares; Issued and Outstanding - 4,455,134 shares at March 31, 2013 and 1,251,339 shares at June 30, 2012 Additional Paid-in Capital Accumulated Deficit Total Stockholders' Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Common Stock par value (in Dollars per share) Common Stock shares authorized Common Stock shares issued Common Stock shares outstanding Income Statement [Abstract] Revenues Cost of Goods Sold Gross Profit Research and Development Expenses, net Selling, General and Administrative Expenses Gain on Sale of Assets Total Operating Expenses Operating Loss Gain on Sale of Patents Non-cash Provision for Claims for Liquidated Damages Other Income Interest Expense Net Income (Loss) Income (Loss) Per Share: Basic Diluted Weighted Average Common Shares Outstanding: Basic Diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Income (Loss) Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities - Depreciation and Amortization Gain on Sale of Patents Gain on Settlement of Accounts Payable Stock-based Compensation Expense Non-cash Provision for Settlement of Claims for Liquidated Damages Non-cash Interest Expense Changes in Operating Assets and Liabilities - Accounts Receivable, net Inventories Prepaid Expenses Accounts Payable Customer Advances Accrued Expenses Net Cash Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Proceeds from Sale of Patents Purchases of Property and Equipment Additional Patent Costs Proceeds from Sale of Assets Net Cash Provided By Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Gross Proceeds from September 2012 Private Placement of Common Stock and Warrants Private Placement Expenses Incurred and Paid as of March 31, 2013 Proceeds From Exercise of Warrants to Purchase Common Stock (50,000 Shares) Payment of Principal and Interest on 10% Senior Convertible Notes Net Cash Provided by (Used In) Financing Activities NET INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash Paid for Income Taxes SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: Issuance of Common Stock and Warrants for Settlement of Claims for Liquidated Damages (370,000 shares and 370,000 warrants) Issuance of Common Stock to Satisfy Deferred Compensation Obligations (245,326 shares) Warrants exercised, shares Common stock issued for settlement of claims, shares Warrants issued for settlement of claims, warrant shares Common stock issued to satisfy deferred compensation obligations Accounting Policies [Abstract] 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Inventory Disclosure [Abstract] 2. INVENTORIES Debt Disclosure [Abstract] 3. 10% SENIOR SECURED CONVERTIBLE NOTES Disclosure of Compensation Related Costs, Share-based Payments [Abstract] 4. STOCK-BASED COMPENSATION Equity [Abstract] 5. SALE OF STOCK Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract] 6. SALE OF ASSETS Goodwill and Intangible Assets Disclosure [Abstract] 7. SALE OF PATENTS Settlement Of Accounts Payable 8. SETTLEMENT OF ACCOUNTS PAYABLE Claims For Liquidated Damages 9. CLAIMS FOR LIQUIDATED DAMAGES Principles of Consolidation and Operations Use of Estimates Income (Loss) per Share Income Taxes Income (Loss) per Share Inventories 10% Senior Secured Convertible Notes Information related to the stock options outstanding Net Income (Loss) - Basic Interest Expense on Senior Convertible Notes Net Income (Loss) - Diluted Basic Weighted Average Shares Outstanding Potentially Dilutive Securities Diluted Weighted Average Shares Outstanding Income (Loss) Per Share Antidilutive shares excluded from computation of income (loss) per share Raw Materials Work-In-Progress Finished Goods Total Inventories 10% Senior Secured Convertible Notes issued on June 25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest are due at maturity, September 30, 2012 Accrued interest -10% coupon due on September 30, 2012 Outstanding principal and accrued interest Statement [Table] Statement [Line Items] Range of exercise prices Number of shares Weighted average contractual life Weighted average exercise price Exercisable number of shares related to stock options outstanding Exercisable weighted average exercise price Stock-based compensation costs Unrecognized compensation costs related to options vesting Unrecognized compensation costs recognition period Gain on sale of assets vehicles Customer A member Customer B member Customer C member All Other Customers member Option 1 member Option 2 member Option 3 member Option 4 member Option 5 member Option 6 member Option 7 member Option 8 member Option 9 member Option 10 member Range of exercise prices Customer 1 member Customer 2 member Customer 3 member Customer 4 member Customer 5 member Plan 2011 member Plan 2006 member Plan 1997 member Exercisable Number of Shares Related to Stock Options Outstanding Non-cash Provision for Claims for Liquidated Damages Non-cash Provision for Settlement of Claims for Liquidated Damages Gain on Settlement of Accounts Payable SETTLEMENT OF ACCOUNTS PAYABLE text block CLAIMS FOR LIQUIDATED DAMAGES text block Number of Shares Underlying Stock Options Outstanding Private placement expenses incurred and paid Proceeds From Exercise of Warrants to Purchase Common Stock Issuance of Common Stock to Satisfy Deferred Compensation Obligations Custom Element. Common stock issued to satisfy deferred compensation obligations Exercisable weighted average exercise price Issuance of Common Stock and Warrants for Settlement of Claims for Liquidated Damages (370,000 shares and 370,000 warrants) Common stock issued for settlement of claims, shares Warrants issued for settlement of claims, warrant shares Assets, Current Vehicles [Default Label] Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, Plant and Equipment, Net Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Goods Sold [Default Label] Gross Profit Selling, General and Administrative Expense Operating Expenses Operating Income (Loss) NoncashProvisionForClaimsForLiquidatedDamages Interest Expense Weighted Average Number of Shares Outstanding, Diluted Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable Increase (Decrease) in Customer Advances Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities PrivatePlacementExpensesIncurredAndPaid Repayments of Long-term Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Schedule of Inventory, Current [Table Text Block] Schedule of Debt [Table Text Block] EX-101.PRE 10 peye-20130331_pre.xml XBRL PRESENTATION FILE XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. STOCK-BASED COMPENSATION (Details) (USD $)
9 Months Ended
Mar. 31, 2013
Range of exercise prices 0.27 to 20.75
Number of shares 401,587
Weighted average contractual life 7 years 5 months 15 days
Weighted average exercise price $ 4.48
Exercisable number of shares related to stock options outstanding 200,921
Exercisable weighted average exercise price $ 7.93
Option 1
 
Range of exercise prices 1.2
Number of shares 207,800
Weighted average contractual life 8 years 11 months 2 days
Weighted average exercise price $ 1.20
Exercisable number of shares related to stock options outstanding 57,800
Exercisable weighted average exercise price $ 1.20
Option 2
 
Range of exercise prices 0.85
Number of shares 9,000
Weighted average contractual life 9 years 9 months 4 days
Weighted average exercise price $ 0.85
Exercisable number of shares related to stock options outstanding 9,000
Exercisable weighted average exercise price $ 0.85
Option 3
 
Range of exercise prices 0.55
Number of shares 51,000
Weighted average contractual life 8 years 10 months 10 days
Weighted average exercise price $ 0.55
Exercisable number of shares related to stock options outstanding 20,334
Exercisable weighted average exercise price $ 0.55
Option 4
 
Range of exercise prices 0.27
Number of shares 40,000
Weighted average contractual life 8 years 3 months 14 days
Weighted average exercise price $ 0.27
Exercisable number of shares related to stock options outstanding 20,000
Exercisable weighted average exercise price $ 0.27
Option 5
 
Range of exercise prices 1.35
Number of shares 1,200
Weighted average contractual life 6 years 7 months 24 days
Weighted average exercise price $ 1.35
Exercisable number of shares related to stock options outstanding 1,200
Exercisable weighted average exercise price $ 1.35
Option 6
 
Range of exercise prices 1.25
Number of shares 1,200
Weighted average contractual life 5 years 7 months 28 days
Weighted average exercise price $ 1.25
Exercisable number of shares related to stock options outstanding 1,200
Exercisable weighted average exercise price $ 1.25
Option 7
 
Range of exercise prices 6.25
Number of shares 1,600
Weighted average contractual life 3 years 8 months 1 day
Weighted average exercise price $ 6.25
Exercisable number of shares related to stock options outstanding 1,600
Exercisable weighted average exercise price $ 6.25
Option 8
 
Range of exercise prices 7.75
Number of shares 1,200
Weighted average contractual life 4 years 7 months 28 days
Weighted average exercise price $ 7.75
Exercisable number of shares related to stock options outstanding 1,200
Exercisable weighted average exercise price $ 7.75
Option 9
 
Range of exercise prices 11.5
Number of shares 800
Weighted average contractual life 2 years 8 months 1 day
Weighted average exercise price $ 11.50
Exercisable number of shares related to stock options outstanding 800
Exercisable weighted average exercise price $ 11.50
Option 10
 
Range of exercise prices 13.75
Number of shares 50,427
Weighted average contractual life 3 years 1 month 10 days
Weighted average exercise price $ 13.75
Exercisable number of shares related to stock options outstanding 50,427
Exercisable weighted average exercise price $ 13.75
Option 11
 
Range of exercise prices 20.75
Number of shares 37,360
Weighted average contractual life 2 years 2 months 15 days
Weighted average exercise price $ 20.75
Exercisable number of shares related to stock options outstanding 37,360
Exercisable weighted average exercise price $ 20.75
XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. 10% SENIOR SECURED CONVERTIBLE NOTES
9 Months Ended
Mar. 31, 2013
Debt Disclosure [Abstract]  
3. 10% SENIOR SECURED CONVERTIBLE NOTES

On June 25, 2008, the Company entered into a purchase agreement, as amended on December 11, 2008, with institutional and other accredited investors (the “Investors”) pursuant to which it sold a total of $600,000 of 10% Senior Secured Convertible Notes (the “Notes”). The Company repaid the outstanding principal and accrued interest respectively owed to Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. on December 15, 2011, and repaid the outstanding obligations owed to Mr. Arnold Schumsky on September 28, 2012. As of September 28, 2012, the Notes held by the Investors have been satisfied in full and the obligations thereunder have been terminated.

 

The Notes consisted of the following:

  

    March 31,
2013
    June 30,
2012
 
10% Senior Secured Convertible Notes issued on June 25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest were due at maturity, September 30, 2012   $     $ 50,000  
Accrued interest—10% coupon due on September 30, 2012           1,250  
    $     $ 51,250  
EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T M,&,V93`P8V8B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C5?4T%,15]/1E]35$]#2SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C9?4T%,15]/1E]!4U-%5%,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/CE?0TQ!24U37T9/4E],25%5241!5$5$7T1!34%'13PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/C9?4T%,15]/1E]!4U-%5%-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T'1087)T7SDQ,CAE9&,Y7SDW-F1?-#9F9E]B M.#,V7S`S9C0P8S9E,#!C9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]# M.B\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8O5V]R:W-H M965T'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!296=I2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#@V-S@T,#QS<&%N M/CPO'0^,3`M M43QS<&%N/CPO'0^+2TP-BTS,#QS<&%N/CPO'0^3F\\2=S(%)E<&]R=&EN9R!3 M=&%T=7,@0W5R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^43,\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P M,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R M.&5D8SE?.3'0O:'1M;#L@8VAA'!E;G-E2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XR+#,U.2PU,3@\'1U'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65E M($-O;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'!E;G-E'0^ M)FYB'0^)FYB'0^)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P M8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PW M.#4\'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E M2!A;F0@17%U:7!M96YT/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#4U,"D\2!);G9E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^)FYB&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XY,3(\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960L M('-H87)E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X- M"@T*/'`@F4Z(#AP="<^5&AE(&%C8V]M<&%N>6EN M9PT*8V]N2UO=VYE9"!S=6)S:61I87)I97,- M"BAT:&4@)B,Q-#<[0V]M<&%N>28C,30X.RDN($%L;"!S:6=N:69I8V%N="!I M;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z M(#AP="<^5&AE65A<@T*,C`Q,RX@5&AE2P@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^/'4^57-E(&]F($5S=&EM871E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@'!E;G-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!D:79I9&EN9R!N970@:6YC;VUE(&]R(&YE="!L;W-S(&)Y('1H92!W96EG M:'1E9"!A=F5R86=E(&YU;6)E2!D:79I9&EN9R!N M970@:6YC;VUE(&]R(&YE="!L;W-S("AA9&IU2!A9&1I;F<@8F%C M:R!I;G1E28C,30V.W,@,3`E M(%-E;FEO2!T:&4@=V5I9VAT960@ M879E2!D:6QU=&EV92!S96-U6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE M/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF M;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^3F5T($EN8V]M92`H3&]S6QE/3-$)W=I9'1H.B`R)2<^/&9O M;G0@6QE/3-$ M)V9O;G0M6QE M/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^*#,T.2PY.30\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@F4Z(#AP="<^*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,B4G/CQF;VYT('-T>6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@ MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)2<^/&9O;G0@6QE/3-$)W=I M9'1H.B`Q)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE/3-$ M)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'!E M;G-E(&]N(%-E;FEOF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-3`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)V)OF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,C@L.34X M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;FF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z M(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$ M)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$ M)V9O;G0M6QE/3-$)V9O M;G0MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M MF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0MF4Z(#AP M="<^4&]T96YT:6%L;'D@1&EL=71I=F4@4V5C=7)I=&EEF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-3`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0MF4Z(#AP M="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3`X M+#`Y-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,7!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$ M)V9O;G0MF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@ M/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^ M0F%S:6,\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*#`N M,#@\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^*3PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,BXU<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#AP="<^ M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE M/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^1&EL=71E9#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/CQF;VYT('-T M>6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE M/3-$)W!A9&1I;FF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^*#`N-3`\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z M(#AP="<^*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,BXU<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M2`S+#0S-2PP,#`@86YD(#@Q,2PP,#`@9F]R M('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,@86YD(#(P M,3(L(')E2P@86YD#0IA<'!R;WAI;6%T96QY(#,L-#,U+#`P M,"!A;F0@-C(P+#`P,"!F;W(@=&AE(&YI;F4@;6]N=&AS(&5N9&5D($UA6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M"!A2!D:69F97)E;F-E"!A"!R871EF5D(&EN(&EN8V]M92!I;B!T:&4@<&5R:6]D('1H870-"FEN M8VQU9&5S('1H92!E;F%C=&UE;G0@9&%T92X\+V9O;G0^/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P M8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'`@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UEF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@6QE/3-$)W9EF4Z(#AP="<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)V)OF4Z(#AP="<^/&(^2G5N928C,38P.S,P+#PO8CX\8G(@ M+SX-"B`@("`\8CXR,#$R/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/"]T'0M:6YD96YT.B`M,"XR-6EN)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^4F%W($UA=&5R:6%L6QE/3-$)V9O;G0M MF4Z(#AP="<^ M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3$E.R!T M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`S)2<^/&9O M;G0@6QE/3-$ M)V9O;G0M6QE M/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,C6QE/3-$)V9O;G0M M6QE M/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^ M1FEN:7-H960@1V]O9',\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V)OF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-C@R M+#DP,#PO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X M961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA'0^/'`@F4Z(#AP="<^3VX@2G5N92`R-2P@,C`P."P-"G1H92!#;VUP86YY(&5N=&5R M960@:6YT;R!A('!U2!R97!A M:60@=&AE(&]U='-T86YD:6YG('!R:6YC:7!A;"!A;F0@86-C'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ M6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE/3-$ M)V9O;G0MF4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)O6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,2PR-3`\+V9O;G0^/"]T M9#X-"B`@("`\=&0@6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0MF4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE2P@86YD('1H92!C;W-T2P-"F%N9"!W M97)E(&EN8VQU9&5D(&EN('1H92!A8V-O;7!A;GEI;F<@8V]N`T*<')O=FES:6]N('=A65A69O3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^07,@;V8@36%R8V@@,S$L(#(P,3,L('1H92!U;G)E8V]G;FEZ M960@8V]M<&5NF5D M(&]V97(@82!P97)I;V0@;V8@87!P2`Q+C(U('EE87)S+CPO M<#X-"@T*/'`@'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)OF4Z(#AP="<^/&(^4F%N9V4@;V8@17AE6QE/3-$)V9O;G0M6QE M/3-$)V)OF4Z(#AP="<^/&(^ M3G5M8F5R(&]F(#PO8CX\+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^/&(^4VAA'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0MF4Z(#AP="<^/&(^17AE6QE/3-$)V)OF4Z(#AP="<^/&(^17AE6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3@E.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^."XY,SPO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ MF4Z M(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,3,E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^ M/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.2PP,#`\+V9O;G0^/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^,"XX-3PO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,"XX-3PO9F]N M=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,"XU M-3PO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^,C`L,S,T/"]F;VYT/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^ M#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,"XU-3PO9F]N=#X\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@F4Z(#AP="<^)#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,"XR-SPO9F]N=#X\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)W9EF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^,2PR,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,2XR-3PO9F]N M=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^-2XV-CPO9F]N=#X\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,2PV,#`\+V9O;G0^/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M-RXW-3PO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-"XV-CPO9F]N=#X\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O M;G0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.#`P M/"]F;VYT/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C M,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^,BXV-SPO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.#`P/"]F;VYT M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP M="<^,3$N-3`\+V9O;G0^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#AP="<^,C`N-S4\+V9O;G0^/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^,S6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,C`N-S4\+V9O;G0^ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^-#`Q+#4X-SPO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)OF4Z(#AP="<^)#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU&5R8VES86)L92!O<'1I;VYS(&%S(&]F($UA2X\+W`^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X961C M.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2<^/&9O M;G0@&5R8VES92!P&5R8VES86)L92!I;B!W:&]L92!O&EM871E;'D@)#@P+#`P,"!O9B!U;FET3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X- M"@T*/'`@2<^/&9O;G0@6UE;G0@;V8@8V5R=&%I;B!C87-H(&9E97,@=7!O;B!C M;&]S:6YG(&]F('1H92!O9F9E2!S:6UI;&%R('1E2!R96-E:79E9"!O6QE/3-$)V9O;G0M2!T:&4@26YV97-T;W)S(&]F('1H92`R+#6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M28C,30V.W,@2G5N92`R-2P@,C`P.`T*9FEN86YC:6YG('1R86YS86-T M:6]N('=E&ES=&EN9R!*=6YE(#(U+"`R,#`X('=A'!I3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@69O28C,30V.W,@8V]M;6]N('-T;V-K+"!T:&4@0V]M<&%N M>2!B96QI979E&EM871E M;'D@)#,T+#`P,`T*;V8@1F5D97)A;"!C87)R>69O6QE/3-$ M)V9O;G0M'1087)T7SDQ,CAE9&,Y7SDW-F1? M-#9F9E]B.#,V7S`S9C0P8S9E,#!C9@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2P@ M4&QA;G0@86YD($5Q=6EP;65N="!!6QE/3-$)V9O;G0Z(#AP="!4:6UE M6EN9PT*8V]N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA2<^3VX@2G5L>2`R."P@,C`Q,2P@=&AE($-O;7!A;GD@96YT M97)E9"!I;G1O(&%N#0IA6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU2!O9B`D,BPR-S8L,C@V(&EN('1H92!Q=6%R=&5R(&5N9&5D M(%-E<'1E;6)E3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P M,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R M.&5D8SE?.3'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE2!S971T;&5D("0Q,#8L,30Y#0IO9B!A M8V-O=6YT7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@2!R96-E:79E9"!A(&1E;6%N9"!L971T97(@9G)O;2!T=V\@;V8@:71S M('-T;V-K:&]L9&5R6UE;G0@;V8@)#6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M0T*,3(L(#(P,3,L('1H92!#;VUP86YY(&5N=&5R M960@:6YT;R!A('-E='1L96UE;G0@86=R965M96YT('=I=&@@4W!E8VEA;"!3 M:71U871I;VYS("AT:&4@)B,Q-#<[4V5T=&QE;65N="!!9W)E96UE;G0F(S$T M.#LI+B!7:71H;W5T#0IA9W)E96EN9R!T;R!T:&4@86QL96=E9"!D86UA9V5S M+"!T:&4@0V]M<&%N>2!E;G1E'1E;F1E9"!D:7-T'!I28C,30V.W,@2G5N M92`R-2P-"C(P,#@@<')I=F%T92!P;&%C96UE;G0@*'1H92`F(S$T-SLR,#`X M(%=A'!I65A2`Q,BP@,C`Q M,RP@86YD(&%R92!E>&5R8VES86)L92!I;B!W:&]L92!O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#AP="!4:6UE2!A;'-O(&5N=&5R960@:6YT;R!A(')E9VES=')A=&EO;B!R:6=H M=',@86=R965M96YT(&1A=&5D($9E8G)U87)Y(#$R+"`R,#$S#0IW:71H(%-P M96-I86P@4VET=6%T:6]N2!I="!I2!3<&5C:6%L(%-I='5A=&EO;G,@;V8@ M=&AE(%-E8W5R:71I97,L(&-O;G-IF4Z(#AP="<^#0H\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE2`Q,BP@,C`Q,RX@02!R96=I6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!A;F0@2!T:&4@0V]M<&%N>2!A;F0@=&AE('-T;V-K M:&]L9&5R(&EN(%-E<'1E;6)E3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@0T*;65R:70N($EN('1H92!E=F5N="!T:&4@ M6QE/3-$)V9O;G0M M3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@2`Q,BP@,C`Q,RX@5&AE('=A2!T:6UE M('!R:6]R('1O(&5X<&ER871I;VXN(%1H97)E(&%R92!N;R!R96=I6QE/3-$)V9O;G0M2P@:&4@:7,@8V]N6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M0T*,3(L(#(P,3,L('1H92!# M;VUP86YY(&%L2!3971T;&5M96YT M($%G6EN9R!&;W)M(&]F(%=A2!S:6UI;&%R('1O('1H92!T97)M2!3971T M;&5M96YT($%G2`Q+"`R,#`W(&%N9"!U M;F1E<@T*=&AE(')E9VES=')A=&EO;B!R:6=H=',@86=R965M96YT('1H92!# M;VUP86YY(&5N=&5R960@:6YT;R!W:71H($UR+B!38VAU;7-K>2P@86YD(&]T M:&5R('!A2`Q,BP@,C`Q,RX@ M5&AE('=A'!I65A2`Q,BP@,C`Q M,RP@86YD(&%R92!E>&5R8VES86)L92!I;B!W:&]L90T*;W(@:6X@<&%R="P@ M870@86YY('1I;64@<')I;W(@=&\@97AP:7)A=&EO;BX@5&AE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[ M/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#AP="<^ M5&AE($-O;7!A;GD-"G5S960@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N+7!R M:6-I;F<@;6]D96P@9F]R(&1E=&5R;6EN:6YG('1H92!E2!D871E(&]F('1H92`R,#`X(%=A'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^5&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L#0IS M=&%T96UE;G1S(&EN8VQU9&4@=&AE(&%C8V]U;G1S(&]F(%!R96-I2UO M=VYE9"!S=6)S:61I87)I97,@*'1H92`F(S$T-SM#;VUP86YY)B,Q-#@[*2X- M"D%L;"!S:6=N:69I8V%N="!I;G1E'0M86QI9VXZ(&IU2!F;W(@82!F86ER('-T871E;65N="!O9B!T:&4@28C,30V.W,@9FES M8V%L('EE87(@,C`Q,RX@5&AE28C,30V.W,@8V]N65A&-H86YG92!#;VUM:7-S:6]N(&]N($]C=&]B97(@,34L(#(P,3(@86YD M(&%M96YD960@;VX@3V-T;V)E<@T*,C8L(#(P,3(@=&\@9G5R;FES:"!%>&AI M8FET(#$P,2!T;R!T:&4@1F]R;2`Q,"U++"!W:&EC:"!C;VYT86EN'0M86QI9VXZ(&IU'!E;G-E6EN9R!V86QU97,@;V8-"F%S'0^/'`@2!T:&4@=V5I9VAT960@879E28C,30V.W,-"C$P)2!396YI;W(@4V5C=7)E9"!# M;VYV97)T:6)L92!.;W1E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$-B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@8V]L6QE/3-$)W9E6QE/3-$ M)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U M)2<^/&9O;G0@6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE M/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE M/3-$)V)O'0M:6YD96YT.B`S-G!T)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&YU;6)E&-L=61E9"!F&EM871E;'D@,RPT,S4L,#`P(&%N9"`X,3$L,#`P(&9O'0^/'`@&ES=&EN9R!A"!B87-E"!A"!R871E'!E8W1E9`T*=&\@87!P;'D@=&\@=&%X86)L92!I;F-O;64@ M:6X@=&AE('EE87)S(&EN('=H:6-H('1H;W-E('1E;7!O2!D:69F97)E M;F-E"!A"!R871EF5D M(&EN(&EN8V]M92!I;B!T:&4@<&5R:6]D('1H870@:6YC;'5D97,@=&AE(&5N M86-T;65N=`T*9&%T92X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N M;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0G/B8C M,38P.SPO<#X-"@T*/'`@"!A3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T M,&,V93`P8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D M8SE?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'`@'0M:6YD96YT.B`S-G!T M)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#$Q<'0@0V%L:6)R:2P@2&5L=F5T M:6-A+"!386YS+5-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C M;VQS<&%N/3-$-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,R4[('1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@2!$:6QU=&EV92!396-U6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE M/3-$)V)O6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!P M861D:6YG+6QE9G0Z(#EP=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N M="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!P861D:6YG+6QE9G0Z(#EP=#L@;&EN92UH96EG:'0Z M(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!$:7-C;&]S=7)E(%M!8G-T6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^26YV M96YT;W)I97,@87)E('-T871E9"!A="!T:&4@;&]W97(@;V8-"F-O6QE/3-$ M)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y-S9D7S0V M9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO.3$R.&5D8SE?.3'0O:'1M M;#L@8VAA'0^/'`@'0M:6YD96YT.B`S-G!T)SXF(S$V,#LF(S$V,#L\+W`^#0H-"CQT M86)L92!C96QL6QE/3-$ M)V9O;G0Z(#$Q<'0@0V%L:6)R:2P@2&5L=F5T:6-A+"!386YS+5-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)V)O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\Y,3(X961C.5\Y-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'`@6QE/3-$)V)O&5R8VES92`\+V(^/"]F M;VYT/CQB6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE&5R8VES92!06QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE&5R8VES92!06QE/3-$)W=I9'1H.B`Q."4[('1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$ M)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN M92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H M=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF M;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE M:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@ M,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@;&EN92UH M96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O M;G0@6QE M/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@ M6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@;&EN92UH96EG:'0Z(#$Q-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R!L:6YE M+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!L M:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!L:6YE+6AE:6=H=#H@,3$U)2<^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V)O6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SX\9F]N="!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`S-G!T)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&%G9W)E9V%T92!I M;G1R:6YS:6,@=F%L=64@;V8@=&AE#0I#;VUP86YY)B,Q-#8['0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^)FYB'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&-L=61E9"!F7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&5R8VES92!P'0^-R!Y96%R&5R8VES86)L92!W96EG M:'1E9"!A=F5R86=E(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XD(#'0^,2XR/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A&5R8VES92!P'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R M8VES92!P65A&5R8VES M92!P'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES92!P'0^."!Y96%R7,\&5R8VES86)L92!W96EG:'1E9"!A=F5R86=E(&5X97)C:7-E M('!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,S4\ M'0^,2XR-3QS<&%N/CPO'0^ M-2!Y96%R&5R8VES92!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!P65A&5R8VES86)L92!W M96EG:'1E9"!A=F5R86=E(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XD(#8N,C4\'0^-RXW-3QS<&%N/CPO M'0^-"!Y96%R&5R8VES92!P'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!P'0^,3,N-S4\&5R8VES92!P&5R8VES92!P'0^,C`N-S4\7,\ M'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQAF5D(&-O;7!E;G-A=&EO;B!C;W-T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,3(X961C.5\Y M-S9D7S0V9F9?8C@S-E\P,V8T,&,V93`P8V8-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO.3$R.&5D8SE?.3&UL#0I#;VYT96YT+51R86YS9F5R M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E M>'0O:'1M;#L@8VAA&UL;G,Z;STS M1")U'1087)T7SDQ,CAE C9&,Y7SDW-F1?-#9F9E]B.#,V7S`S9C0P8S9E,#!C9BTM#0H` ` end XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. INVENTORIES
9 Months Ended
Mar. 31, 2013
Inventory Disclosure [Abstract]  
2. INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:

 

    March 31,
2013
    June 30,
2012
 
Raw Materials   $ 298,244     $ 277,392  
Work-In-Progress     348,588       289,748  
Finished Goods     196,443       115,760  
Total Inventories   $ 843,275     $ 682,900  
XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $)
Mar. 31, 2013
Jun. 30, 2012
CURRENT ASSETS    
Cash and Cash Equivalents $ 1,278,384 $ 145,923
Accounts Receivable, net 283,074 341,900
Inventories, net 843,275 682,900
Prepaid Expenses 72,255 33,719
Total Current Assets 2,476,988 1,204,442
PROPERTY AND EQUIPMENT    
Machinery and Equipment 2,359,518 2,355,968
Leasehold Improvements 553,596 553,596
Furniture and Fixtures 148,303 148,303
Vehicles 19,674 19,674
Total 3,081,091 3,077,541
Less: Accumulated Depreciation (3,051,369) (3,035,584)
Net Property and Equipment 29,722 41,957
TOTAL ASSETS 2,506,710 1,246,399
CURRENT LIABILITIES    
10% Senior Secured Convertible Notes    51,250
Accounts Payable 371,836 410,316
Customer Advances 3,300 6,387
Accrued Employee Compensation 188,441 171,205
Accrued Professional Services 57,984 62,000
Accrued Warranty Expense 25,000 25,000
Other Accrued Liabilities 11,360 912
Total Current Liabilities 657,921 727,070
STOCKHOLDERS' EQUITY    
Common Stock, $0.01 par value - Authorized - 50,000,000 shares; Issued and Outstanding - 4,455,134 shares at March 31, 2013 and 1,251,339 shares at June 30, 2012 44,551 12,513
Additional Paid-in Capital 41,921,209 39,009,215
Accumulated Deficit (40,116,971) (38,502,399)
Total Stockholders' Equity 1,848,789 519,329
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,506,710 $ 1,246,399
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Statement of Cash Flows [Abstract]    
Warrants exercised, shares 50,000  
Common stock issued for settlement of claims, shares 370,000  
Warrants issued for settlement of claims, warrant shares 370,000  
Common stock issued to satisfy deferred compensation obligations   245,326
XML 18 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Accounting Policies [Abstract]        
Antidilutive shares excluded from computation of income (loss) per share 3,435,000 811,000 3,435,000 620,000
ZIP 19 0001019687-13-001918-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-13-001918-xbrl.zip M4$L#!!0````(`.N$KT):!2S,'BW)Q](>X0&;NBQ8/!N[_-=[^3N]/)R MC_SK_7__%X%_;_^GUR,7C/K>$3D+W=YET`^/R94SHD?D)QK0R$G"Z)C\ZO@I M/@DOF$\C'AX^/C M01`^.(]A]%=\X(9BXN["-'+I5-8XHBY#2.$X86[\'UGZ^XUR)JFJ+*L'3WTH MRYF30#I%DM5#23^4M4^R?:381Y(IJ"]QDC2>ZI.>I/Q?EOWMTWWDLR/\+X&J M".*CIYB]VRL5\5$]"*/!H2))\N'OOWR\R>>24:`:](O(8&W7C+-4$ZL'V8OYY*RRJ1&EI05 M23VZD"ZF[L$@?#B$%Y!>5GJ2W%/E(GE$^RLA&X?PMDC(XE!39'-=^;(4188T M[@T<9SS-T'?B>YXX?U$!!MY$H4_CRCS\346F(`R"=%2-RTNBPV0RIH>0J`>I M:,3<:;[-F>8S``9\7(V.OZE`=W/^Q_DTPSAT&;2_$:93L>GL%>T"N704<\;> MTC[A-#P:\LH9TPGM%1D.GF)O+W^-*M_MQ0Q=QAXY+$1E[<0-@X0^)81Y[_8N MHG"4(3,!7!*BL)ZD]F;ZI]EHD+!D,GTZ?RAMXP"VD^4H)MY/RM.(6GV;BD;^,4B4U[N MF7IO+DOQ?`Y`\3`WZ6H[G\37_0R8T5.E5V;;S#LE[V<%F*K(WW1JI-=)P)*1 M%IC4K9'R%BN76JSR*@TVUV+E)BU6V6:+7>T9_W,-84X8R+_0T3V-OIC59X:D M@Q$M\6OZR@,P3V.?N2S)L!*/0!AAPEL'"\>?QB=I M,@PC]@_U/@<>C>Z2T/TK*_R-[P3QA\GY$XT@]*,WT!?26R<8T),G%N^]QZ[M M:,Y,;P\K$95+_8)<(N?<>N)NPR=NP289>Q8U<3=ID[=HFPR]RQJPF[K!V[1-AE M[=C5A%WVCETB[+)W[&HTFRKMZ"4TG2KM^%6/7W?4]UDPR'96^">!=^*-6,#B M)(*J>:#G3UA+-/Y*Z`=8O-2GU_WST=@/)Y3>T>@!V%3-RQ/?#UW^Z[I_2]UP M$"`[;W@5G(9Q`IR\I>,P2CZR(.?B5%,=L^[8*KB&MV/KM\[65[42BE:_[M\Y M_HZ1=1FY9+J=CQ3UD3O6?26L>U6^[I;&U(G<(70>9_2!^N$8S9'W'#L>UN.A M@#%W_E#4'^Z8^0TQ\^7YS'S;IOS:][;*S["W]75NU9S?`+SUO:TJ[I/_>G:C MY\5Y>7V)4K+SZR3F8I]=W\[/%$TNVGDWS_.MS_.\6+96>-\=6[]UMKZF/FPW M'OJ6QD.ORH_NF/D-,?-5^M>GJ^;?4RN]13MECSV`'Q=MBWFO<+C8?`8IV6ZUK#! M(L8JJ26E9S0(1RS8I':S71;U5@DNWL]90<"@T+>Y0/$-M3:&G^)UYE%V=,Z; MS2T=\-F3(,&#HTC.SUL\*V?=23GEW>7UU?D^N;3Y>D=.0VC,;F\.GU[ MN$KVLNY3*%;D^)?@0YY^IA-AY64WN%):6=U9Z*;H.CY-QN)%E*7>OS/YY>Q5 M8K/HXSSS`\+RRYYDI;2RNA-XZV&*"]\9"*OI.WY,,PUS`LJ23],HPLA64"K)"VK/;7 MT$\#F=VR,)1%@RR,]F$M?V!SF:3M&6M',TIF'L01N)- MZF[D^'AFWE0\/SW/"29E"'.BJQI"5N49@2_@F7AA_ZW.-X(E2:O5(JFDBKJ,AR-(/K!0"?KW*[3!,-*/+%P3N]"$$W0Z_(7>9](/.HR,';\;N_R MZF+OO:;INJQJ!K(C23N*8)G'.C2H@Q?E9,R`89)102.#I%$G3-.7M M8:74VBH+.Z]3J6BF85N6H,J;B(X=YN4352U+JZJF;,\45\IN#$"D[*:BZ'I- M`)?!`SR%9G=%&Q?LH>G'N? M0J*V%:W)<^5=IZ,M'B'.6ZID:LWPG#HQSMKB_\[_3B&U#XGBD^34B:()^`5^ MSF?C]J_IMJ+.@`DIZPRAB.EDQ;142_M2$&41(]JZ;GPI@(J`#3754,J.KQ'" MFRB$<6TRP7%^`KDQ)U]$^"D*X[AQ2Y5,4]?DLD],"2 MGUFIH!42H>(W1?(1AA9T&/K>Y6@V2XUBMH1T6$;,TQ_*+ MXPY90*-)9SY!477`4HH05ZMH!T:HZP:[Z'(C,"N]1HM(#@(;W11P3!6!5ETX M0M:Q(:1M!@=BH'24^C"F],XH/Q6=3S/#;Y_RY9[`.QGAB/0?_GREZ.8]#]#, MF@_*.@'TG`45Z\U@F&G8SU!0/I!K/A35#-6V%\>%XDJ$^*I+ABE+FY1\9,X] M\UG":-L!MJF8DEG2MRRYF6Z1PAJZ:2MR'=W7R9!&0(\HI5YW-K#EDHM8KZ(] M(*$8`-J#U!02-`6>M3O+R*:L2*7)E(V*.D$FU(XL2RN/W6HC M.TWC)!Q!X_,>\$:/UAQ2K5)LM$)X"PQ"O:U:IK$@AF(^Z,:9X&102S-HLJ3* MQO)LT[STYAB$S&#*EEH;PVD8/$"HP7!"+$QH1_;097!QI3I9JZ0]I!7F>8K9 M4<#\=WL)^)/2/2,S1=.Y_W93>HHNEV?T%L0V42M2X7PU0USMB>-,=S*TQ;)A:T6'QEFSL:+!AH^N MS+0&%9]AAK%Y?Z&K7;/;96W`9%BZ69J6*8FOJ;GJH405T2X.8C319&<$L?:)!2X;UM&Z:03$TRRB%V M)KR.TMJ5KEJ269Z0::*T;C4;NJYJHP[TL&W%]^J=U*U MFF)95FG@NZ2E$8SZE:V8:KE#Z09&W>K7)66IIEWV(<^-MRX!5:A[ZPO:M[;ODFR[3-5F>-=^7=X% M;755U90Y%[M&86MT=4FJV995WD2]773UPUY;,Y\-7>W0V+8,R:J)CF]>NPH# MUXF'$$<_,/R`\2*,3GV'C6+X\9']G3*/SQ@Z(V?035=KX"9J*=\Z5TM[M[@% MZ+EJL:$;``(,W"X``9)M6F[YR6'!1QB&70=G+!Z',BHTF MXKS9HO;:XVW%-!2K%/L+ZNX0<@N^=%-=;`N`S<#+&8 M6ADISA0UQ%*7)HC%T-2JV+DUEKH]5D_5;-O6M@&E;O?4TVS)LJ5:4*YHTC5/ M#%F;FZZ;4U%;?_WI&PN&F697ZEO3H9WZ!A2`T9PMJ!X\$HUHW&7P*VOE`&E! M00/]M7L0R]8[!=!!?R!FYGJ1Z-PND8VE?("7&)IF5"B2=U'?)K1VNXRD6E4; M2'4IH)?GC[MRH7_IB]T*Q?'K&_#2AS6;T5ZWA]J2#,F=7J&R! M;"-/5J\NV^8V@6WDRQJ3E;UI]\@V4FL-,JU]97YP8N8^)\FXPL:H&A-,/I"T M;8':%KG:H=H6L2I1_4;98`AT.WF`<'=`KU(\F>FZGY-P_;JX$.%68%4565;* MGTK7!+*%AF8M0U9U355>2AFVVBJ>J0Q;;1%B91#YD+"3L;!NEA>[ M1=1V!;7VK(FE*"VAXJD@Q42Y1[T/D\\Q]2Z#Z1S4B9NP![[WM:/I2-U4I/EY M'D']W2*O/WFIRJIBV%T@AU%=A!^_G]'L_Y?!XD<\G=A:EJ>T*:NV)75O5UIIS,U3^[72^GMOEE/?< M7&R%DH8X6DY]KP&R:F'[CB:)SX]/N>Y_V>T)8DBV5YX6VQ:FNY,J3Z;N9,Y= MG=\&5:FH.9S:\^V*/+=+KV,X56>8U[NV:BT1#;T\KG@&6W8(7M.MY[;\\L4. MZ\\G*&^$>P[CUL-GS'T`_QSV$[DH:&UG8^A;1-ST$N)UB+<(M_:.:^@BK:W6 M=[W]K)JRY>;;\G;*]6='J-L$W_ZRPO6;WC7MF2W_NII1:[CZ-MU4E7WK.7Y[ MFWY?[$*D]1N-)6$_Q8-?W')X'93CW2W,7/3RS1YB&MOCZR`(1[TQ;GVB,:A' MZX/F-IME%^*O\K$#JW6U0U4W'K>U\JF+VT)5M^^U[&<`5;<'-M5R.Q-'M6+& M-MMNT_E+*W1WB[KV=(1F2K:D=0$.+"X#VBS[3SO9'> MVDLO- M59$MRY`WM]<*]=T"KSUA;6J2O;!ONR'P6SK.:7S=_Q@&@T\T&IW1^TXVG.IX M!&3Y$ZQJ56T@U;7(149G'Q3UTU_W\)$MH_CC$?-)L MWK4!A&T4H>TG8C<1>W`2>N,[+BT-4N++P,6#[SP8PN!Q9IVLW4F6A2>/U]'; M%=8.HN%RA>$I-[@(>MWOF&'\B%99K_;8E5H[@=F!>:JOFLAN=UI<;^HDKI-5 MZ-[*IVS4`-`U^-K?$[8Y_9/SA$=6=M-2Y\YQ7I#?0'WM,5@- M]7=L$+`^<_'$\FQ0#)WK38BWC-+X$P#YX-=HFN^_]Y/C,8F3B4_?[?4ATQ&1 MI7%"/K$1!`I7])'[),[J*+^,1DYT8`%1T0Z)JBFY_@`ZXC\F4)L MWI_L?3](CE$R"BP+[\7L'WI$K'$R39+B#W!T$"2,80SU_7>R>ASVR6D8Q%`H M+YLV<0*/Y!M/K'F/]"(=E_ME&\_"$+\)Y:2'2@LT"XR,YH M?/R=;$A?"+LHSD]#2AS@%[\O#QC&$;G32J$>Z6>1G>.#%'C`(Q@"U>BG'B5) MGAWG;`A4YPUN$,-U5H(7Y;HQOUHSS.IS?V83X/X!KVP&V1Z'H>]/>N%C`-KB M]#YF'G-P_P/'\@.JR'-JYG%^LU_QP#K^\8"<^(!MUEP`7`)A1Y9PA@[5X7V> ML>-R=I&A\T#)/:4!H3[C%YZ"?L;G[F:4/-A1;XO4RSJ=*=IJC#?. M04Q$[B>"?R9!%'OD[=2+@9?%P@+D<"QMSG+2G"[;,^ M6#L&6_M0"5A8IV@V?Z8!;UN9AGX8)@$>.,T[*7X>;F[EJL*+`4&KHP"T$:'0 M.CSR?VE`9Y17I7V"?>`^2<(!Q9?0N=`;D`$LYPRE+OY_U< M\A3@'1(T&[HC?<^?8*`4#+B.$8NY6T7/ZB8AWGLNZUE1BQHBSBBS2"F-8F1I MP!JDC_=$Q4,0.V3W+(&6+N-C5(S82`:)-X>BQF+^]OQA MVH@FXC<1;_(Y@,<82]O\\`@(=ES+J=.`SX(F'FF;$X+HO<=(2?>;@( M>*$OSEQ;'WT=O@&L+.9."4R&SGYF)N<>(XDB'G#S2R4!J8_%G]J'EZ!D(C(% MBSTQ=HS,APATC`$+4*$/X[.\E'&81BX:[\1-4AZ:9"A'S@1Z;:B?*$O-R#QL-_H4YBU'% M8_XE&7&R3\E(P+\EPZ;/Q7(GX/*Y1T"'$S'A[/,R#L1+^4@#A8WY=-3WKO`!26G^>0^8U\*WFX,O*6I3=0*3#BB;(`%`2>SJZ, M(5=94):=L0Y2,-XF"H\])0O&37UTKN9 MH#&`@T@=!CMH+S`O1ISQ+(S>6"LD3J%/<.("0>9'(0S.URNXB\_AH@VR#F>< M;?&!LL7Y0!$EBACR@,.XR"/A9!A12L``R3#.AS._X/XJHLH\;E>Y>A[`XX\B M@`X@^EZ7*^OY:-;-H[FQC#.K<`B/#I8M8;VIV?((?!9_YX,UKS@IPO%=O,,$ M2WQ/72?-8D8.J.#D@._"2XK,85S8>=<9;3>0[(>^'SX6-&=9.RG7&-34*K_3 MGV,CI\$&@DUI>?1G-,[L,(HK>>"]7EC&/`6OS:F^%!*%&AA[L/J,B"&_=ADH2C66I<-.`YO`Z, MD@N9EUO(RHW0RQ!`@4JQ4.JGF_7:J]`I=V==8H_QG MM/,:E113GI-BV".^4)*\`)U?K$Z479V\N#K9M9.75R\UGA012F@8<3#V%T1+X[Y_^J_&4A+)^V M4)4WHF:YH@F96P\I]FWITC'A,_4U^Y<<@CB"QCU],4]P=3=3H=U#VX-U). MQ\EI,#54O3^5$(`4O!2\%+P4O!7^( MX(V).AU.6B6`BOR8$J&$]7$8O6'YD>R,*HB2NB/YNA<]U>J6T3.@;V7F1>"0 MU>6"O]QS\T&)HV2P[W9*"KQ*@1\6W9`"[ZS`#PV32)%W5>2Z:NB:VI\,6R:$ MBGR6K;&7NM2E:^UV.476[78EYR7G+ZW=+G.^HA5IQRZZ)*W\*%P,@:8(##1^ M%#%0,NAG4HF*>QRHQGBJ#D9E/C!_ M7#9VTS4&M9;QNJKWA^J@7W9#W;KEJL[D]5WF3.^[^'!J>C7.GC*220R9O9*" MEX*7@I>"EX(O[Z%H$U6;'AO^OUV MF?,5K4C'Y[WSM>'YVW>ERK1W)%UK5W)>?B3,BV_&SSDHI2N!P-:5?O^6NMIQY[4DR<=.B3M@2:E?3G2'DII7XJT]9[6 MMF!^15[)H3GL(_P2>=3ZY/HL/9,+D[;T3"Y)VM(SN1AI:[UI!U+,/Q(B3NY1 M1Z!\3HK%E,"3$3F%X&&$S_6=^9;-0;2RR&)KM/? M\[W!RA`J-%@RPO]%L&AX3B3LZFUD:+G>2D-0Y3MK#&:L[5I;@YM=*0L6/A*L))LS'\$&H:EM MP+38ML\L[\$%&E(@P7D41C[10!0@Z##[,T)P7O@D#'W[/N*@:*&7`,[B;_0EX2V M##\3@P2VGH!,1'AZ!#(7D,,<"!%XL_1\TU_E6&F2,4];ON>">D)`>B($1`5T MAPZ;<:CE&-;1568E1H=8Q8J`D4?BDM'8058AX*?\"`0Z)BXX1(4`A>2X@L0; M$C3B4TMDQQIM!,DU2+02N>_8WYAC/WH@'I`NK.6._5>"\9C,L@+E4($JUWS@ M4_31#`ADW)ZAIF41NC.(V6*R"3\DH<"*?$*>3N]<^A8D-H M56&(FDV-@",`%L=QE.0)]L5\F.-(S3U:%'`0GNQ9QD05C&.;POW]QRBX>C#- MY4]?@-GV'$;CAM?R_QU_=ND]`O^>O MWMF!!=8%+$+R+O(*!?F9S?_?W]Z#SX6NQY4VOM+TT$-_Y$KK7_7UO_UR8GWA M(Q!VC?N?(>&QFASPW?&>.7*NY06A\GIN^P'.(57A?X$?^D8A1'3_FUAP2$F" M,(9Z38!&)?3G^4-_UK:[/PW85;*#(,KND]^V`D$>A%@FA5%*&(@CGM+:U_81 MROZ09;7&20Z9LO$7PD2,T4+DW[M6=[SV`2U[64G1NI3NVG+$_F*C#2=D4;-?8TUJV&Y.I.AXTS_:*YFU) M@M[;KAT\PE;M'["U/_44+.<(GB;]5\G]%M.1.ACT6\+E(HM^8MYV6+3Z4!V/ MRN;2NVHMOGJAZ2B9@$]+5/E,$_:305\UQF7OP[D<>]%]R8XFACK56F$NTGJ+ M-)2]*RB]'L!^Q^[#SL:N/[D*AH048X@)?FVB)NF&M]YB:;HKA>),E*S"#)RR MC'SKT0R88L*>A9(:*A8^F`M>+N"YRCMF,2K%T'71IO)LAX_0`%`61IB!`!M* M647HQ\?L*Z41J8\GAAD1GII]C60(F0[&%&;G/XI'DY_?(#E!9,(0@3B>]K-I M+9L!J2$9:V^NO!IIO,P!_M:U'V)01KK=$GK=`&=4UGKFB(UIKSTB[VN&23Y; MFO:,0O79HI*E;[N6O13#Q8%&G),<)S);0J%XSSP5^04>85[W"_!*9('>1_#U M[>VM\C]WJO*A=]=+\D(%+]_Y]I,9,N7FSPCSU?BM^"@G&Y(W2@@IVT*^=P\Z M)9J-R?OH]Y1KWT4.?[$>HT7P;<43IHAUN0QYZ\:$6C?@5/X^_1R8O;!=3,?( MG&FM%5A?1NYJ_DIFL&CRG1NZ(/.CE";#8[U@QC#]@@'WCV M25BKT6@CJ3;%,U#Y4/D>9Z#*N&P)25CQR_W0O#`3!Q<7J.1;-27G!^Z.*XEG$ ML+6%&>)%ZRLUXRJ!^BF)7NV=2I$@]OGA[7^9F0=FLM$%=%MO,0 MW(8ZZA*NUTQ0/#5T-+$):99'AR70,F4W=;EU\1##)"\*ES?$2\$?FV91C:,/ M+';5OY17_G8^[%^9W9*R[YSLAU78KD;/WZ;YH"TYGHU44/+*ISFF!I@;4'3Z M,W,P_OS6"\*`[LFDPQIWY@KS)T$E*:-))9'>+[@'OKJGHR169@!T<"%W=FD6 M^=GC,7]&I@].9>[4:,9C7#\^*HZH\93"JZ&A3J83^O%5?Z`:(ZW@+*LX;HMD MT,Y9G(V:B;-3_#"?9?&$#.[6,1"-JRT=Q$A.R:V?L$&&!,QQX`M5>6`N_"#V MZ[,%E@:%^.(3/RWFXG&XUS20*Z!:4P<#X"6-!_[=[ZO]D?:&9]#PB`U%!+&I M&8-1>$LZ`530SC#3B/9&'/_@9S\>L"B)Y[.2]W5UJDW2+Z::]J:G;!,<$;-- M>(E\\D=_Q3&T%TX`YT4X[JM3\2.*4]\0(9XINJ(Z-`;4SX".[.00+)%"I[\"[!0/IZ.:^!G1 MA(^V/XOG-YY2HC-+N9/B,-HY6#[@/S^"2<.%-VF,,SIKG#I:AKWGS.C^6NZ&0]1MC$D=',F5">ZGLYM72TV=R> M;LHO/@V0$B?B8'[1)',])7NK@?+`KS,`P5BFB[FI3.:46P0E8\H+9W^-;&T- M!WG*.C]NGJZ.W(P-W6IE'5,817&91#H,3&U37GT.QF,TAN7#4)YMQX$YDKZ4 MZ0+/(V/)!3\5C(>*`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`,7[,KQ^'_I/;P`LN,"=*2EUB_J+RE="6 M=66[=6&N/""Z'?^F8FCJ:A2,8*=!T`(.6,]K2!YRFM^N;.)@"M"G.;8T##JR MZ;KW+Q%TCE>1?TJXK,+/5D]YG1J:S==3<_-&19DF6-*@/PP%H,`N(N`&*]%& MU"5#'0IPZ=<."T!#?1.,A45W%R=*XLTS=CGYZU5_I$Z,Z1OL#R3B,OX5#8CN M.C8=LIT6[&U0=1&VRW$8OW43B(`!ABN.17V7@<$F=4S!N;.,I<=TES*P$X2" M?Q6PSG0(-ML&=;4BWX=F0%0"6!%GC>NY5S`V&V6$EZ^#7G,9P6\P8@Y]3<_Q MQFH'VA1RP!>*^DO(HBO*:=,6CR0A7?&]E>F$JZLYO`QSU/.=V;,]8PJTCUR& M#X@(_$@0A8S%L=MVN^^6ORW24[Q>NU#;A$%>,[]N3K4)R*!0K\7D,L8CU9B, M8C.;OYM^`RM3+S2H)2QB;$3O;OZX^>D+"T.'QO-I?@UV'5$68(U'?Z-%)O0V M@^:>(JHGBRR-`18X71NI^F!*PL`;Y,5X8(K0@+@43>4).(K8#AY>..^R!Y@5 MM'(MN6]#TNB3G=M85M-U=4Q=]13T!NEA9@DE`N)E%'':8Q0*['*'HY%ZH;F[^`O:U65 M*OWHXEWY3E5._%8@EKGM@O6S8:EPE8MOE">`WF M'EP[VW0TYU*45KR$Q=00GE"[4008]A3GV`D8:<@`4*RNW/>Q^)4)9,__] M43&L57,$Q5H2L"VJD7%TB9:4K>#<+TWT%^Y763NEDOV!A5DQHYD=QK9ECJN! M(DCV$?.9]B/F#`GA6D<.FAJO"][2=E'3<&DW7?.!KT;<*4$D%#"406#Z*V'@ MYJ;MI[3&^U/8!$0.U]T"X)MM>]@L]`W'2%$V6424%+%)F7DPSC"91.BNS)+U M"?>U@6=Q4\PMM>OB*ODB^Y&1*BF\C^Y8#,`4/!)8T#T.UHPU_-^1FUG1YYX7 MN@BI378)K'@*!50P^)<)B>T[\8<,.U&R`;4>+V+>`Z/E(7&#/S.P&B2D6_@: M_4N4V6?V8`=\FW`7W8-!580M1D5Y;_L+H`87P`A>]X',IUTRC#>PAG+-^1OW MZ2JPW5JD=.K:U7^KHN6$0`(E!Y>6<<-R\QVV*(A0`?TLP&LFO00C:(4>KM7Z M4!7X68A5M>!+7?H[)V4DW@$G>![YKAT\0K./]KV-P.-Z[!LC;0HGB>]7A,0" M^O5_?_W\07G-_A=E^+ M9+FE#3*,Q+$Y@A:H8QP3`>:@1^?8%WVHD`X<]![M!"Q.$ZMCY;?L:%SS@T8(S<[`>RH4!WYS"14 MO^SN2EVWQ5RU$1&(?@%:;6Y5@&6HPRF;S'M<2:A%!`W#'RD`21OP)(C`&9%A M4THP6F(TC#;L=V'G:N+65YF#LHE1!E[DXP80;`UM5F(J%^8*K#;(Q^=OFCU`?P1WS*2S95@_S5Q.#PL+Q M?XWP;F\0W4H)D&C<+:"G%L7SYQZ9^F13.,%E8?P=,`O_1>!PPIMX%G?T*Z:X MH]]-X&NH:=(C^!BV%XI`D,K$E#/89QQJJZ>\LYV$C!+D*B5(?F_$>>;!&@_#;+"M,FC- MT2;@+\WCD`R\_.8`_@GO_T4>JLK2B;B52QM;>AB7`8OH(+^`Q1@&"M+E+ M`O4PX!+D&]JE""P]PWPWX_5(D(P\X(9F20"FR*,@M=A*&4;V<(T5WJ#/"@/A M2$X^8]#HIDN(+!<40ZO$I8)E;=_.9:.&DSKKI@`ATKXA!_ MZQB,B4ZF*(STL1?$O-XGQG7>>QT!'(>J:`=B;4D9BU%2FNI$SH:)F.>4AZ3V M4I0CUJ`]@.H.'.\!O#X`KD[',JFWP-M[WU:5_V+.$\-"':`*MM]730/6B2\< MD,+5(QD]I'"X_^7V1[20P.2,CH#)^5G90D%!AKM$Q#'Y]IZK/:KK1ZZE-)+[ M)*V=38N_"'>S=\\WN2FQH^O:I',)\OT-C="%B+>@%*/[EN,8@*U:-8L@MKL] M:]O,6T/R5NIM!WG;C-Z>N:D_*3UR1*5&M%%VNG5FR4$V.M&/`[7LCWZHPT3^ MQD(L3:/HX@<*':3G/12*E>YI+1-DLBHD\G)C1PR]4JRW.@A\W1],U>FT+"9' M(TQ[(]7A9.HPF!JJWB^+WR#5X^.A@#*61!7:@&N.I.B@-[]`F M!G6$Q>###(9JOZJMD63Q)HO[X"8"F\<5Q2DDBPMSD/VA.NA7M&EKHR=^!'?N M,F" M1\1\Z[[&6VXI+UI47=Z:7IBHNKS%O3!1X:SJJ\.]RW4[M%4^VPA)QP8F62-9 M)5\4><=\ODGIX,)^S/[D$:&7T?57P'AS12-:CVMHH,61U"Q;[UH>3%+_3JY?@W*0N5*_9+Z M=8!^#:5^'1L-;)DR-1--[&EUQGR;VT@W8C/:?*Y0&DWI]$G]:I=^2:=/ZI=T M^MJA7]U0ID8T1^M-&\X>EX*0;PX,HF[@C0T,FCR@"V*!(BD"#9[`3;+X,0*C M)L:'=V=L)F0[*\2@>@%E:A.(''-H7\WO;46C$DF^T/R.X&A^@E[*.'0/@7818PG9E/#' ML\AA*V7!PD="BV)SYB-^$#0E<-@V,,:P?03-?7#MOUB*#32/PL@G&@@_COT9 M(<8:O!Z&OGT?\1E/-'@)?AC^?L_"9\35W`+,EP*@91#BV'<[(-2_;22Z,Z'O MJ2H0900/EZB8@,F%=@A#B+Y"\H$!MN@81@>3;1:49\V"F0%!,"%&X0.HJFF% MXBN?(-00',L*4RPY1+$BX#QXA8R"@-P2*$B(-AFD0.X?BRTR(`CFJ&2!9Y='D2*?VC)0B@XN8P2E,X:/CF:0@<"T!S"93AKE/MN^Y MV"H'+/X5YM:,0[Z!0C#$*Z1&5(2IC1Q'29Y@7\R'*8G4"%!=[\F>9:Q)P3BV M(*(7F^9U$_[%>F2SR$'HP37;+X(XOZ[>$BK<6P=Z:Y^%E_A=^;XE?E<%+;0? MWTGB=YVW?"5^5\B0.4GV\E?A=4F^[R%N)WU6!6-M0O"I'M'M$)R_N MO8A!'C#1)7[7WA*Y;$`6B=\EU4'B=TEUD/A=4B%*70@@\;M*GHR5^%VGOF=* MW@4F921E)&5T"3*2^%T2O^NLZX@E?I?4%(G?)36E%>$-J2L7IRL2OZMM+9P\ M/]?>%B1K)&LZR)HN[S$E?M>1#.SR9>L=87&7+TGO"(N[?+EY1U@L\;LD?E?K MXN\R1R)E)&4D970),I+X71*_JQ,QVRYO*2],5%W>FEZ8J+J\Q;TP44G\KK:U MWM;D*R1K.D@:[J\5Y'X7:T?F&2-9,U%LJ8IOU+B=\FKT/$%;Q"=!_KZ)H"9"*$%WO7F'!8I!OZ04!QG M#\71VLNS$W08&L5]8AJR1J=ZG`9Y'7I]$OUGY+)T*'VM<*%C MWOO1)XFS&)O1*_ZL>B%^-I^5C[#0^+;I['MBZ/POV]2:NFS3F$Y48U#]UFN.QVI]6?Y%N$V;I=*;H=\__=G7K7MWYWH//@N;/+W;D4&Q_,%&' MDSHO`&QO"PU=L#A5QX.6W;!XP([C"!:\MUT[@`VT\@_/F\F3Q'5EV:8C=3#H M-\[>(ALOA596:/I0'8\JBK!VTSI\]4+343(!JW88"!G9W4;X9-!7C7&=QWA/ M;FBD\+<1/IH8ZE1KV&#MCNSO#LEO#^6_8_=M#=\CL#9!/,1!=S9K6=A=!N!E MN!;_D`'X;\;"::E)T[8<81HCN](+U9`-.2+&#(,*% MQE7R.F`,5<70M(F*JU'RC0UK+CS`Y#E0A*NG&2JO=/!)E"4#3F*2757NF>G# M@/%MCFL$+R$Q^(KINM&BE[W81%G"RY:]A+4*,\ZF9?E(4?+Q,_Q/F44,6UF8 M(=Y-ML)A+D.VN(<605N51(-D[N$$0%\'W\/4L`RD0$L2.-14;6]_O^6P;:=+ M2URO6;1XNNADH2TO6H(U10-'L&_"K.56XT/L6_W!LM,$`;?*L;56KE-1D#,, MMZI&5>6L[;S3H2N7(EUBZ.S\KJB4LM[J-9W`TNR.DFY&.[='1JE`^E(SA\J<86.*H5*^ M*_4XQ8J7V6::05S]G,2OT*_JPQ88?^,QUN!<"ILG;0JKMC\`]MET'QB&VV^^ M,]^R`Z8T&@&[\VU+)$%E=+-RX?X64:`(I-NH4/D=OE*H]0@UOC+Y*KXRN5'9 M?F8+T\:S15M M+B9U,7[(4!J;.LNCI+6I-4(TZ2)V;4>X*VU#O;%FM=_O(D9L1_A;L_;*>$C% MTJH5A+>]+30#]'[(X;8V<*$N](VU.R'2-O07>V5$9'*4VI] MN>NI\V2J-#8U7EO6&TGEE::AF]R5IJ'#RBOC(547]DA3(TU--]D[[(UD?8@T M#=WDKC0-'59>&0VI?$,IC4V=QF8DC4V-H#^]D4P<2-/02>Y*T]!EY971D$J) M&O=.@,/2AA;DEJ?[[!W(:(@T#1WEKC0-759>&0VI>CKHO5IONVUO"\V444I; M4V.=GPR&2,O05?9*R]!AW97!D&K%U9=;GGJ!H`;RO$&=21E=E]R5QJ&3[)7& MH=OJ*R,B5>\JM6[:FPL!@NN/U?Y(;IUJ#*H8TIF1QD4:ET[)1ZJ_C,M43Q0= M].:,'FH_OSHKXU4.`;/B7AJZ&D57A_(6L3ISW(,S*G\Y-Z,UZ`TF'93.A1DI M0]/4Z3GM-,YM&HWWARHYTE-+49"31Z>$ZZVL;R&I?T=!:,]7U/O71Z:8#P\^ M>S!#IMANZ-MN8%O*D^E$!&`;/C(B!%&<37]=+3R7 M)6],?L[#);LSA67PQ6)(98)15M8@E)_AZ2N="N3HPU=#K-A7%9\%2X:PTV$R%R M=$D`:R5R;?[2O[Z\^YLR8Y8-(@T0>OF7*WVD#X9C(QW8WF34,@X],PZCQ#AT M0]?ZDV';A@$BT/<21W\PG4X';1N&D1E&&6E<#6"=ZT\K',8M0A*R(/SDOO5< MVM7"]X@2#RU_FG\UOQ\X&;X']D^N[<`"XT?L;\J/E?2[K_(:D^EPDC+KQ3XK M(;*$:M;"G!*Z]%*_Y;4)S#(L,2>VDT1$#6/8VT;J$WU@C-LTA`;M8UU#:-`V M%@XA1C05@*8<+E=840YB^REUCJYGZ)(MP"_+>,""S`=C%H]KMU3:KN\AOWLO*IH M7#`W?88_F(Z8D?3M=0@;F/LH%'/5=)S8V7=GOYN^;[IAWGEK92HPR:( M-M&FPZS;<:,9F MV!5N2H$Z).G3_,;T7=#VX([YU,/UPHNJ7`O`9&J:ENI$)>0U-N:#IL'(T#H\ MY(.6D(Z+^:#E9:+K]0_Y%G91;NCYJ_>V:P>/;/8/SYOEK<=U\&G.Z1Y=];47 M_/WA>*1E#711ZX?34,9AUZ>CP:!_,`V_>_ZW6_?.]RP6',P'V%Z/!Y,"&G*M M'TY#&3[T!Y/AY'`:/IO/'TW8;-O0WL%L&(_[4Z.`A&SC!U-0A@G&=&(,!GM2 ML!9:.'3TP[R57FOU@$Z/C)G\SQ8VAMADXRK=].`5[#O'N MYH^;GSZ;[@,#>\<#\.S.MT&QRSH8OV#UA1)Z"I5=_/W'[2U6UN?_Y]Z:_I'A M]@`XVC.:[->(^T7(Q28[[J<=#QOM>)!VC+OKYCH>IB+N-SKB44:W&NUX''<\ M:KCC2=SQN.%I/$U8K?>:M1]:TG._:=.5V*[]K"8/B(C\Y1&QBO7XDJ8/)_'$ MSO=Q?/=KUOI%8@QM/,%EOTYBC++$3+6Z2>F7)66HUT[+H"PM`ZUV6H9E:=&- MNDD9M8>4<6E21G63,FD/5Z9E2:G=L"1KRLO361L8=9OXQ9IDYWXNQ@YV\IVD9.<^;M).=@XE._?T]':R M,YM3E^PLXZSNM)U]J9U[.MR[ER+)SCTW#3O8.9+LW'OCLX.=/)HFV;G/YFW7 M9,<;TR0_]]R"[F)H7RKH_MOH'0P5`=T3,I1V\3?I:9J:@L:&IDT-700-MG97 M*5'[AI*'F4ARHQ0>$E]NE,#246=#Z_<'IZ"P="S:T$[$PT,BU(T2>$C+(D'1MU1W>3 M/T!Y#,F^P\JG[J9_3#\.)/<.JP%#Y=,^ZIKDWV&E;,"__D==JM^!!7EWHS_& M'PW)O@/+"N^&R+Z)9-]AQ9%W_3\F'W7)O<,J/.\&4OGV9U]2IWIG2.7;WVG6 M,G-7EW[+WOS3,^IGM&[3=K-8.MZ*L2_,?[(M5ASU_@U/Z`38.G8>?/7XL=SD M][=>$/[FA7\PX(GE/;CV7VM7V^QSB&TT'@PR)Z=J([`Q3O`$P'O/%X](*\J> M#_WE3@=WMP%V%%)9>"P;>GO'^/_Q,!U;FO;LYCLV?ECEW\:U(Y-A?[1VU'U' MGU70N._M+E?CX?IA_*,HO+8L/V*S#[9Y;SMTN+4*3AK]T6BRB\S-;JLB=?\K MQ?J#T4ZAOTRK,)"@[M?6GY'MLSO?6S(_7-TY)MA-=W8#3Y>'W<=2<,ATF,UG ME^^[6JI+\/FE0Y)T');-`FSQBXF7[-7*M\%PFKDW9(_.*Z9[7PV=#H;C2NA^ M,;&\+:\,5IVO^]ATN+IU`Y`HZ4Z<33[@EL*M0?W<"=XZ:$FY=)6>PJ M(RCT*0ZNN\?[6047FJ*_S4P[O-9>LO#H^GK)PJ-KZB4+CZZCERP\NG9>LO#H M>GG)PJ-KY"4+CZZ+ERP\OA9>\K""^G?)Q`IJWD_"Q"2VD+ETF4<)?O-"]LX. M+,<+(C_%<"A='5>`KJ%K+X&29'`UX-5B;(TUL`_PK&TW`4(I@?%1#15;H5>N M`OLO1D@B],HG%]IBD5IDM4Y+K3U>E@H`[&V:[6V@P54UDRGV:6 MLJ3S*/#2*ZTWU7K*C6D]\E_$L)"G-]8/*X0M)!!STBXSTS$7U$Y!4O;)\.@S`3C$AU3A'Z-.?OQ MTRPT#'3Q#-,5$L(TP-Y1=[Q,1SWEK:!P9OLP-%1";-^; MSX%2^`>V9%OVTN2*2@H"/\)T$@`UL=R1!R'FPC**9M+=H$0$ZN`2V/,=+&3( MG)7R:J*IFJ;A(+G"KC7>V\0O:LH&[+1$+]B%-6BBD]!?EM:OFTXI,FN\N![08#*36%Y90[+0UY62J8I4&E4*&CF@\>>&=#_R9V9 M9OAOF$`?K;=1"/H.S?[KR[7RX>L[!#/"IAC>-QM`[T3)TC$MQB?7`_XWMGEI MA[=@T&8S2J2B1N./2[YLDBT02FV9P:,R9\#.:`DOHC46!C';6MYDVQ2+YC,G ML1UQ%VMT9>U>M,1_ZE.PJC(,3`.\-`,"VF+20?BMI@WL*T9\Y87(A+(ISVG(B+&83\NV;%M MJH!#F$@+8N"#S+)BM"RQ]1[+,GVXL"9W5ENBZ8"@O-.F+< MD<`7MN6#K7)G7F!Y2T$'#.:9@:5%#"QHPU=0:=W062F)]E(+`37APB0"6F>1 MQ0U,5F6>/?\;$FR92QO-EDL#0I.&7P(+8;%P@'I_Z?EHS$#02UC,`VF8:C=, M,+EAG?\W*`0*BVA*E*9XTH+7C:J"]\'B5,$%&A3B`3P%L:`2U%Z0>F&TPLXV MUUFW2LYOO M8#G`_\=1+&":XU=K'N"7F[<9WX^OI"XN\O<,M!1V#X6.(CSB'=@C8K\^X'WD#:R]ID*X_[+=B.'?WQA; M#Z[A5_QJ?Y!M(OED?B?S+'4Q M,JVGQA`56YL0'7/;-5V+IC`T&IBB#89&"M3J`36WIUP'-$># MR`FY`7?IF"!2Q+Z+[6JN[0R1HFIIQIV.OCY11X:.6C@83=5)7T\V?5RM'9I9 MFVY/;N0SEFL4=GSC0>H28>/P2)^L>TE;2*1]%8NM=.8E?2@G1^V3XR[R@\B, MK2$W3@C=]QF7RH5R;='60)].1ESU8%HX]E_<\,$/Z-=BE9%)2NC@CL<"P:[@ M8RKTY/MB\CE#:/4>',2Y+7;QV<``SCLW,ATBPP'WGB-G*/887_]"';Y:L5@H5]216EN M0L7*O1:7PH4?E/^)?-ADCU`VUI-=5>Z98\-Z$^07A7ARPU;FP;7GMH6;CG3< M03P="E@>/H)#3=PT!?80N-D2_(FMPQ%!]_$.TX7]%$)81L+7A8R/DC=F@"7?![B MH-?))4BV"?3(T/A'B]^J:CYI::AZ"W1+TT[3,$H!B'/)0U5YA M4KXXLS1.QX-\,PS\P@X5;(RS4C=;1CP+((7#UV9<9&J)K]/;E"E345@VZI_+ MN6`1'BSA[-,\4YF7P?YZ[_E?6!@Z9$#@)<>T%_CP@PU=T';JG?`,*ZAD'1F9 M2V`JHZRY\1Y1.[R=N&/J-8^`$*Z'H'UKA$?CP6@PW*41!]6/;E2A%HJ=I_BJ M@Y<;9Z[GV8>"'.FQHN[X2KQ2)_G[4I'G_M9))3.3!RZ$^(J-?Z1R(,*ND]`7 M+7Y?EB!3\(*^V&$D)NE[C-O>WMXJ_W.G*A]Z=SU:KPI>O!/N)%];Z#O^`3'$ M3E@C'9YZ,]#_-,%;]7GR!C.#.!OR+GL2%#=A#B]0G`YH!0;8*7#_[*'/@;N8 M(.,RJ'LK!U%01D&4UZ;CP?:JM`JJV6#HQON9V"CM&_B>BX\0W'CV@+&U.$&2 MA`I-BA7"7@V/O MUZ,O&%)\S^Y]%+BB4^1A3"+(Q2+(Q202`B^"]C'JLP!5R^3&7HWUJ:J#TVD& ML,V*K6X2U2,7%3@"K\\6+$U]\015)K=6'*5%(F!7*O*)A;RD/'P+WSY M9P2N+VV4@U@:L`]+0JIR"]6$18DUC)L4H\BDK&59@F25R217MDWO]>Q&^FVR M.N6F]._0CA>),@9\0V08L9EX?@O%W4$D#XIL=H5:Q].--#<#S\%X!KQLH5=" M@X#.X1<\.@@]BYPP)963">7#_BZ$N8*4D+9;<70#S2JV"M,#Y]6SN>)65P29 M/!=K)5"W*<#?4_[ESD1>)IEKVRCG&:D"!A.3>$K*@^E'8[=]/B`>DB#J!<\H MC>ZS,/+=M71:W,Q/8+#?\'WG>@T1D8!U1/V-3>Q^Y4+YRJ3=K6UJ4)P@R>B- MFD2"7]^_X99,U!ALU-<4A<&!N@+.'A`<%W$(;5(0?UL;![T5>]+9H:"5CG4- M2)A'CA/3O38!%&'QTZ4H0WZ:,,OD(#,QA?SJ(N8]#\5MX5J.8LJ($J/C2'HN M^(TL_6@*HZ+S.B;>.";HB],0+EMC=.$,WEF\-=0*BK?BZ'!:P*6*N#T/K_*` M'1_$!D?V*KY2=A9>R>6L\N6,R-S=O@@5BC1VP70NM+:5E!IL*%.:OMN$7&*UD"8GGO)JO"R427K"X<;C[A=>VY/`WU.0E!8M59^.]N;FP MG=5/)>2[TZ1=;W/QD5Z$ M5[\>X,AJ>M'N;->Z4T$,4,5]D#CW(`930)@`:R=:/K.EYX=DKS%1/[GZ;U'. ME9KO?JP_/)[!-GB?;9LKD_2PZB\@][:(E\C[YGK/(,4'IFY,%*Q)QO*TN&K/ M,9\#4*-\A5Q2Q";J#E)%WR)W,1_$GH!O-Q8PYI#VN4FUW`8U2$604D%%;S#E M83=#6]4G^\'SJ4P93-`<-Y/F@VF[`7?P>:=2V=J2U_BGQQSES@X=SV_#TGXI MTJDX=ICQ`?('D_)YBHRPUR,J0@4H3O92F'%+Y$TT7&)+F$3=>*1,7]LI;59- MXU`*PV'KGZ[MQ0J#040"^0O`+5Y!_-'OQ>33QBSQ@7;O5+?*BH22-JIFBN'H MA!CJ5$&"0O@L-)@D*)<6X92*/Y4,#^T05KPB$`7E(T5*/5$B7H:V1Z0(N0!M M87ONEAQ2P>&:3.FXR>^^FR6YJ&R%Y`Z^R46M=K/YZPK<"S^,6%R3 MV$`L$ET//:O*(Z.D&49V9OR$0%+_C"JV6ML*U2WEG>'UN3\T:V+I9_ M*:_LZT8F-&ZV<)&/`S)87TN#PD@1!13@JMQLV7]57JM61)RY3L-^LN[)Y/TF+=[ MS#LY)WV.QJ^M0!\02\<69AP7GINVGQX&HF,\GGM%E2^QD\RU@8D3V/S,?V;! M0V/&HXE;$[29W7`R57.FK&B*HJ+>L^2J%)Q+(V-*9M0D$YJ<&N[K\3*>"J90MV>'JO%$XM58$JVZ$ MCC97QB(R;2]+XN:!.;,M15&Y=`-U-J/9(<:S[LZ(+N); M9'(GBL5+8<&,X?FV1QLVIUA'\`JO7P#`4+F(]G);7GXR+J.`(?)S.W3E&,+4(VQ&-DDX?[Z:QEP MP+9L&3!2JFX>)@FHY>[^]8?4DJ7/?[S,7>T)41\3[[;2N*A7-.39Q,'>]+;R M8%9ULV48%YT=K$KAK>A/RN M]:TYNM'ND(>H%1#ZN_;5>OE^UZL]EH-"]>)B!+VPJ@W66]T:S5W]<:5^/&]S]NV'^/EH\T`,?S;UY\?%O9D?*Y>4'HM'99KS=J_[GO MF?8,S:TJ]AA(-JILJ5@O:72-Z^OK6OCMMFFBYL2V@M#&T['"W"P8DC1><@H,!_V-*-H,SOEBN4RKY@RAP,]C+Y>P M1-Z&%@7%S!!XD.4>S&AJ+Z?EFCDC8B#Z@\E@P:(5@%=(M=D]E,=MR_)G79<\ M'\QLHH,S\'JP78CW=KP4YG(^M^AJ,#'QU,,3Z!Q\W+;)$IS.V;`GDB&_;Y.F@?$V.02E)P3!)4HWD5I^4&04Q'B MH?CY%R;XG:AX%^BC-^T1Y M%:(NFTMQ8RW6S6G'>(69%:#-XA"F9_;2#07LP=][%.@%AG$.T_NMCF;^V>F,3>W=0U]_:!OPS6_;JM>6<9?8>\RZK.Q&Z#[$&U[#VMK$ M\A_#`MO2KTXM:U$#Z"]KR`W\[2?,&"ZK]<:FSO;+YN/O:X-H+2F;AF\?X%J/ MR`T?^WW8^:L3:U.3QRTK&X#EL!\=&`4_@4W#*%T/6F#)*T@083V6(X4@;5RZ M'2/2J:T1ZB!Z6VG4Z]O'6-3>,YYDP7/3HN:SY,8ZJF*PD"W]A)(Y5]<;O9+" M8NP"`L^O:,\(3V35TK?6`!>+M@F7V.TI\GXM,-I%$>>XM>X8]1%>BLF012,Z38MCLVEZ^],H9 M8`_!W&)&7,>8+RAY6B^>9`&612`Y4Q8'+%]ZY0#K+JF'`YAI@X!=_,)^R\0K MH[WDE%H;*X-PFU3FQ(6V]K%5.TY^IS0`/\W_)PK)7_N M=J+N5'',XM5Y3#*UA MZQ&[.,`HI^B8UE!FY3&V'PGZ3K:LRF'3F2]DW/CU,9BV'R0BTVVI,H!,PAF$*$+^D\>D1A0'^4")2:Y)_#UO3]/2)=..?/1'0%Z)XC'*7SR=2IDV3*M;=X>60ZE5=I$!8QHU6FB)]K<0E[ M\/=9=VZFOW48;>-L'K:-4WNWU^]O9]B/FO/F:B31599$YAA^W'?Z(,V@JPV& MG9$^-J"!(EM4PQ4TF%-,N,%_KX74[/6$O"5W_?GU:\D!+46C^REH7PSE$DV+ M^,%@(XYL0?[CCZ%@KR3$V1^L4=E)]TT>@1;9W MN@WV[9)PJ6S#&M=A,VDD>S$7AWU?%A!;.0'S[ALL=R98P_[P?I] ME6S41(DEAP,A^(HI0CD<[V`JX_<@["%_X+$WD/SX:^?Q3)Y!('GZ)H17OL`* MQW/#@S$FZO&W*Z:V5"4*)KG?`R8E^:HX$1,4AV^,RIE7'P6YAA5K(]FD4CE. MU7Y*,Q5#,&-PX+6QOR!^6`X<3`POL+PIV]21&X^%J"6[32YD!=6@'(SL#28_ M8&.WM9S`.*+P"0EU4KWPO7J]L MZ>:?6KJEHZ$GG=@`.6&*G\D=X1&!;1CG+0*C64+W.$>`3`QX_S)4^7)93, MRAQD'@GE^6IIG,$H8P*>GG\V9`HJ.73R!YU'@B.D%^6BJ#FS*.(>!!M?2^`T MEKP/]SCLLC50_FO:*;.974,ZQ61/M#_)VW2/')`>JT?E?#/DMI2 M#,U/:J*9(;MR.,$\B++3.=IH_=/PDN=<<0MA(J1B2%ZKB601[;P!:%..FL_% M=(]&>-;_1M#DGKVO-(QBXU8!.D$X%:WB""OF#4`:?[U4&-,DH2"HBI9UQ%7S M!E#=/R1/&-,XF2"BBM9Q1-7R!O!,OF!7)/8F2`5Q5;2H4T0]RF'+$7V]9'W$ MRDYJ!W)?5;81;!36CG/'"\"9<=QT3W?ZY MQ!05/,$!*R90Z?F6",#09X- M9^I%.=(SHO(T>^>_N\YJK.8P0Q"]/"V=8O1Y2_&0%"&*> MC7;>^_)A%L9>2G<@#K)S(;@.)DBMYHA`V,T*Z>@LJ+TZ?N<%41O[X/B;XY1@ MY#)<4GL&<^=B(5*X)S43_P%!LZ#NE`NCZ5?]#!'%Q(G743@&4*P+R>GR$'EC M&S2+5J94?`6L)#5DC9R/4$-I4;TD-63%$06/+2EP:7JT>?[#89OGSW)X2<$K MU2.9/K+K_[!ON\1?4@1_-"XT\^'^7A_]Q>0PC;N^T35:>G^LZ:W6X*$_-OIW MVA#$;AD=LR1ATA:"(XX_Q3F^O-",_E?0_&!4'DMBM[!'3%['F6Q>:(WZKYK9 MZ1N#$?QH/8S`:,""OG9&8^-+KZ/U!^/RN,^YI7W+=Z,>Y_L*S&$\:/VK^D4W M0X;OAYV^&9YC4Q:O*;>X1_PUXOR]!_YTT!ZS5<9GJ4S%*ED15Y=QKCZ\&H!`#9;=.SW,06NTD\DNZX]*:]6_=;EFS\Z^4C`7*R7=D<%KEB/N+Y MT.17NC!"M]!OQ;@LD@M+9_V@R^@C41)ILZ`;;#I60KKD[=J1F(D\?)B86O2( M,S@^%[-$\HY[?@2*W-,3CKK05@:O(^OY'E([Q9;+6^'AM)5[BIHS$1$IXX*5`+CG+36!RY,E8HTVTDKU6('8K6?H]9CFK ML+*#V_K@'2&[XC66O811&)ULJ94)=^DS,VZ@2Q1?,J=F9<]>,IG/F*XD2B\B M4I0_.=FM=>8+D:BP)&J??-8W!L;^>P3UP2?_`U!+`P04````"`#KA*]"/.^Q M_1$*``"(:0``%0`<`'!E>64M,C`Q,S`S,S%?9&5F+GAM;%54"0`#>?*347GR MDU%U>`L``00E#@``!#D!``#M7&USXC@2_GY5]Q]\;&W5W`?`AKS!3F[+`2?K M6@(<)K,WGRC%%N`:8[&R20?>F!;'0 M08NE!5U(;FPZ;@O-V@44JE4&M5^@;2#\-%)#M7/77;;K]=?7UYJ-7L`KPM^< MFH[8U&EHA748ZEIBJ)L4$EJZINY,)/'/GQM=L=F4I&9M/26V=(%+Y!JBU*R+ MEW7I8BRUVHU66[QF[,\%[LH)^Q/7HO^S:?[9,NUO;?KK&3A0(,&QG?;:,6\K M$2M?FS6$9_6&*$KU_SWV-'T.%Z!JVC1(.JP$K:B6I'92J]6J>W<#T9CD^AE; M01_->@`GU$SN&F[8("I\6=_A?0JNPUR7234*C19W>J),XKA;0=F7; M4&S7=-]H4/'"`TK`>YKF&$YO*TOX1CN4FI0UM+N?6-JZ;TN26HY),Z,BU`]` MV$&V@RS3(/PT[H!%O:K-(72=/'BY#3EB&P),'#.')-F`=3#01"W%HJ9Y"VD0 MG<%TL*0#&PG>7J[-UL`/;0MT%:+!P(%\%@U[6\08;8M\E4,L2\@6>J,(^_ MN4T+&%TM8"Z<>X1[YI^KS;#8!0LPRT^O_)9EC9K%CI[%CZ)L_8YI8`NR85M7 MH?,`&\S4!ISG!$8GLJO@-C\P(F5I7!9#N]`%IE4017>4E6Q#'V"ZJ'[)'X0_ MI+70S&-T?WH+SKG'2H\]='#+/E:L3*UYHV0GZWYJBEWC[0V6H6T60H#U`&22 M<+3SE,I/4("B)9]+#].YW%/5"J,6TW3H1K?LR]40% M_'&'G54-M`#FGJ#CK4M`[/547<#%,\1[PMUNRA\KL*S]$'H-^..RD2OO"RUH M4RHGX12L+/=@4@;-MS&3RZ9MTO&M1_[=P@W7Y"G.@$:`G"K\0*V67*;M15&4 MA*H0M(A^!+8A;)H+6^UY(,XOP89P&P1C6.0BGSN#OC;HJ5UYK'2%.[DG]SN* MH/VF*&--^/34EY^Z*KGS[Y)Q)U?<0B.:AQDA?-K26X)1.47;T*"++(.T,?GS MJ/2),8-[83!41O)8)0+EQB>[I!M:X,_3L&2',9='696&7S; MLP`J"=K3XZ,\^DK-T-2'OGJO=N3^6)`[G<%3?ZSV M'X0AL;JC*AH?6Y(JQB'@FUW`C9J@]K\0OP]&W!"Q58Q#C*U=C,V:((D_"YK2 M5P@WBB MVJU*A[":N["NWV$-R3C5YX:+H38=HKS817E#4"KC<<\;1ST7;L8L0\R7NYA;-:'3D]5'3;@GN=U3__OD3PA=^5%^X);4AY6L0S.N/C3N MDSG-UWS4Z6RGVAD:][%)3?BTT(@_9X[C#'"?(G@(^=`IC[/BQ;_0RMCL>YB50M@%_YQ/C5ALRMY- M>LXAV:?Z'H*.S>#,:<_9&K;Z?&A';%;/3/P0NX\\P&XA?0NP10\A(IQ8)_/J M6U/@/'M%KI53G0&PK#?(BK(.+=<)KM#2>*,J2OZIPY_\RY/P,91X":KD8VB4 M!9ZAY?4]&2I?E23!^@G@'D>7A&F8?:%=O.\0^G8HWXE$"H"P@;$MQ5)?$=!6`>-VXJ+5PG& MEAF<.<`PEC3>54=>N7,R@/T%C2>2@]A+L,&2WA]:P';NWI0UQ+KIP"$V=3@" M]@S*:S.5E3QZ*I0FB1LVF;38#CCB;&PJK[Y7!L4-[?J;3D4S*+VG0AD4WSU+ MI`]')E*"\XKB8;!A=M#T]]T2U7-I&E>;AW(U?G"! MPI]L\$B/_B9T(FVV9":%QWM[&[S@6.:.!BC#SJ(GK(XJS!$#4V=/;F$X8(A#+[,)&E,/*LP1`U-G1BXA.&2 M(0R^S.3BW,,0-30M#!=QBBAJ:%X9I+&%H,8?!E)C?G'H:HH6EAN.$2!DED M>7CSA2:M:)@VJ_)`)SFX((K1OT5M6$PW9`FQ:_;0J?LT"2D)[Q9\;R;NS+&E!+4 MSKNW=Y$A>/.^#O`*L+')1F>P0;:+ M@>ZN@#6&>-'(JB.7B^24*70T=Z269([/T]@<$W&'X_OC+L4?#T32=51["+&) MC!V7;(U\>^US<$%P\KPLTPVIM:EB9R"_9[I_S309I&G]H1:C+7OMF8>9N+5 MV3$.U97%%\3??:G/I,<]9'<&U#S=HW9G0U\^1^\*FL6A173.-J\8MV3;D(T% M";WC;E:MRIJ:#9W,+8B]=!SE0`?G80E]Q!>%G_DHAA@CZ$`"9TY,Z,(7:*$E M354??R8=&%H>9>>V/!*P>J#P+=UB0D_M'$SIE^NS\SXF-Y&.<7:QO+BF&)RZ M;#[X$"//DOE>1;&)=)0S%A\H86T0?\=/,GWZM5.'UM-HN^F?ZF MYXF>/_WYVU.`7G"<^%'XTZN3-[U7"(=NY/GAPT^O[N;'_?E@-'J%DM0)/2>( M0OS3JS!Z]>?__O=_0^0_?_J/XV-T[>/`^X2N(O=X%"ZC/Z);YPE_0I]QB&,G MC>(_HB].L**_1-=^@&,TB)Z>`YQB\B![\2=T]N8=1L?'&F:_X-"+XKO9J#3[ MF*;/G]Z^_?KUZYLP>G&^1O'OR1LWTC,WCU:QBTM;SS%V?0HI>DY]-_GMI/>/ M/YQ>]<[.3D[.WGQ;DK)<.2F1.^V=G+WMG;\]>;O&I]T'S?:F3KI+R M?;UOO?P_F?J?`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`6^8J,&BUB)TP>8[BE,V:]49J+3HFR:4%O\HOI0(8BNF@;++L"W[T MW6!W7CWC-5WS.#FCJU&,*]/A+\/?!JLDC9YPW!=20RQB@@DJ<-3QHN?6_:P` MU71K(87Z,`+&C?/W*"Y`)8JAMDC0[#1.!K0^>VM*62='*S1^KD8$42FYIR%Q M2QRX;(\#E];BP&5+'+B$&`+`Y8$=.VAW[,":8P`[#L6)03<<2*10Q,1@]]^29#B:5(_NZB,G> M6@2NVD]7GULG@0)4DP29""0"C$(/?Z.[/:,D61%RTME%NL[^5S&>?3$##6]0B!E1U/[:EU M(D@A29Q]`B/BS!^=&%\Z"?;H61P<)FP]@_V:]%?I8Q3[_\3>'6%F/$\C]_<, M/5WL3R[7PV\X=OT$3V/?Q3-22-7&SD'>9#*6';"JJH'O`*^QWC@.7[9F*RN$ M$9-&3-Q$%#UMBZ*GEJ+HJ3**GL*+HJ0;/F6:[@SKSO,V9YY:<>:YTYCD\9Y[K.//\ MH,Y\W^;,]Y:<^5[IS/?PG/E>QYGO#^K,#VW._&#)F1^4SOP`SYD?=)SYX:#. M_-CFS(^6G/E1Z9'P_JS(LV9UY8/,B\.NUO5: ME^MZEMS9A-9)$C#M6MDK4>`[+L>J5 MHM*QAUHK*EZ@6"WB1(P[5K9BU'@.R['J5:/2L8=:-RI>H%@YXD2,.U:V>M1X M#LNQZA6DTK$[KR'M:<,3!\3F0Y:3(.B'7M][\D,_26,G]5_P\!O=EFKY<*.C M#:.;E-L4K[;]V,6`=2+N@KK)U-S&49ZO(F#?@M3MH,(0$"Z[C]A;!7BR'#X] M!]$:XSF.7WP7B_=9^T&0YUZ8+&?8C1Y"NMN:?1$_B)(TN5S/,/VF8>R'RIW\ M@[_6:(LQ5(FU1G;@=\)IEV8*RC7E_+4H6J+BQ2A_,V*O/J:)0SQ4??D1VKR> M*FX`H`P!8A".T/T:92@0A0'J^U:*<+*<.T%+#R:0,]GFI#"KC803`L-J&3)N M[$/D*),^1Y&7H'D4>#!8,L,))E7W2/K)*_R"@XA]NY;W;4K>:&F:9%*'HE2Y MI:$&AFWZ6)O\*S392*:BN[=AC&2N10]LD5\5RYE-"6,S+3&T#T]8^[O4HR2%#I*,*C2`6F30(4JZM/< M24P95;3W.6-(L/OF(7IYZV$_FRR0/YIS!/+3;QF*&7Y@"U]A2A.6-DHM%S-! MJ3:0E$$R&>N$:0'&?DC7>HBX#7;T"1"/@KD. MG`=!N1K/3;%!"*M@0>TA".^+$'&I*PH91(5L^'JPBF.*T4]<)_@%.[$\&,A% M33&@#6Q!!ID<"%ZT@.-/7C!QE,DCJF`U.&2#E9]Q$/PUC+Z&<^PD48B]+-6! M="`DE3<[G&R!71]62H1!D$@'89-)HZ28F#J(:A[_3E51H9MGJ_BS/5)]B8)5 MF#KQFETKTCRWH)`S2R()S#IY&D*`2"-&IB)+J8&8BD6&Y,$PV[?WPX?L]A7Y M]$LB;G@.JP3=F,H*90&Q1PE02J(?$E1JY%?FH-R2138Q-@](/_H0Q?(5D(:4 M6>X((=8I4Q,!Q!01+LG*1WZ-5"YKCQ#3U7W@N]=!Y#07XR4R9LD@@%>G0D4` M$!%X5!(:9(*(25KL8Z*GIRADB6NRE#:35BY/";:['<8(@ MF-2&3KHNE\^_\^4YIF*?-70U0(\S%4D[C.&@BOE2B@%D2Q-;&U?86LW>F;+# MAP9DX,VN6IDLK_W0"5V?M(`H\16'$+JI&CWPWZ$PM4/[&GK6N;<%6.[P?*%* MCRZ7RJC01K\6^D#.O/>3!*=)"PV;0B8))P98I59=`@R)A+"XG8CY?+B80Z)" MOCZ@Q0A.UCPQ)'!Y?C0$@=%$C([;E+B;S8:W"P2)-0,GH8?KZ3\TW?*+$Y!R M)/UTX,3QFHSQV0W-DK)KZAK]N*9+<6H?W.@H@F%=%[0<"XD2^RB"_5%1AT'( MONM&*X)FAEU,D-T'^!:G>?N2M4&EBM&@I@&^%ML4\F#(I@&2ZQ=S%;31.4(A M!G)!ZRA\(="C>$W*(2ES7<0DA43@JI2I/@=#$0$H;E3['42*_`E.N8/8JS#;@]2LQ M9=)@V-4*D;\B,U>HWR$/@U?"B\I5O%(I6+\T7LHKN3087K5"E-\8/_HN;HQ7 ML4HA;_N^>"FGI,)@*-6&4'U9_/6>+HN7?/Y;W!G>P-YX9NPSWB:<\E/=XH%1 MK[[@^#Y*L&@D+0)UJ/O8#SQJ5D6$-B40XV5I;%!KP)J2:6$5SM%@T*OONJNG M5>"DV+O"SS%V??9Y.?D[P&Q3./3Z3_2<[3_9[]+BRA=(]V3>\%KU7BNEL:Z] M%]MFFL%%U@Q"_$`!*]*9+>LI5PEMK*K*EU-A,:*&B>N<)XO^&-1!A+'OW/N! MG_HX(?1E9X[IS+6\2+IE_51?W>@21,="U18D-'7!S"4[`N8ZOU'_+4;# M.5M>G2\F@[_^93*^&L[F/[#%UL4OX*BJ=]Q*I6")CAH'K^32$"G7[0A6A6PP M.#6(0C*C3WUZNB)*<3)UUO34A'J'L4W);%ICG0+40?=Q6S=-NE'<0,P2!><51'BW`R81MGK-H))I8$0RPE/.F)JEP:!GF* M"T[ZWHM#'-=R($(J;31.J2'7`I18%`R!U/BDE]$4XC`H5%Q1,,-LQ8/OT26% MU]`S22OM8E0)UJH$AFJZ2`5A*UZ1SJ^\B*)ZZ00,`N80M8FGD#?<#:IA-WI" ML3`8@K4AE!%K&D=+G"2$34Y0W'(")+(1:-[*37]V8IJY=,T0.XKU.Z&PX=51 M!>#&NJA`$@R9E/!D3"JDBY.F,$@T21])!]\Q1+4IF2257@&JY%)K@"&9%DPN M8SI50@7E*FHPV*;-,-NLTF.29?:T+M%KTZ9^WAD<;3JOUD-9G^^V(O\=K,%W M7G6'N\I>R5NC_`B5$S.[ZBD&65_GK,N`(8L$&'^36S4-T'_UWO1.T+,3HQ>J M@XY1?Y4^1C&[*_`8G?>.>CWV7Y2PA$%_S#)D>FR'N9(\B,B^.WIW?GYTF?7VGYR='9V45%[']6(49G/2:U\SWG>YI'>A[+ M$>$$4\?W1N'`>?93Z7A?*FUT#JF&7)M!BD7!<%F-CQOSE]*(BA_[(HW%+9I@>&=-E3!M+-RRHM) MPN`>/X30'FO8'KSI#=I@S0&D^,1S@*KX#RA3@,&;MN,?6YX:@75@9YN#.K#X MIHE6?&#L^SFC4QG;3IUX$K/$7AX;YDYQS')9MH^*Y9J6YAAM19%,.V1J8'I1 M?:RJR4EE5O*:C.BNHB!PX@0]XSB;.?P(CII93M7-!*J]>G@-2U2409=0L"D. MD7H2C$K*%5/24@DHQ[))N&X=%-)6N56'K.15)@J74S5\.GSRF0)0+LE3>^NI M6&65)*VWCCQ%DPH:84T/%0A;39B0(G#`>1.M9>DH4(P"$.C'T4S":_\Y#F_ MOVFR'(4I04X_PF[MS+2T3?=L'8K4[.8T5,',!KKA;>OYIJ1OW4/B4TF:REOB M.2=Y)%/<%Y]^B'8=Q8/`\9\2\L?8_\?*]]AI,.?)>1#GLNQHP%C"RZT*5F;% M[*0-9;"U-7(NN584'E,CJ+2"EE&,,COLSXTEE)N"$3CI11U)2J?16=PG;0Z3 M6E;=E"(6-WUKB@IT\P85D2R8X-<"4/Q-628*A4(98/6B!B=EEC!"B'6>U$2@ MA"@U/'Z;+I."]57K+4Y;Q_$-&9/D$,*K4J,F`&O4+H(FROR8[]^^IF)`#L85 M9^B+(W\M^_]R<:.)/UI`U_)]2&3!]#PM`"5G`#(.T4N^LTOB/\&DTZ63^*YF MP7-9FT2JP56QB`F"I5`579,_[!E,LESYP2J5'IB42MLD3`.RBC*Y*%C2U/%Q M-\9G3V$0YV?L/SP2-/T7')-)W.WJZ1['DR5W+J^E,^MNQB35MBUDE8-=;8`A MYY;`FZPMS*#<#BJ.9&:',2N&@/2?NN56]:L=;4#DM+0?[F0`VF[V-N`!=]^2 MXN0]A>ZQ]7R8'I[#9#W%OH:'O&CIWE+L__PNZ'D]^GJ/KV>0& MT>MO^XO1[6?4'RQ&7]B7X,KA*IQ5VE-(WA'@^DX6:?O>WU?9YE22[Y..2/!+ M%M$,4Y_Y`:X5;Q'M)^0<_K5F$R^9J<1Z!J?#OA-,\S)44#ZG5/E:E$:H?!FB M#9F^B/Y*_V8C!/H6TKPKY^TV+T+',)JZSA5W$A_HJ9IL`,'W@R-"KH=\^X"W.[9-_JV23C':1KDDZ;&K2:B\U4: M2L;.N&D7H#S7UJIA/1IT@BGE3ZG)OAT`>?U,L<&(O>JU$K*)O438Z(J)$G!M MK40H:9U:6O#X]9'(_?WXGDK7[O_8UYDD_7.YU>:P\QE=76,VS^MV*[#J[*Z> M)>L$W0M\S<.\]1#Y'1SM92=%\\I1G\T42AJ_-D(,E;LKHBYFG8+MV*3\@GE: MD\R58TRB]Q7._B6S8UJTS129C4C)-*.26Y),=-O3]^QFU7":GWU402,=T"XF MP=!\/^7@%IX?R?^CB=!J2R3,%)N=5HQ!62[A*Z(8-<^PB_T7P72HFZI=PLL+ MHV8UKP=M7[D#9NFUG!M)0#DG^(+13TM"\C9?^L5UBXY=#@K@J\E740`<,'F4 M_$GK4@(JM:8Q?G9\K^V;GS8UNP03%T+-L;H._.`FQ-LD7"X$+`N`/%*+EQL[ MZ,'H7`6+CMI*\)FGMP()[M$1.U7H$E!2F-0@V]``/]*1@I?=F@^I^]8^5[7PN#>J!P=T."H+[ M5+@;;M$1M=;3+*"IFZ5:V,/95Z4A`%36**@&I156P$3=K:&WG7T=W7X9SKN< M?35ZU;R+L9=<$RK0@Q_:>:YT%`U?0:]9D,9U]"U:8-BI#544:PME1"MMWR=\ M]L1$9\V.0"ZBOON/E1]C@IET"NEZ2DJ3]D./WC+&DO3**JB#`:/,[%RP&D.U MM:&=1^N,G%M)(J`>R>@W85S-E=D>3JD)E+JZ,;1=SRI1M2)HFQ)X6FJ&T=K- MOS1N(GI;`93@R74.G:-G%PMV._9N\5-?'7!7WSET"OM[2'F<]0?;.X_6H4ZC M=IL^?10$DW,R;+RN6!&AV71,_6T$%9#-F`0:@$AIFZ2*47 M*U6'"*0J,]8F/)`O:8>E%G6%ICYL6N3>X4^*@PP]E$3 MR&&+`S<.OW$"VI2G./8CKWGJ1U)YW4P8O:9X MB\+5[C#NH`^+T%L@YR@]7*#1[6`V[,^'Y`_$E@OZMU?9'\._W8V^],?#V\7< M4DH-<1'[I"''\9HTM2].L.K@U8:BX21;S\PS\]2)T^YNE4$7+OB(/'B$+H>? M1[>W=.UG$.XV1^C MJ]%\,)[,[V9#2M%R*9IT-->3V4U_,9K<`EE[SO*K+9QO.!&L[DFE#)]!%T%L M'#>OBH"AE!@7%^38T)JNK]&D%'DN2:8$@R-%8RBR])6[C*$GF$-<^8D;1,FJ M]5Z@WW+*Q6#ON2\^\54BYQ[\VR]09SD.)P'Z'G]I6[B%TS(Z'79Q^RE?(D MNPB%&BM^^IH;W7GYO$M;6T1S,C!+ENLKO,1TGZJ:LVQR'_@/["_]]J5OT&Z; MZEIP=3O2M0:X[70L@G9[22.4&T:%Y7IBO(IM]/KTW?G1V>G[O'T`V4D2)P#L MT^;ZP!K^Y7HCDF]?]$ES]DA7/GFFLG36GJY'(>FI5VPGI-A?DTT6#OM*^VD@ M]UMY[+LG6R;HN8F]IGW4G"NA.?&6'CJZ0V\'*9H0-SLF@$BJ+D(G)> M=K=AC)O;%J_D9U<#,#BZ)6IIA&SE:#[4-QP_=QGK[V#,7F3=>HR_M248?-X5 MODX`)L/Z)!_6>\6PWJT.ZZ.-61BC^#S5DA\^3*/`=S6NX5$H&+U`IQ5X[>H; MJ;1UX36J>O$'SNYN;_NP7NJ(^'WV^'5V/!OW;!>H/!I.[6[:L/IV, M1X/14'D.QN1V999?].2X=N"2"9N]C$T%N'[]FD@2 M#(&4\/@KUNY3R/&I7IBVT"25MD\QO!U-9N2?P=UL M>(4&$Q*:9HO1Y7B(;B<+,/&I+!;;7BLGQ#,S";TC4_C%9/#7X\O^G/4K-]/A[9P= M,(;1*+*]VI8NHBEDDK)B@%4&UB7`$$H(J\F/3`A=E00P&-Z7)W[)\;G_!`=MF M=0*L/97?S:3A'#X[%[Z1WF=K>V!XOH=""#)6,)-'B!FMIUDM[L^CAH^747R< MT(R"D!I^CB+OJQ\$I%DW,]-JA_>.-DS2=JOB54G;R0`8RFZ#FLO;EMLH M\K?D5HK@##@+-ODR]%GZ9:IQ*RA"EI0:`3/(`I:$#G4YM MX>GB#1J,^Z.;.;J>S-!X]+>[T14905VAJ_Y-_S.4[?A!%"910`OF1R$[U+EN M&\"K58SFR]``7\N%H9"W3K<.(`7YE6D>T""[5ZEF@,TL\ZL8P7QJ<$>3\`Z3 MU'\B[4F6W[,I9))88H!5*M4EP)!'"*M)E[LL;W$I!H,40R<._?"!IEAD>]1Z MP:A5R^@^KUX1:AN_:A4PQ-+#R1_%9GFF7H^C)/D1D2B4G;*!0;@R<98>T^3B M5A*5:7!+)@N&5"T`)6P"E+5L[CYB;T6O\VJVCRL_6*4T#W+V<2`91B;M7SEM M:\WH^8/=BEP[C;"=*:/T?<'Q?93@L>J(PD[%^*Y"YJ:HY=<2`WI]1Y@N5.MJ MW=7M,%JO4&(*JW7A+&I4E8Z:!H/T=P3Y9DGBH_CM&F9_@`C%XQ&L=?U$I@J*B+E`^M^7U: M^66%]%XM\'=J:3:Z?&:Z<^,M[<`,JXUB;A=87YL/F9+)9@`C[2T[&3!\09'*I=OA;CJ4/46%+90;RV^= M1!-H`T!VBU9^%4I&70:TGZ:Q?[]*"3>>F6[$%NS MEA?4"@)W@*6Q-2$I(2=E^&L+$<3&!Q95$3#M4(QKFX,GQ?T.9*#Y/ZL0H]/S M(T0P?#PB8]"-J$^X10>EFVLAG!3]U\F;T_/-:/0(W6,GICG[_6*CB0A1#%3$ M"4]C&'JD8L&ACM"X)IBDHX0DNEJB3[)CRTXU6 MSX38E&QL2[0+QIJ]J@28IB^$Q>5J*(30KTP,2+Z9$M;8#_&(_"F;OX@$K;"#`RID M2"D%CR5-:`JF4%'$9'>FB^1+^1F]N7.R+&[AG,:^*[X^4")H[&MX)=#R^W>A ME'4*M$+C5\J(+%UQ+2X]I3V,>[!T"?5S$2+P30EC;A=#*_U=?PS#T4),W"$A M)D1=O)_+&/?4&Y1IX-7W^]XW[_?-#P]4QD2-+=@9?G)\NC5!1EML$V_E!`L< M/YW*HJ4-),;OI[93U=RUU69A6&^E]LO.K6\7)PN<_&2!N]%#@;\$LL76>OUW M(KO_.Z^QS]E]M^$4QW[D-2JMUC.J7&8*`:CKZO=?M9UNK]_?ZV$U?Z-E;FWV M]>'>@49[.3(Z"6T?^"F$C8T!6P&7PT&II'72:<'C;H#8R*.P,6"L?I5VL"_2 M9"D@VUI.2\.IE$O5:DY$=6CNW>9241JNSDTZ2T,OAM'Z#)=6U9B_;A_XC8]! M](<+\$Z0MN#D5]Y(',VO*JM=*N_2&YY@C,&'3\]!M,9XCN,70A5Q"6_IED9" M"4KYF["]^>IS>F/5;93^@M,9=J.'T/^G])NU`[[/:`JQ0U=;[8CUH5YF/9": M*B&76B^,2Q%!TZP.AHIA$'TUF&^R#E9?V=SC.HKSGZA<<]QD"\2_1/M65K"1 M1B]$\*\?"53%[AX>2A/T%!"Q:VF(]=GQPX1^GH*324BOWDDFR^SJ"!&EY-*` MOK'5`,E=ST)4Z!$7=C<6F=$Z3-RP2]BM6*? M:E;'W=4I3`-5LUY?\L0Z_E2KYXO`=3SH*6>!Y#K>:!7SP.+]=P/@DGZB.-$4L^-Y[#J M60R..^T9!(B)H:+&$XL5GJUFG4BJN_845F6+H'&',ID,.K%>OZ?*^CV%6[^G M.O5[:KU^SY3U>P:W?L]TZO?,>OV^4];O.[CU^TZG?M]9K]]S9?V>PZW?O^^5]?L>;OV^UZG?]];K]X.R?C_`K=\/.O7[P7K]?E36[T>X]?M1IWX_ M6J_?"V7]7L"MWPN=^KVP7K\G/?4$HP>WAAO89%.,GL4ZWN5C"%`UKH*XCX\B M#KTZ))M&-Y[#JG0Q..GJD,W)=`%"-IUN/(=9S^HI=5G/-B?5!0C9M+KQ'&8] MJZ?693W;G%P7(&33Z\9SF/6LGF*7]6QSDEV`D$VS&\]AUK-ZJEW6L\W)]I1` M.NV=R+K!^F-8M2S$QN6Z)?^/YEZPV0=F0'NR%8WZ8XAUW%.O:>1UW+.YJ$$Q MG%Q_C,PY0-=\&4W4"?//];YY$>+8YPLT)L\/^W%A"N2D@3I[C-`W89Q&3Y6X.U[,$WOF=BJ%)A(U-=L$\-%K0X6(R'-\/;!9IN1'K M7>CA.%C3_'>@1JS3V'\AG")3'I=%B/R:N604NC2EG]YR'-/5@N:X; M:&Y:F&FCYT(=X5R?YOIG!EA&PV=BPHXK(Q=C+Z'W'!1[1)-E<3_1(IJ2^GQT M$ERYHDW@ULXVH+EXVP+P[LXL(6H*%;9HDRZLT>EG80]E!K/&;8$K3Z'='D/O`?V%]\`-[)&BQ&[*,HW-TYN4TV$:DX MGBU(9(9181E53:.*;8OG#5H.-(-<@A9B$Z_SHV$VW'UC952Z8=F(I>G>NA%N M;0F6XW8M!N?C:DKS/!,ZS>N2MSNO:'>U3QLCN^WN7S]K"2C*&2[U]Y.]1-XC M5JZRW'Y!GWWH'?5ZO2('%C56_/0U-_HC MB!Y26'^2I8$NRK!8M`5RG:Z/>C^IT<)EAHXTDN4>RL,%9Q7ES$4D7NYJ`):G MMT3/93PL6GZKI_/F;,?CY>V++#&!XJ:+F@"@I`QB7-R'J4SJ".5R,!,PG%FO M5#&>9F46`NA7,@=P5D&*QE1=F;C_@-2=QM$SCM,U/?F1DHY]2#K39]K(/L>1 M^,)`M08@OVG*$[]?[+?I14@#%%[L@V(`'LODN!^IN(%J/J&(U2^@]&G^I8CU"#8 M49UAT.*`Y")"E3P@"FC![!@!B*K5<89\@`&HXEM2._5MI'(JL(U]Y]X/V`W9 MBC$;+P6H>A7@FE5=$;4UA-O<;41F;X]1X.$XH0TJ78LJGI<"5/$*<,(TL;GH M#R@31OTTC?W[5:0C8*XK MR=3)[#,SD,TJ:B90;L.2+R=DQ.S01,K%R2*1VS@A0!Z28^._[,\EBRJW-8XM M@8Q"-WK"8\F"C4`,8KT+T,EK/A-&KZFXE9TB!VJ(`&I0,F3%^H_(#S>?#FU,@''B-,;T_+9BMY[H>>GA`/_=BW0KI."U?3=)@]_;L"2\VYQ.BA& MO![V+M=W"?9&83F9Z;MD_LX6&T5.U-<&Y,PM0'/S!)RB0?DI-#&"[M?H-;5# M?/LCVDP%-[9L;9UFIVB31=1WR?PEQIWVW?6U`?EW"]#<)FMN@FZ"Y$:`[HPW MRTHF3J0@/ND-Y/NQK4J0G2G%JN/#C3*RNLDK"4&C,+_P;:NH*]`&Y,@M0'>, MNJ4I>U'7R+>[0%;!\Z?=RG7U0,PB<1)PS9D=3@+R_:PFXS?C< M'HW:A45*@6RIO5Q=/Z)1(/]LB5D^H@0)5G0)'BV^1MF/Z`:GCX0[OR[8B3#Z M=L1>;^O`RZ:VZ&`O3*-XG1\:7$BS0W75!4D.3<@J-I0FRH.6$/U*QQ==?,G+ M@_2?`J;*9U1-STO5G\;D+_)S\1/YGWL2[LDO_P]02P,$%`````@`ZX2O0OV4 MN9>6&0``O8$!`!4`'`!P97EE+3(P,3,P,S,Q7W!R92YX;6Q55`D``WGRDU%Y M\I-1=7@+``$$)0X```0Y`0``[5U;<]NXDG[?JOT/7)\Z57,>?)&=FW-F]A0M MRQG5*))6DI/-4XHF(9EG*$+AQ;;FUR]`4C>*`!H4*8#>S,,DL0&PN[]NH-%H MH'_]U\O<,YY0$+K8_^VD=79Q8B#?QH[KSWX[N1^?FN-VMWMBA)'E.Y:'??3; MB8]/_O7?__D?!OGOU_\Z/37N7.0Y'XU;;)]V_2G^I]&WYNBC\0GY*+`B'/S3 M^&)Y,?T)OG,]%!AM/%]X*$+D%^F'/QI79V^0<7H*&/8+\AT'O>>C-I77^\O/YX\1[XO7+3.__=S;VP_HKEU MZOH4)!N=K'K148KZM:ZOK\^3WZZ:[K5\>0B\U3>NSE?DK$#]M6E.B8\#,&LP7]U^FJV2G]T6GK\O2J=?82.B?(CTS?Z?B1&RTI4L$\(900GXST&*#I;R<+M*0? M;%U15:"?^QND;[1<$'L)7:KN)\9Y"0K;V`^QYSI$Z9P;RZ-2'3\B%(4B\H0= M:Z1M:`5$,(^(6)#EE2:T<)1JJ:;&B"B(X6`Z6-#9BH`G)5K^"/51V[;"QSL/ M/YSZU@.9B.W9GO3LG@Q,9M&\?$R/W9D)!DNT@H M=KE1#J>ZZS\18>``0%I!TPJDAGP7!V-DQP%R"'3$HXCY\_`.!SWW1YQ.B[?6 MW)J)S4O<\UBS9K6S9_6S*.R[$PIL13SLCE7I.@`CD]FAYC4!*$3X$+6M#T!* M(9V/I:&W*+)M=-)5Q9Y8:IUL>3)A;0ET?A(D`A4?2$PQ[YP4X7]$+\.`FS_U?(=(^UN;/?/*%[1[&%[ATR/AJ]P(!+5L/.M\YU' MI_D01H%E1ZN!/.L!>7K1RL)I?R,_^I[2,$(SEW[:CV@(DT%Y<=,\I=NJ8`:V@0,'!02NU:!68.\H MP'X(,&MQODAV_Z?VH^NM=6<:X+FL+#.Y81$GV_(E-!P=A#;A)+"\+K&5ES_0 MDHO"7EL@#"T-<6#PK0*(%2,3,JS`?M,F0+%?:B7V(BY52GN(`A<3%AQZ\"(0 M>ZXM4/Y76LJ_D&\50)B$&H=2=.=9,P8`N39`P;_12O"%?*H0>#L.*(]W;FA; MWC=D!7SE9S<'PO!6*QA$W*M;@K\BS_O#Q\_^&%DA]I'3#<,8!=REF-D'B,T[ MK;`!R4$=0%^P1W;[5K!,T@Q"+C![;8&`O-<0$`;?"IW5U(9':($#&GU)DQ[X M/BNC"Q"6#QK"PI>".G02+6F3*76&`_Y&(M<2B,6UAE@4\JP.@F'\X+GVG8A_`L85C@]X?D<^TD,;OQ(&`\'<90DN!$CY4]2W(Y0?+3<9@-$ MHG(7F+J#Z9[HCOR,M9APVD/AT7,[SA2`>E2HDP['9*LU%!$]-^@,Y@OP^/5\ MC[T>^4$M07)QWM\Z0GYIG!KKS"KR]_:@/Q[TNK?FI'-KW)@]L]_N&./?.YW) MV/CEOF_>WW;);_Y1*E2^K653*WQ(`(O#TYEE+5)50UX4KGZ2U[GLQ]_7U`ZF M=ZY/>'.)2>#0!43685T/MJ#RO*7G*P(N\HU4QM=EP-B)LQ0R6N4T=B@(F>,. MPF*OK=)8.T.V>])G<*@'"#3#DTS*](_.C]A]LCQ":FA&;2L(EL0?25+G6<$P M6%^ED7D^!%B:&9VP6Z6_C9"-",$T6P!%&:LL.^)V41K#!R,%85L/@%9))TM" M(`.0W29*8_E@`(K8TD/@PP`M+-?IO-`L#\0W!49;I7%\,`1<1O7`8H<7R+*N M.$X/GW^*&-N2.:%ZBL@OG5[*+).VA+`(1Y:7M%1L.7B!@F@Y]*QTET;6P,5< M[)@!^BD-]HN=-##G>IC59XMPZZ-@N4WJIP"'K(@`KX/2@#]<\!C&C4XP]9`5 MHD?L.=WY(L!/Z84J'DR\#DK/`DK!)&9?#YCNXL!WHSA`A+$[]X7^C8L2I[W: M$X-2*`FY/Q0D1M+F%_3HVENI^CDA;WZM-LI?2J9YWDH[!D\H>,`ATM@UX!F* MJ)/:`X)2R,+DT'1'D.RNXWGL)1?74/)"0Y8M3U^1H.#XCCFG9^Q_)3]G"H4= M@*AH>+4'&J4TJ&K9RNO:=:IK/II1(M1K&Y-%=L2$WP6J%?6$4*J=5XK#*\V< M578N,1=&`>#8U1-[*6?1!9>SFXM2S[4>7,^-7!02`20)"M2'1T%(A1$M!;$` M>'LH>ILF*1X\MSA;5L+,V7@!Z3S1C!S! M$02S-?C86@-8!"SK@4MGOO#P$J$12G9`^QPR$`+T@V)53YQ(#BNP&/1`C5A\ M$$N@Q6D/1:F>F(_T1,=G6P]TR*;%B>WH*WTBP"<.$*5Z\T#;_LZYL#$4EWHB M*7*X\!G6`Y1!]$BF8DF[$76"@E1/8$,.))@`]``+#-`AH-03L9`#!01$(\,6 MTH&*"D(3EWJ%)IH2C-BZ^L+-+-UK!H6EGL"#7*B!Q:0>$)B.DZ@342S+=;I^ MVUJX$=-G8+:&`E)/2$$.$`'+>N`RHJ\]^<*H5*P MM;BN5_RZ^?KNWE6YNWO&+SOC_KS+]WJ\_Y^^_V&^/S&,09#PZR0>\A`%R4UX M\7:`W5/I7<#2&P21)+2#+GVQP(RC1QRX?VWF739D^SV4W@@L#16+42"LH+K=W!-SQW<#PA M?WSN](DK.+@S!L/.R)QT20--'G7H^H1UM*9>X"DQ6RL-DSPA/V;>'=C\6J4K M)Q#S;K1CEQ]=IJV0N*&?,';",?;8JTBNE5(?3$+H#/::?U<1D32A'KZYL0MF0(\G.0:9Q>ZF9,;MX]2WTUJR@.PKL<\ M.$8>&7.6EE?UZ/T,9^[ZR6/UM"(#'RYH9Z4NG01N^;86/Q,=^2DJRW^%`7,HR!XWD&$I?M9``J)1HFK]( MTE>^PH@*)Y4544A$$.(]9%;<7.W#&!)`BSC68TNRHHJ_]]AKI?8I#2D4"OEK MOD'U423T67)MU+Z2(3-'%O'6=$=EE8"V.I,51,O9S=4^52$!HXAC/6;`/)4W M5NC:0%"RMFJ?B1"*F0/)#K-ZXG'K>G'$/'IFME;[_,,AF.08U@.5K\B=/1*J MS">RDYRA?CQ_0,%@NG<2*YC5Y(=1^[B##(YE1=0L@'G3H^08:I]_*`U7"`JUA@=4F+HR_AW'GXNR(AY"\^(:9OC MWXV[WN"K+ADQ6UFW:P[A*=$%7=3N,-NK2!4!^V9Y'R*GZZ]CR:8=N4]I@C^? MPS(#:9(ZS00QMUTM*2@]EOX:0PFUX'.`O"6"#$HO5?X[3D.'818N[A*%#"=X MA&SR;S>I4;$A?H*KL=/Z/ZLT0Z@:M3D6-GIH(N1A488VP;JJ+1)S+"RQK%AT MT@&]3EAKJE:C0!/*']4V],CB]61`J5(7?5.I&(D`E&A"+8K(YB[UJ'-O_G&0 M%_136]Y'D0*`9*G'LK$Z7T!.&\_IX2O/66`U5EOM1P'(?*D=+UUG6\VJ2-V! MCJK)?416L#$5=E:>:58(5%WZV MQ)I_5KC/[:K@J\OT'P1]E.>QU:\1!3+2U=QWB\>"$Q+\:M<@7%@#KQ7Y'M>E]1U$,EK1>HV;L/^\M,V?L=56; M-'BL:8,A,3T"L$=69A#7@+2^]IE^/8'"R/[T)CU?R(R@ME!872N" MS(S1"+?N8'=.=>FQ:I"6%]@K]?RS5\L/]_RY`ZDMA%:1YP\0E1ZSP?8T1M]7 MIG$MPOKF95_`?,_HI[9XV@'`,&9YKGAJR@,:!NX344BRI-AHZQ'%L.O;M,:; M0Y896O*("1*PM]JB:%5!)24J#5,SMY6M\X("VPV)LF6E,(D;.HP#^]$*D9QU M@D=26X*M>GN5%*$>\_$(+;)MQV#:P_YL@H+Y+7I@UP9C-5=;OZT:-$7":/[& M"RZG@STLU47BJE$)>8$UW1FG[)*UB_Y!=Y1/9*])SZ91X&(G?\[!4!*Y(=26 MK*M&3ZV@R-04;Y.4-.9PHA,8*UY6UU?6P6+?*9B3 M;MW0]G`8"]^@/'Q8*-SU1.5D#;$J,=84GBL,"1+:5@&'0Z_M53@^%/=Z0GR5 MX8AK$<[QE62"QT3TX71YF_D-VY=+!P^>.]LM3P=1#/B84&6H)]1W-&60%;*F MQ0K7,Z6@CO6[O[M&,*O:;'8FKW2%JUCZ+B7+1Y0:0G%9 M;4EWL(1T:@)JY65PZ,B:<,&2'T9Q<6TYP,I*Z5C6=:`;=L!XB@MQ'VAW#?.L MQO%\;@7+P73LSGQW2AP=,N&GM_R(KSDD3I>]?6*T]JC>$R]JXW^2?[3.C/'] MY\_FZ!OUHL;=3_WN7;=M]B>&V6X/[ON3;O^3,21.5[O;&2MTI?:9$[TTR>F@ MTHWBX34A&G#CL;,@H)U5NC9BH'8<&REQ*#:ZHAOS:\OZD+>LRS.CV_]"]B># MD5K369&]!`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`704Z4ME@(R5^D;*AO5!@=X MPG]M?F_RYO>!F%]G,NDEZ17)*IJ>!8R)-7XS;WJ=4M;(.,+BD"K*E8#TK/*T MC?-!H>L(ZJHT)P&.PXXK*2$3U>E(XH2YM4V\S=O$]9G1[IG=SV/C;C`R>MW_ MN<_RD&[-S^:GDE%)UJDNDU!1-BV@8Z7'S\SOB>P!U%.E.<`QV#E7A@M$]0H! M.D%FGB2WWAUTDFS\LAI997[>:SE4WN19$J5(*%L*[8_;16D.E=P),H1W/6Y0 MW-.;^YTP&Z$OS"A?G^!MW!8WIGQ2SKN3U^A@C,0^Q$Y M,0W'Y6>$6]>+(WK3.$V.)*YL*,Y(*SM:@U+4#A-8Q4_I*\IW8]FU(.M-!\-] M/>EO&TU<4]BF+X'YT004@@)W;U!:G*Q,&FR.W/0ZEH&63;+3P7*;GFVWT4U* MG*2-%G5I1MX=A.TFFV%QXA[#`"]ETO>T,+J?>7P,(RZ^A)FH0WK',LSN>"\E M3;W\P*\KFZ\Z43=BKWR+(LOU"J:,O90_RK'\P<49'Y! M.(BC,+)\AXB"-^M*CM&@HX)2TM$#V.2MVNQUO%05$Z+-*`KC0@]/4\ M'U>!O<,EI@?L^=,3T;4A9G,@0MR(RV0#SK><1? MB!`'30V75\81)1`064>W5<^+^8=@(O9FM0T$]>EJ';E/^QGZEWLWW,I%A(SU M)W[&ABK@@Y#D4'4C\DQ.Y9+7/3LOMA<3[:`%>VCP,DZU:#][P)Q3IE@L5S-V M<^)(E0I3GW>"F#'>O2MO^<0)#8*XKR=S8DW7R'K^;$4H<"V/O9\L;-N@G`@N MMWKX*6L2O^+@SZZ?5#D+A8CD&BN-L9;%I)!AS4"Y0M,SM'(' M7@S"]UHU(P^+P9PNTUIZZ)A=%?L5L\MUR_>O5A?TD']:G/`"O20;;X-CN[*I_123_=^HQH7@=#&W)MU%8Y MJL\&MA$L%$M-A732;UT"(+B4A*"FND7'A.#RB!!<`2"XDH2@III#QX3@ZH@0 MO`%`\$82@IJ*+1\3@C='A.`M`(*WDA#45`#YF!"\/2($[P`0O).$H)YDTJ-" M\.Z($+P'0/!>$H)Z*@`?%8+W1X3@`P""#Y(0U).9>U0(/AP1@FL`!->2$-23 M3'M4"*Z/"$'K`K(WNY#>G#4?A;QDZH4!M$66WB._ADWR<7;)"2V#Z0Y]K.@G MHZT69;=[^;C[MD2Y3-8DV-TK?`R)YAOI4>F:*\MBOO0X\MX<)?&+JF^?-B5% MU;,+=EMWKG(7M$:(6BOY>1O[R=E4;'D3%,PO>9'>8U.B1]EMKO8H1$@C%=U; M0[8$$&82N&%(X%-:K-P?HL#%3DX(.S.5#;MX7 MY[;A7FD'2`*8'G<+?Z:"_4P%^YD*IE<+#R\1&J/@B4SAC)7" M2VAQZ074$;+QS*<1G-212S3R9CE""QPDG/+RPFK_;#,4HW8QZ)$Q5@UW&]ZX M26-U?4P'C3J2M>YL&VH2YX%Y9!5-?\@C8\X^(9\XL;0JING,Z47(*/7C.B^4 M0Q1R8^Z28RC=)=1KB+M%$4M(5H^0TX@`0FAX)$3?HB?DX:1:<48Q5Q5`/=4^ M]G,T!9"0HAZP4\X&4UJGF6_O!>V@QQ#UA.V.ARE31'H@6,RY5%RH$4=*?#Y? MP8MJ$(7NTRN+(0U`T?A4.,'IJY#KWU-=[>/H&XHVZGZ(QUCN>PTX8JI=VGI, M#K6QF`:GO`Y*G9,J4-VV?+%DI*PT^PW]'PV)DY_\'U!+ M`P04````"`#KA*]"0TC"N:L)``#Z5@``$0`<`'!E>64M,C`Q,S`S,S$N>'-D M550)``-Y\I-1>?*3475X"P`!!"4.```$.0$``.U<6W/B.!9^WJW:_^"E:JIZ M'[@87+F$+4+5MT9*=D'^_1[YP\R6&3D]<2_*0$.F< MH^^<3SK2<>1<_;YR;.D!,TZH>UV1:XV*A%V36L2=7U?NC:IBJ)I6D7[_[5__ ME.#KZM_5JM0GV+8Z4I>:5 ME\\FXN59NH_DYO5R-R:>%[[[WU2^N M97Y$JNZ8NK7Z,J[??K%O^.WJ?K:?%GP_J\./<_/;?<,@K M;BZP@R1@WN77E:UH/K9JE,WKS49#KG^Z&QB!7"44[*QLXGY+$Y?;[78]Z(U% M$Y*K*;-CTZVZZ)XBCM>6H9?DR!.7>\@U=^0M;ZVP+7Q>#SMW1$FJZ$4H2F)1 M"^_)<6S6YO2A#AT@+S>K#;G:DF-QGU?G""W7*C/$IX'IJ"-%Q:6NZSOICEH> MJWM/2UP'H2I(84;,M=[S2KL*`$$T\U1P04\*NE'ON2V%QP-J+ M6D3;EWI1ADH0[4G&7_T>A-# M>G<_5.Z[&O3\YRWT<6Q'B(%_"PS[&;*?X6%7-IN4UG&D2.]V!CAMDM;QX_I, M7XJC$HR:LE`RY++).$(C1^Y(^ZHV5B08";VLG)=PJXHN^31^? M864CEDW*>7%25,7X0^H/](]OI.1&^YG$5D`GFZZ+X^@Z\?1F^(Z#V),^,\C< MA8.@B>"`99K4AY.1.Q\!,R;!T6(J*)M-T:4X?T$Y9%/N,R@>);DF&?=W=\KX MLZ#%T&Z'6E]3E>%$4E15OQ].M.&M-`(65:UGG!PWFOL`;E"V)F"[(3O*[_>C MW*Q)VO`#3'Y]?(IA-+!+*#.P"=&P(-T\8.:1J8V'U%O/[%R1[%"W]T/=JDER MXQ?)Z`TU?0P_U/LQ9!](11]ZXXEV,^A)0WURBAQXU/Q6O4%N;O!C)NR MH]G:C^;E)IHC.-8-3S&JS_5"_AU#W M)I-!<'8.IF]X+C,@\I\5V,].+O*JC8C#^Y0-R'<_+%NZR$'S^"B1TY\=]_/] MN+=KDCI0M#M#ZL,Y8J#]=1\5,EWE3KD]Q0-$H=KCF'KE^;I%OOBAN@5JS&B( MM_(RG8*)2$L'D19I9%/V8Z6F]"X'_IGZ\W1CFUME[JR! M`H+9\3^V*#UA8M(+T!U*4JF>,`&%DGX7>XC8!^T3L4HV08FR]\"- M(AKAC;-<`H:(B;^"/>`CR-OH9K.8J+B/8U%:CW5Z?&YM\3L++:4]FX=$K;Z_ M]Y_N>`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`UX0,[@)%+JQ]?NST,+G$J\7;P.=;&'V-,+(!Y2UT1\ M,6+T(?C7*'W*\NXMAVX=JG0`+7^K\[#GMY*_&D8<\TU?<:P!7EGA(BU3OJ%Q8]WV`0[/]5C:F)L M\3ZC3F^%F4DXUF"8N]/T:UK-1KG/MB')BY M&[Q`8.S/P>OC)0V6=OJD.CFA!H#ALZY$3J0.,E'5* M;7DC7,16*N7&`K'-K#E0Y]B33:#_`B[&DSD':R2RZ^81>J_M:H*90Z?YCQAX M;>=SSCC[9_1"HJ4[HN>@GN"5=V-O;7P%98^MK+S8QDM,VLQ=99^V(I*E8RT; M=(*T8J)EX&R,W#GLA?&1"@Z9YB9Q9G6^-A-#7SQ/T&>[:3[1^MIY+(J;P)". M.$_@M<$'0!)W5A6Q3DDK_/X>L.%AWT!^,?%-JK>GC/`S[^#U!+`0(>`Q0````(`.N$KT)< MZ)'4;$T``%<4!``1`!@```````$```"D@0````!P97EE+3(P,3,P,S,Q+GAM M;%54!0`#>?*3475X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.N$KT)^9RSA M]PP``'*=```5`!@```````$```"D@;=-``!P97EE+3(P,3,P,S,Q7V-A;"YX M;6Q55`4``WGRDU%U>`L``00E#@``!#D!``!02P$"'@,4````"`#KA*]"/.^Q M_1$*``"(:0``%0`8```````!````I(']6@``<&5Y92TR,#$S,#,S,5]D968N M>&UL550%``-Y\I-1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`ZX2O0CUZ MP=IE+0``P&8"`!4`&````````0```*2!764``'!E>64M,C`Q,S`S,S%?;&%B M+GAM;%54!0`#>?*3475X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.N$KT+] ME+F7EAD``+V!`0`5`!@```````$```"D@1&3``!P97EE+3(P,3,P,S,Q7W!R M92YX;6Q55`4``WGRDU%U>`L``00E#@``!#D!``!02P$"'@,4````"`#KA*]" M0TC"N:L)``#Z5@``$0`8```````!````I('VK```<&5Y92TR,#$S,#,S,2YX M`L``00E#@``!#D!``!02P4&``````8`!@`:`@``[+8` #```` ` end XML 20 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. 10% SENIOR SECURED CONVERTIBLE NOTES (Details) (USD $)
Mar. 31, 2013
Jun. 30, 2012
Debt Disclosure [Abstract]    
10% Senior Secured Convertible Notes issued on June 25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest are due at maturity, September 30, 2012    $ 50,000
Accrued interest -10% coupon due on September 30, 2012    1,250
Outstanding principal and accrued interest    $ 51,250
XML 21 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 22 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Mar. 31, 2013
Accounting Policies [Abstract]  
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Operations

 

The accompanying consolidated financial statements include the accounts of Precision Optics Corporation, Inc. and its wholly-owned subsidiaries (the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation.

 

These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the third quarter of the Company’s fiscal year 2013. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s consolidated financial statements for the year ended June 30, 2012, together with the Report of Independent Registered Public Accounting Firm filed under cover of the Company’s 2012 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

 

Use of Estimates

 

The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Income (Loss) Per Share

 

Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss (adjusted by adding back interest expense on the Company’s 10% Senior Secured Convertible Notes issued on June 25, 2008, if applicable) by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options, warrants and shares issuable upon conversion of the 10% Senior Secured Convertible Notes. For the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013, the effect of such securities was anti-dilutive and not included in the diluted calculation because of the net loss generated in those periods.

 

The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:

 

    Three Months
Ended March 31
    Nine Months
Ended March 31
 
    2013     2012     2013     2012  
                         
Net Income (Loss) – Basic   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,181,427  
Interest Expense on Senior Convertible Notes                       28,958  
Net Income (Loss) – Diluted   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,210,385  
                                 
Basic Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,135,432  
Potentially Dilutive Securities                       108,095  
Diluted Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,243,527  
                                 
Income (Loss) Per Share                                
Basic   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 1.04  
Diluted   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 0.97  

 

The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 3,435,000 and 811,000 for the three months ended March 31, 2013 and 2012, respectively, and approximately 3,435,000 and 620,000 for the nine months ended March 31, 2013 and 2012, respectively.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets.

XML 23 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) (USD $)
Mar. 31, 2013
Jun. 30, 2012
STOCKHOLDERS' EQUITY    
Common Stock par value (in Dollars per share) $ 0.01 $ 0.01
Common Stock shares authorized 50,000,000 50,000,000
Common Stock shares issued 4,455,134 1,251,339
Common Stock shares outstanding 4,455,134 1,251,339
XML 24 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Mar. 31, 2013
Accounting Policies [Abstract]  
Income (Loss) per Share

The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:

 

    Three Months
Ended March 31
    Nine Months
Ended March 31
 
    2013     2012     2013     2012  
                         
Net Income (Loss) – Basic   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,181,427  
Interest Expense on Senior Convertible Notes                       28,958  
Net Income (Loss) – Diluted   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,210,385  
                                 
Basic Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,135,432  
Potentially Dilutive Securities                       108,095  
Diluted Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,243,527  
                                 
Income (Loss) Per Share                                
Basic   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 1.04  
Diluted   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 0.97  
XML 25 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
9 Months Ended
Mar. 31, 2013
Apr. 24, 2013
Document And Entity Information    
Entity Registrant Name PRECISION OPTICS Corp INC  
Entity Central Index Key 0000867840  
Document Type 10-Q  
Document Period End Date Mar. 31, 2013  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   4,455,134
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
XML 26 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. INVENTORIES (Tables)
9 Months Ended
Mar. 31, 2013
Inventory Disclosure [Abstract]  
Inventories

Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:

 

    March 31,
2013
    June 30,
2012
 
Raw Materials   $ 298,244     $ 277,392  
Work-In-Progress     348,588       289,748  
Finished Goods     196,443       115,760  
Total Inventories   $ 843,275     $ 682,900  
XML 27 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Income Statement [Abstract]        
Revenues $ 655,341 $ 382,264 $ 1,717,406 $ 1,380,787
Cost of Goods Sold 496,580 371,941 1,348,834 1,119,850
Gross Profit 158,761 10,323 368,572 260,937
Research and Development Expenses, net 159,472 198,608 533,424 498,842
Selling, General and Administrative Expenses 350,180 309,913 900,060 837,987
Gain on Sale of Assets (897) (7,308) (4,599) (9,457)
Total Operating Expenses 508,755 501,213 1,428,885 1,327,372
Operating Loss (349,994) (490,890) (1,060,313) (1,066,435)
Gain on Sale of Patents          2,276,286
Non-cash Provision for Claims for Liquidated Damages       (629,000)   
Other Income    1 76,149 534
Interest Expense    (1,250) (1,408) (28,958)
Net Income (Loss) $ (349,994) $ (492,139) $ (1,614,572) $ 1,181,427
Income (Loss) Per Share:        
Basic $ (0.08) $ (0.40) $ (0.50) $ 1.04
Diluted $ (0.08) $ (0.40) $ (0.50) $ 0.97
Weighted Average Common Shares Outstanding:        
Basic 4,279,467 1,245,339 3,211,274 1,135,432
Diluted 4,279,467 1,245,339 3,211,274 1,243,527
XML 28 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. SALE OF ASSETS
9 Months Ended
Mar. 31, 2013
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]  
6. SALE OF ASSETS

During the nine months ended March 31, 2013 and 2012, respectively, the Company sold equipment that was previously written off for proceeds totaling $4,599 and $9,457, respectively, and recorded a gain of $4,599 and $9,457, respectively, which is included within operating expenses in the accompanying consolidated statements of operations.

XML 29 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. SALE OF STOCK
9 Months Ended
Mar. 31, 2013
Equity [Abstract]  
5. SALE OF STOCK

On September 28, 2012, the Company closed on agreements with accredited investors (the “Investors”) for the sale and purchase of units consisting of an aggregate of (i) 2,777,795 shares of the Company’s common stock, and (ii) warrants to purchase an aggregate of 1,944,475 shares of common stock, at a per unit price of $0.90. Each unit consisted of one share of common stock and 70% warrant coverage. The warrants have an exercise price of $1.25 per share, subject to adjustment and a call provision if certain market price targets are reached, an expiration date of September 28, 2017, and are exercisable in whole or in part, at any time prior to expiration. Certain directors and officers participated in the offering and purchased a total aggregate amount of approximately $80,000 of units in the offering.

 

The Company received $2.5 million in gross proceeds from the offering. The Company retained Loewen, Ondaatje, McCutcheon USA LTD as the exclusive placement agent for the offering. In addition to the payment of certain cash fees upon closing of the offering, the Company issued a warrant to the placement agent to purchase up to 194,446 shares of common stock on substantially similar terms to the warrants issued in the offering, except that the placement agent warrant has an exercise price of $0.95 per share. The Company anticipates using the net proceeds from the offering to fund start-up costs associated with the previously-announced order for micro endoscopes as well as other recently received orders for new products in addition to working capital needs and for general corporate purposes.

 

In conjunction with the offering, the Company also entered into a registration rights agreement dated September 28, 2012 with the Investors, whereby it was obligated to file a registration statement with the Securities and Exchange Commission (the “SEC”) on or before thirty calendar days after September 28, 2012 to register the resale by the Investors of the 2,777,795 shares of common stock purchased in the offering, and the 1,944,475 shares of common stock underlying the warrants purchased in the offering. The Company filed a registration statement with the SEC on October 26, 2012, prior to the filing deadline. The registration statement became effective on December 14, 2012. The Company is obligated to continue to keep the securities registered and, in the event the Company does not comply with such provision of the registration rights agreement, it may have to pay damages to the Investors.

 

In conjunction with the offering, certain anti-dilution provisions of the warrants issued in conjunction with the Company’s June 25, 2008 financing transaction were triggered. As a result, the number of existing June 25, 2008 warrants increased from 318,621 to 469,831 and the related exercise price of the warrants decreased from $1.74 per share to $1.18 per share. The June 25, 2008 warrants expire on June 25, 2015.

 

Pursuant to the Tax Reform Act of 1986, the utilization of net operating loss carryforwards and other tax benefits are subject to an annual limitation if a cumulative change of ownership of more than 50% occurs over a three-year period. As a result of the September 2012 private placement of the Company’s common stock, the Company believes it may have triggered significant limitations on the utilization of those tax attributes. The limitations, if triggered, would allow the use of the value of approximately $34,000 of Federal carryforward losses annually for the next twenty years, and the same amount for state purposes for 20 years.

 

In December 2012, stock purchase warrants with an exercise price of $1.00 per share for 50,000 shares of the Company’s common stock were exercised, and accordingly, 50,000 shares of restricted common stock were issued.

XML 30 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. INVENTORIES (Details) (USD $)
Mar. 31, 2013
Jun. 30, 2012
Inventory Disclosure [Abstract]    
Raw Materials $ 298,244 $ 277,392
Work-In-Progress 348,588 289,748
Finished Goods 196,443 115,760
Total Inventories $ 843,275 $ 682,900
XML 31 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. 10% SENIOR SECURED CONVERTIBLE NOTES (Tables)
9 Months Ended
Mar. 31, 2013
Debt Disclosure [Abstract]  
10% Senior Secured Convertible Notes

The Notes consisted of the following:

  

    March 31,
2013
    June 30,
2012
 
10% Senior Secured Convertible Notes issued on June 25, 2008, convertible into common stock at $1.25 per share, bearing interest at 10% per annum. Outstanding principal and accrued interest were due at maturity, September 30, 2012   $     $ 50,000  
Accrued interest—10% coupon due on September 30, 2012           1,250  
    $     $ 51,250  
XML 32 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
9. CLAIMS FOR LIQUIDATED DAMAGES
9 Months Ended
Mar. 31, 2013
Claims For Liquidated Damages  
9. CLAIMS FOR LIQUIDATED DAMAGES

Settlement Agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P.

 

On January 17, 2013, the Company received a demand letter from two of its stockholders, Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P. (along with Special Situations Fund III QP, L.P., “Special Situations”). The letter alleged that the Company failed to maintain a current registration statement for the sale of stock purchased by Special Situations pursuant to registration rights agreements entered into with the Company on February 1, 2007 and June 25, 2008, and sought prompt payment of $719,100 as liquidated damages and an amendment to the terms of certain warrants purchased in 2008. A registration statement covering the shares in question is currently effective.

 

On February 12, 2013, the Company entered into a settlement agreement with Special Situations (the “Settlement Agreement”). Without agreeing to the alleged damages, the Company entered into the Settlement Agreement in order to resolve the claim without requiring a cash payment or extended distraction of its resources away from operational activities. Under the terms of the Settlement Agreement, Special Situations agreed to forego their claims for cash damages. In return, the Company agreed to: (a) issue an aggregate of (i) 350,000 shares of common stock, and (ii) warrants to purchase an aggregate of 350,000 shares of common stock (the “Securities”), and (b) amend the expiration date of the warrants issued to Special Situations in conjunction with the Company’s June 25, 2008 private placement (the “2008 Warrants”), as payment in full of the alleged damages sought by Special Situations. The Securities were issued on February 12, 2013. The expiration date of the 2008 Warrants was amended from June 25, 2015 to May 11, 2017. The new warrants issued in connection with the Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration.

 

In conjunction with the Settlement Agreement, the Company also entered into a registration rights agreement dated February 12, 2013 with Special Situations, whereby it is obligated to register the resale by Special Situations of the Securities, consisting of 350,000 shares of common stock and the 350,000 shares of common stock underlying the warrants issued on February 12, 2013. A registration statement covering the Securities was declared effective on April 26, 2013.

 

Letter From one of the Company’s Stockholders

 

On March 21, 2013, the Company received a letter from one of its stockholders demanding either (i) return of its capital investment in the Company and rescission of the purchase agreement entered into by the Company and the stockholder in September 2012, or (ii) compensation for its alleged damages in the amount of $179,316. The stockholder claims that the Company’s settlement agreement with Special Situations Fund III QP, L.P. and Special Situations Private Equity Fund, L.P., disclosed in the Company’s Current Report on Form 8-K filed February 13, 2013, prompted the stockholder’s letter.

 

To the Company’s knowledge, the stockholder has not filed a lawsuit. The Company does not believe that the stockholder’s claims have any merit. In the event the stockholder files a lawsuit, it intends to vigorously defend against any claims.

 

Settlement Agreement with Joel Pitlor

 

On February 12, 2013, the Company entered into a settlement agreement with one of its directors and stockholders, Joel Pitlor (the “Pitlor Settlement Agreement”). Under the terms of the Pitlor Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Pitlor under the registration rights agreement the Company entered into with Mr. Pitlor, and other parties, on February 1, 2007. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Pitlor Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Pitlor Settlement Agreement.

 

By virtue of Mr. Pitlor’s directorship with the Company, he is considered a related party of the Company under federal securities law. The Company’s Board of Directors has acknowledged that Mr. Pitlor’s entry into the Pitlor Settlement Agreement is a related party transaction and has approved such transaction.

 

Settlement Agreement with Arnold Schumsky

 

On February 12, 2013, the Company also entered into a settlement agreement with one of its stockholders, Arnold Schumsky (the “Schumsky Settlement Agreement”). The terms of the Schumsky Settlement Agreement and the accompanying Form of Warrant of the Schumsky Settlement Agreement are substantially similar to the terms of the Pitlor Settlement Agreement and the accompanying Form of Warrant of the Pitlor Settlement Agreement. Under the terms of the Schumsky Settlement Agreement, the Company agreed to issue 10,000 shares of common stock and warrants to purchase 10,000 shares of common stock as payment in full of any amounts due to Mr. Schumsky under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on February 1, 2007 and under the registration rights agreement the Company entered into with Mr. Schumsky, and other parties, on June 25, 2008. The shares and warrants were issued on February 12, 2013. The warrants issued in connection with the Schumsky Settlement Agreement have an exercise price of $1.50 per share, subject to adjustment, expire three years from February 12, 2013, and are exercisable in whole or in part, at any time prior to expiration. There are no registration rights associated with the securities acquired pursuant to the Schumsky Settlement Agreement.

 

The Company has estimated the fair value of the non-cash consideration exchanged for settlement of claims with Special Situations, Mr. Pitlor, and Mr. Schumsky on February 12, 2013 to be a total of $629,000 as of December 31, 2012, and has recorded this amount as a non-cash expense and current liability in its consolidated financial statements as of December 31, 2012, and for the quarter and six months then ended.

 

The Company used the Black-Scholes option-pricing model for determining the estimated fair value of the new warrants to be issued to Special Situations, Mr. Pitlor, and Mr. Schumsky, and for determining the value of the extension of the maturity date of the 2008 Warrants held by Special Situations. The Company valued its issued common stock as of the closing price of the stock at December 31, 2012, which was $0.85 per share.

XML 33 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
7. SALE OF PATENTS
9 Months Ended
Mar. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
7. SALE OF PATENTS

On July 28, 2011, the Company entered into an asset purchase agreement with Intuitive Surgical Operations, Inc. (“Intuitive Surgical”), in which it received gross proceeds of $2,500,000 (less transaction expenses of  $36,829) in connection with the sale of certain intellectual property. Pursuant to the agreement, the Company agreed to assign to Intuitive Surgical all of its currently issued and non-expired patents and pending patent applications, and Intuitive Surgical agreed to grant back to the Company a royalty-free, worldwide license to the patents in all fields outside of medical robotics, except in certain exceptional circumstances.

 

In connection with this agreement, the Company recorded a gain on the sale of such intellectual property of $2,276,286 in the quarter ended September 30, 2011.

XML 34 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. SETTLEMENT OF ACCOUNTS PAYABLE
9 Months Ended
Mar. 31, 2013
Settlement Of Accounts Payable  
8. SETTLEMENT OF ACCOUNTS PAYABLE

In December 2012, the Company settled $106,149 of accounts payable with a vendor for a negotiated payment of $30,000, and recorded a gain of $76,149. The gain is included within other income for the nine months ended March 31, 2013 in the accompanying consolidated statements of operations.  

XML 35 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Mar. 31, 2013
Accounting Policies [Abstract]  
Principles of Consolidation and Operations

The accompanying consolidated financial statements include the accounts of Precision Optics Corporation, Inc. and its wholly-owned subsidiaries (the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation.

 

These consolidated financial statements have been prepared by the Company, without audit, and reflect normal recurring adjustments which, in the opinion of management, are necessary for a fair statement of the results of the third quarter of the Company’s fiscal year 2013. These consolidated financial statements do not include all disclosures associated with annual consolidated financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s consolidated financial statements for the year ended June 30, 2012, together with the Report of Independent Registered Public Accounting Firm filed under cover of the Company’s 2012 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on October 15, 2012 and amended on October 26, 2012 to furnish Exhibit 101 to the Form 10-K, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included thereto.

Use of Estimates

The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Income (Loss) per Share

Basic income (loss) per share is computed by dividing net income or net loss by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing net income or net loss (adjusted by adding back interest expense on the Company’s 10% Senior Secured Convertible Notes issued on June 25, 2008, if applicable) by the weighted average number of shares of common stock outstanding during the period, plus the number of potentially dilutive securities outstanding during the period such as stock options, warrants and shares issuable upon conversion of the 10% Senior Secured Convertible Notes. For the three months ended March 31, 2013 and 2012 and for the nine months ended March 31, 2013, the effect of such securities was anti-dilutive and not included in the diluted calculation because of the net loss generated in those periods.

 

The following is the calculation of income (loss) per share for the three and nine months ended March 31, 2013 and 2012:

 

    Three Months
Ended March 31
    Nine Months
Ended March 31
 
    2013     2012     2013     2012  
                         
Net Income (Loss) – Basic   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,181,427  
Interest Expense on Senior Convertible Notes                       28,958  
Net Income (Loss) – Diluted   $ (349,994 )   $ (492,139 )   $ (1,614,572 )   $ 1,210,385  
                                 
Basic Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,135,432  
Potentially Dilutive Securities                       108,095  
Diluted Weighted Average Shares Outstanding     4,279,467       1,245,339       3,211,274       1,243,527  
                                 
Income (Loss) Per Share                                
Basic   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 1.04  
Diluted   $ (0.08 )   $ (0.40 )   $ (0.50 )   $ 0.97  

 

The number of shares issuable upon the exercise of outstanding stock options and warrants that were excluded from the computation as their effect was antidilutive was approximately 3,435,000 and 811,000 for the three months ended March 31, 2013 and 2012, respectively, and approximately 3,435,000 and 620,000 for the nine months ended March 31, 2013 and 2012, respectively.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

In assessing the likelihood of utilization of existing deferred tax assets, management has considered historical results of operations and the current operating environment. Based on this evaluation, a full valuation reserve has been provided for the deferred tax assets.

XML 36 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Accounting Policies [Abstract]        
Net Income (Loss) - Basic $ (349,994) $ (492,139) $ (1,614,572) $ 1,181,427
Interest Expense on Senior Convertible Notes          28,958
Net Income (Loss) - Diluted $ (349,994) $ (492,139) $ (1,614,572) $ 1,210,385
Basic Weighted Average Shares Outstanding 4,279,467 1,245,339 3,211,274 1,135,432
Potentially Dilutive Securities          108,095
Diluted Weighted Average Shares Outstanding 4,279,467 1,245,339 3,211,274 1,243,527
Income (Loss) Per Share        
Basic $ (0.08) $ (0.40) $ (0.50) $ 1.04
Diluted $ (0.08) $ (0.40) $ (0.50) $ 0.97
XML 37 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. STOCK-BASED COMPENSATION (Details Narrative) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Stock-based compensation costs $ 52,898 $ 34,260 $ 73,913 $ 52,160
Unrecognized compensation costs related to options vesting 167,442   167,442  
Unrecognized compensation costs recognition period 1 year 3 months      
Selling, General and Administrative Expenses
       
Stock-based compensation costs 50,440 33,360 66,539 45,860
Research and Development Expenses
       
Stock-based compensation costs 550 0 1,650 0
Cost of Goods Sold
       
Stock-based compensation costs $ 1,908 $ 900 $ 5,724 $ 6,300
XML 38 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (Loss) $ (1,614,572) $ 1,181,427
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -    
Depreciation and Amortization 15,785 18,225
Gain on Sale of Patents    (2,276,286)
Gain on Sale of Assets (4,599) (9,457)
Gain on Settlement of Accounts Payable (76,149)   
Stock-based Compensation Expense 73,913 52,160
Non-cash Provision for Settlement of Claims for Liquidated Damages 629,000   
Non-cash Interest Expense 1,250 28,958
Changes in Operating Assets and Liabilities -    
Accounts Receivable, net 58,826 29,345
Inventories (160,375) (32,065)
Prepaid Expenses (38,536) (755)
Accounts Payable 37,669 (414,614)
Customer Advances (3,087) (13,673)
Accrued Expenses 23,668 123,466
Net Cash Used In Operating Activities (1,057,207) (1,313,269)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net Proceeds from Sale of Patents    2,463,171
Purchases of Property and Equipment (3,550)   
Additional Patent Costs    (1,724)
Proceeds from Sale of Assets 4,599 9,457
Net Cash Provided By Investing Activities 1,049 2,470,904
CASH FLOWS FROM FINANCING ACTIVITIES:    
Gross Proceeds from September 2012 Private Placement of Common Stock and Warrants 2,500,015   
Private Placement Expenses Incurred and Paid as of March 31, 2013 (308,896)   
Proceeds From Exercise of Warrants to Purchase Common Stock (50,000 Shares) 50,000   
Payment of Principal and Interest on 10% Senior Convertible Notes (52,500) (740,972)
Net Cash Provided by (Used In) Financing Activities 2,188,619 (740,972)
NET INCREASE IN CASH AND CASH EQUIVALENTS 1,132,461 416,663
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 145,923 19,556
CASH AND CASH EQUIVALENTS, END OF PERIOD 1,278,384 436,219
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash Paid for Income Taxes 912 912
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of Common Stock and Warrants for Settlement of Claims for Liquidated Damages (370,000 shares and 370,000 warrants) 629,000   
Issuance of Common Stock to Satisfy Deferred Compensation Obligations (245,326 shares)    $ 674,645
XML 39 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. STOCK-BASED COMPENSATION
9 Months Ended
Mar. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
4. STOCK-BASED COMPENSATION

Stock-based compensation costs recognized during the quarters ended March 31, 2013 and 2012 amounted to $52,898 and $34,260, respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $50,440; 2012 - $33,360), research and development expenses (2013 - $550; 2012 - $0) and cost of goods sold (2013 - $1,908; 2012 - $900). Stock-based compensation costs recognized during the nine month periods ended March 31, 2013 and 2012 amounted to $73,913 and $52,160, respectively, and were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2013 - $66,539; 2012 - $45,860), research and development expenses (2013 - $1,650; 2012 - $0) and cost of goods sold (2013 - $5,724; 2012 - $6,300). No compensation has been capitalized because such amounts would have been immaterial.  No income tax provision was recorded in the third quarter or first nine months of fiscal years 2013 or 2012 because of the losses generated or the availability of loss carryforwards to offset any anticipated taxable income.

 

There were no stock option grants or cancellations during the quarter ended March 31, 2013.

 

As of March 31, 2013, the unrecognized compensation costs related to options vesting of $167,442 will be recognized over a period of approximately 1.25 years.

 

Information related to the stock options outstanding as of March 31, 2013 is as follows:

 

Range of Exercise
Prices
    Number of
Shares
    Weighted-Average
Remaining
Contractual
Life (years)
    Weighted-Average
Exercise Price
    Exercisable
Number
of Shares
    Exercisable
Weighted-Average
Exercise Price
 
$ 1.20       207,800       8.93     $ 1.20       57,800     $ 1.20  
$ 0.85       9,000       9.76       0.85       9,000       0.85  
$ 0.55       51,000       8.87       0.55       20,334       0.55  
$ 0.27       40,000       8.29       0.27       20,000       0.27  
$ 1.35       1,200       6.65       1.35       1,200       1.35  
$ 1.25       1,200       5.66       1.25       1,200       1.25  
$ 6.25       1,600       3.67       6.25       1,600       6.25  
$ 7.75       1,200       4.66       7.75       1,200       7.75  
$ 11.50       800       2.67       11.50       800       11.50  
$ 13.75       50,427       3.11       13.75       50,427       13.75  
$ 20.75       37,360       2.21       20.75       37,360       20.75  
$ 0.27–$20.75       401,587       7.46     $ 4.48       200,921     $ 7.93  

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of March 31, 2013 was $11,200 and $5,600, respectively.

XML 40 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. SALE OF ASSETS (Details Narrative) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]        
Gain on sale of assets $ 897 $ 7,308 $ 4,599 $ 9,457
XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 32 126 1 false 14 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://poci.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://poci.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (UNAUDITED) false false R3.htm 0003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://poci.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) false false R4.htm 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://poci.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) false false R5.htm 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://poci.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) false false R6.htm 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://poci.com/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) false false R7.htm 0007 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://poci.com/role/SummaryOfSignificantAccountingPolicies 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 0008 - Disclosure - 2. INVENTORIES Sheet http://poci.com/role/Inventories 2. INVENTORIES false false R9.htm 0009 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES Notes http://poci.com/role/SeniorSecuredConvertibleNotes 3. 10% SENIOR SECURED CONVERTIBLE NOTES false false R10.htm 0010 - Disclosure - 4. STOCK-BASED COMPENSATION Sheet http://poci.com/role/Stock-BasedCompensation 4. STOCK-BASED COMPENSATION false false R11.htm 0011 - Disclosure - 5. SALE OF STOCK Sheet http://poci.com/role/SaleOfStock 5. SALE OF STOCK false false R12.htm 0012 - Disclosure - 6. SALE OF ASSETS Sheet http://poci.com/role/SaleOfAssets 6. SALE OF ASSETS false false R13.htm 0013 - Disclosure - 7. SALE OF PATENTS Sheet http://poci.com/role/SaleOfPatents 7. SALE OF PATENTS false false R14.htm 0014 - Disclosure - 8. SETTLEMENT OF ACCOUNTS PAYABLE Sheet http://poci.com/role/SettlementOfAccountsPayable 8. SETTLEMENT OF ACCOUNTS PAYABLE false false R15.htm 0015 - Disclosure - 9. CLAIMS FOR LIQUIDATED DAMAGES Sheet http://poci.com/role/ClaimsForLiquidatedDamages 9. CLAIMS FOR LIQUIDATED DAMAGES false false R16.htm 0016 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://poci.com/role/SummaryOfSignificantAccountingPoliciesPolicies 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R17.htm 0017 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://poci.com/role/SummaryOfSignificantAccountingPoliciesTables 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R18.htm 0018 - Disclosure - 2. INVENTORIES (Tables) Sheet http://poci.com/role/InventoriesTables 2. INVENTORIES (Tables) false false R19.htm 0019 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Tables) Notes http://poci.com/role/SeniorSecuredConvertibleNotesTables 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Tables) false false R20.htm 0020 - Disclosure - 4. STOCK-BASED COMPENSATION (Tables) Sheet http://poci.com/role/Stock-BasedCompensationTables 4. STOCK-BASED COMPENSATION (Tables) false false R21.htm 0021 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://poci.com/role/SummaryOfSignificantAccountingPoliciesDetails 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R22.htm 0022 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://poci.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) false false R23.htm 0023 - Disclosure - 2. INVENTORIES (Details) Sheet http://poci.com/role/InventoriesDetails 2. INVENTORIES (Details) false false R24.htm 0024 - Disclosure - 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Details) Notes http://poci.com/role/SeniorSecuredConvertibleNotesDetails 3. 10% SENIOR SECURED CONVERTIBLE NOTES (Details) false false R25.htm 0025 - Disclosure - 4. STOCK-BASED COMPENSATION (Details) Sheet http://poci.com/role/Stock-BasedCompensationDetails 4. STOCK-BASED COMPENSATION (Details) false false R26.htm 0026 - Disclosure - 4. STOCK-BASED COMPENSATION (Details Narrative) Sheet http://poci.com/role/Stock-BasedCompensationDetailsNarrative 4. STOCK-BASED COMPENSATION (Details Narrative) false false R27.htm 0027 - Disclosure - 6. SALE OF ASSETS (Details Narrative) Sheet http://poci.com/role/SaleOfAssetsDetailsNarrative 6. SALE OF ASSETS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: 0003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Process Flow-Through: 0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Process Flow-Through: 0005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Process Flow-Through: 0006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) peye-20130331.xml peye-20130331.xsd peye-20130331_cal.xml peye-20130331_def.xml peye-20130331_lab.xml peye-20130331_pre.xml true true XML 42 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Mar. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Information related to the stock options outstanding

Information related to the stock options outstanding as of March 31, 2013 is as follows:

 

Range of Exercise
Prices
    Number of
Shares
    Weighted-Average
Remaining
Contractual
Life (years)
    Weighted-Average
Exercise Price
    Exercisable
Number
of Shares
    Exercisable
Weighted-Average
Exercise Price
 
$ 1.20       207,800       8.93     $ 1.20       57,800     $ 1.20  
$ 0.85       9,000       9.76       0.85       9,000       0.85  
$ 0.55       51,000       8.87       0.55       20,334       0.55  
$ 0.27       40,000       8.29       0.27       20,000       0.27  
$ 1.35       1,200       6.65       1.35       1,200       1.35  
$ 1.25       1,200       5.66       1.25       1,200       1.25  
$ 6.25       1,600       3.67       6.25       1,600       6.25  
$ 7.75       1,200       4.66       7.75       1,200       7.75  
$ 11.50       800       2.67       11.50       800       11.50  
$ 13.75       50,427       3.11       13.75       50,427       13.75  
$ 20.75       37,360       2.21       20.75       37,360       20.75  
$ 0.27–$20.75       401,587       7.46     $ 4.48       200,921     $ 7.93  

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of March 31, 2013 was $11,200 and $5,600, respectively.